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Chemical biology, the interdisciplinary research field at the interface of chemistry and biology, 
emerged from a common motivation of chemists and biologists to explore the opportunities in 
understanding and manipulation of (large) biological systems using small organic molecules 
and chemical concepts. Instead of using traditional molecular biology techniques such as 
gene fusion or gene knockout technology, the aim of a chemical biologist is to regulate and/or 
track particular biomolecules inside cells with synthetically prepared small molecule probes. 
Small molecules can be delivered at different concentrations and at varying points in time, 
enabling precise modulation of activation and (spatio)temporal control, respectively. However, 
the design of new small probes can be challenging, because they should specifically interact 
with a particular target molecule and sometimes it is even preferred that this interaction 
is reversible. Controlled protein stabilization or degradation upon the addition of a small 
molecule (Banaszynski et al., 2006; Bonger et al., 2011), proteins containing photocaged amino 
acids that can be activated by light (Lemke et al., 2007), or activity-based protein profiling to 
identify mechanistically similar enzymes with active site-directed covalent probes (Cravatt et 
al., 2008; Verdoes and Verhelst, 2015) are just a few examples of chemical biology research. 
Besides proteins, chemical biology also enables new opportunities to modulate and study 
other biomolecules of interest such as lipids, glycans or nucleotides, which cannot directly 
be targeted with classical molecular biology methodology. For example, synthetic sugar 
molecules can be used to visualize or enrich glycan-containing molecules at the surface of 
cells (Laughlin et al., 2008). Synthetic probes that specifically label RNA molecules have been 
used to enrich RNAs from cell lysate (McDonald et al., 2014). Also, small molecule sensors have 
been designed to image differences in ion concentrations or pH inside cells (Zhang et al., 2003). 
As becomes clear from these examples, chemical biology has contributed to great advances 
in many research areas, and as such can be regarded as a new and unconventional approach 
to increase our knowledge of biological systems.
A subcategory of chemical biology, the site-selective modification of biomolecules under 
physiological conditions, has been the focus of the research described in this PhD thesis. 
Chemoselective reactions are described with applications ranging from simpler systems such 
as the modification of biomolecules in vitro to the labeling of biomolecules with exogenous 
probes in cellular systems. For cellular or even in vivo applications, the chemoselectivity of 
the reactions involved should not only be useful for the site-selective labeling of a particluar 
biomolecule of interest but should also extend to broad biocompatibility, i.e. they should not 
interfere with biochemical processes and display no toxicity. Reactions fulfilling these criteria 
are called bioorthogonal, a term coined by Prof. Carolyn Bertozzi at the University of Berkeley, 
who pioneered the field by application of the Staudinger ligation as a bioconjugation method 
to label cellular glycans (Saxon and Bertozzi, 2000). Both molecular partners, an azide and a 
specifically designed triarylphosphine, were shown to display excellent mutual reactivity in 
the presence of diverse natural electrophiles and nucleophiles (now commonly referred to as 
Staudinger- Bertozzi ligation). Shortly after, it was discovered by the same group that another 
long-forgotten chemical reaction, the strain-promoted azide–alkyne cycloaddition (SPAAC) 
(Agard et al., 2004), showed excellent bioorthogonal applicability. It is a variant of the copper-
catalyzed azide–alkyne reaction (CuAAC), which was earlier independently introduced by 
Sharpless and coworkers and the laboratory of Meldal (Rostovtsev et al., 2002; Tornoe et al., 
2002). Instead of utilizing Cu(I) as a catalyst, SPAAC uses ring strain to accelerate the reaction 
of the azide with an alkyne. The introduction of these two reactions, but SPAAC in particular, 
has inspired many researchers to search for bioorthogonal reactions with improved rates 
and selectivities. Further expansion of the bioorthogonal toolbox is important, since every 
single reaction comes with strengths and weaknesses. Most likely, there will be no such thing 
as a universally applicable reaction, therefore a repertoire of reactions to choose from with 
differences in reactivity, stability and solubility of reaction partners, is required.
At the start of this PhD project, bioorthogonal chemistry had begun to move more and more 
towards application for studying the behavior of biomolecules in living systems. Research 
questions that had already been addressed by bioorthogonal reactions were of wide diversity: 
i) discrimination between host cell and bacterial proteins to get more insight into bacterial 
infections, ii) improval of diagnostic tools and therapeutics for the detection and treatment of 
cancer, iii) changes in cellular glycan patterns during development and/or pathogenesis. 
This thesis describes the development of chemoselective methodologies for application in life 
sciences. In Chapter 1, an overview is given about the exciting developments and applications 
of bioorthogonal chemistry in living organisms. This chapter will emphasize the great potential 
of bioorthogonal  chemistry as a tool to understand biology, including some of its important 
contributions to different research areas in the life sciences. 
Chapter 2 describes the site-selective incorporation of a new unnatural amino acid featuring 
a bicyclononyne moiety that can be used for chemoselective protein conjugation. We report 
protein functionalization in vitro and inside cells via two different bioorthogonal reactions and 
also characterize their reaction rates. 
The power of the majority of chemoselective reactions lies in the fact they proceed 
spontaneously, i.e. highly exothermically and with a low activation barrier. Activation might be 
useful in some instances, however, for example when two or more chemoselective reactions 
are used in concert. In particular the use of light as an initiator has successfully been explored 
for protein conjugation in the past. In Chapter 3, we describe an alternative activation strategy 
based on the fast and selective oxidation of a catechol to a 1,2-quinone. The subsequent 
reaction of the 1,2-quinone with cyclooctyne was found to proceed with excellent reaction rate, 
in an overall process dubbed ‘strain-promoted oxidation-controlled cyclooctyne–1,2-quinone 
cycloaddition’ (SPOCQ). While in Chapter 3 we show the utility of SPOCQ for bioconjugation, 
in Chapter 4, a different application of SPOCQ is described in the formation of hydrogels. 
Hydrogels could be formed chemically as well as enzymatically. Gelation was found to occur 
extremely rapidly, while an additional level of control was achieved by incorporation of azido-
containing compounds into the gel during gel formation.
The final two chapters of this thesis focus on the application of bioorthogonal reactions in living 
systems. In Chapter 5, SPAAC is used to selectively modify the bacterial cell surface with the 
Fc fragment, the constant region of an antibody as part of a broader strategy to develop an 
efficient whole-cell based bacterial vaccine based on the known interaction of the Fc fragment 
receptors that are expressed on mucosal surfaces and immune effector cells. To this end, an 
Fc domain obtained from a mammalian expression system was site-selectively functionalized 
12 13
with an azadibenzocyclooctyne group based on thiol-maleimide chemistry, while the bacterial 
cell wall was modified with the complementary azide moiety by metabolic engineering. 
Reactivity of both bioorthogonal functional groups was demonstrated separately in model 
reactions, however, the anticipated SPAAC-mediated conjugation of Fc to bacteria proved 
less straightforward. Chapter 6 deals with the development of a new purification strategy for 
quantitative mass spectrometry-based proteomics, which makes use of SPAAC to enrich one 
specific protein and its interactors from cell lysate. In contrast to protein or peptide tags, the 
azide can be site-specifically introduced at many positions inside a protein of interest, and 
can then function as a minimal tag for the enrichment by CuAAC or SPAAC. We were able 
to incorporate the azide moiety into the nuclear protein methyl-CpG binding domain protein 3 
(MDB3). Furthermore, azido-functionalized MBD3 and two of its known interactors could be 
successfully enriched from whole cell lysates using SPAAC.
15
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Introduction
In recent years our understanding of biological processes has been greatly extended by the 
behavioral study of biomolecules in their natural environment. To facilitate this research it 
is necessary to have access to highly selective labeling protocols that enable tracking of a 
specific biomolecule inside cells or organisms. The current most commonly used strategy 
applies to proteins and entails the genetic fusion with fluorescent proteins. However, such 
modifications can interfere with the structure as well as the function of the protein of interest 
due to the size of the added tag. Furthermore, glycans and lipids cannot be studied with such 
standard molecular biology techniques, because their biochemical synthesis is not controlled 
by direct genetic encoding. Over the past two decades, scientists have therefore begun to 
search for new chemistry-based methodologies to covalently modify biomolecules in vivo. 
Classical bioconjugations include the use of thiol-maleimide chemistry or the formation of 
amide bonds by acylation of amines with activated esters. Despite their utility, they are limited 
to in vitro manipulations with low levels of complexity and by far lack the selectivity to probe 
a particular biomolecule of interest within its native cellular environment. Chemical reactions 
that are suitable to label biomolecules in their native context have to meet the criteria of 
bioorthogonality: i) no interference or cross-reactivity with naturally occurring functionalities 
should occur, ii) reactivity under mild, physiological conditions, and iii) lack toxicity (Sletten 
and Bertozzi, 2011). Furthermore, to covalently label the biomolecule of interest in its natural 
environment one of the reaction partners has to be introduced into the biomolecule and 
should only minimally, if at all, perturb its biological function. In most cases, this reaction 
partner is a non-natural functionality, which thus requires specialized techniques for its 
introduction in biomolecules. The accrued interest in bioorthogonal chemistry has led to the 
development of exciting methodologies that introduce various bioorthogonal reactive groups 
into biomolecules in living systems. Among these, three techniques in particular enabled 
bioorthogonal chemistry inside living organisms. The first technique relies on a pretargeting 
approach involving ex vivo incorporation of the reaction partners in both the biomolecule of 
interest and a molecular probe, after which both components are individually introduced into 
the organism to undergo the in vivo biorthogonal reaction (Rossin et al., 2010). Although this 
methodology does not involve the chemical modification of the organism’s own biomolecules, 
its success fully depends on chemical conjugation techniques that are highly selective and 
efficient in a biological context. The second method introduces one of the reaction partners by 
simply hijacking the metabolic machinery of the cell or organism (Laughlin and Bertozzi, 2007). 
The third and final technique uses unnatural amino acids to install bioorthogonal, reactive 
groups into proteins (Johnson et al., 2010; Davis and Chin, 2012). 
Pharmacokinetic parameters such as stability, biodistribution and bioavailability of the reactive 
probes influence the success of both bioorthogonal reactions in multicellular organisms as 
well as their potential clinical application. For example, when using bioorthogonal chemistry 
for imaging or therapy purposes, low concentrations of the imaging probe or therapeutic, 
respectively, have to be sufficient to label low-abundant targets within the organism. Penetration 
of the probe into deeper tissue layers may be required to reach the target. Furthermore, fast 
distribution through and clearance from the body is essential to increase the imaging contrast 
Abstract
Bioorthogonal chemistry allows for selective and efficient modification of biomolecules in their 
natural environment. Several strategies have been developed over the past years that employ 
cellular biosynthetic pathways to incorporate the desired functionalities. These moieties in 
turn efficiently react with exogenously added complementary reaction partners. This field has 
now moved forward from a conceptual phase to the application of these methodologies in 
living systems. In this chapter, we highlight recent and exciting developments pertaining to the 
use of bioorthogonal chemistry in living organisms.
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or lower the exposure of the therapeutic to non-targets. This also implies that the reaction 
between probe and target needs to be fast, because of the narrow time window between 
administering of the probe and its clearance. It is also important to consider that additional 
washing steps, which can be performed to remove excess of unreacted probe in cell culture 
systems, are of course not feasible within a multicellular organism.
In this chapter, we will first briefly describe the main types of bioorthogonal reactions that have 
been developed to date and which are depicted in scheme 1. For detailed information about 
their underlying chemistry, we refer to excellent reviews in this field (Jewett and Bertozzi, 2010; 
Devaraj and Weissleder, 2011; Sletten and Bertozzi, 2011; van Berkel and van Delft, 2013). We will 
then focus on the abovementioned three main techniques that have been used to introduce 
bioorthogonal moieties into biomolecules in living organisms, and will highlight their potential 
applications.
Bioorthogonal reactions
One of the most commonly used bioorthogonal groups is the azide (Debets et al., 2010b). It is 
small in size, absent from biological systems and inert to naturally occurring functionalities. The 
azide was first used in the context of bioconjugation with the development of the Staudinger 
ligation. In this reaction, the azide moiety reacts with a designed triarylphosphine derivative 
to form a stable amide bond. (Scheme 1, reaction 1) (Saxon and Bertozzi, 2000). Although this 
reaction is highly selective even in complex biological environments, the rate of this reaction 
is rather slow (typical second-order rate constant of 0.0020 M–1s–1) and scientists have 
therefore continued searching for alternative reactions with improved reaction kinetics. This 
led to the discovery of the strain-promoted azide–alkyne cycloaddition (SPAAC), which also 
uses the azide as one of the reaction partners. SPAAC is a variant of the copper(I)-catalyzed 
Huisgen azide–alkyne cycloaddition (CuAAC, often referred to as ‘click-chemistry’, depicted 
in Scheme 1, reaction 2), but does not require cytotoxic copper that is used in CuAAC as the 
catalyst (Rostovtsev et al., 2002; Tornoe et al., 2002; Agard et al., 2004). In SPAAC, a ring strain 
instead is used to activate the alkyne, which then spontaneously reacts with azides leading 
to the formation of a triazole (Scheme 1, entry 3). Over the years, the strained cyclooctynes 
have gone through a range of modifications to improve reaction rates (with reaction kinetics 
up to two orders of magnitude higher than that of the Staudinger ligation) and to reduce 
their hydrophobicity (Debets et al., 2011). In 2008, a new bioorthogonal reaction, based on 
the inverse electron-demand (4+2) cycloaddition of 1,2,4,5-tetrazines with strained alkenes 
was introduced by the groups of Fox and Hilderbrand. They reported that 1,2,4,5-tetrazines 
spontaneously and selectively react in aqueous media with trans-cyclooctene (TCO) or 
norbornene (Scheme 1, reactions 4 and 5, respectively). Both bioorthogonal reactions show 
extremely high reaction rates (with second-order rate constants of 1.9 M−1s−1 in aqueous buffer 
for norbornene, and 2000 M−1s−1 in 9:1 methanol/water for TCO). TCO is the quickest reactant, 
but it is also the least stable and poses a greater synthetic challenge (Blackman et al., 2008; 
Devaraj et al., 2008). The rate of this bioorthogonal reaction can be further tuned by substituents 
at the 3 and 6 position (R2 and R3, Scheme 1, entry 4 and 5) of the tetrazine, albeit affecting its 
solubility and stability in aqueous media, key factors to consider in biological studies (Karver et 
al., 2011). Some cyclooctyne derivatives have also been recently shown to react with tetrazines 
(Borrmann et al., 2012; Lang et al., 2012b). 
All of these bioorthogonal reactions have been successfully applied in the context of biological 
systems (Devaraj and Weissleder, 2011; Sletten and Bertozzi, 2011). Careful considerations must be 
taken when choosing a bioorthogonal system as each bioorthogonal reaction presents unique 
advantages as well as limitations. The choice for a certain reaction type can therefore vary per 
application, and is affected by parameters such as reaction rate, hydrophilicity of the reaction 
partners, their ease of introduction and synthetic accessibility.
Bioorthogonal Reactions in Tumor Pretargeting
Antibodies that are directly conjugated to radionuclides have been traditionally used in imaging 
and treatment of tumors (Goldenberg et al., 2006). Although these antibodies are highly selective 
for antigens that are expressed on the cell surface of tumor cells, they show slow clearance 
from the body due to their relatively large size and reshuttling into circulation after endocytosis 
by means of binding to the FcRn receptor. In the alternative approach involving tumor 
pretargeting the antibody delivery is separated from the delivery of the radionuclide (Figure 
1A): the antibody is first administered and allowed to locate to the tumor. In the second step, 
the small radionuclide is administered and can bind to the tumor-bound antibody. In contrast 
to radiolabeled antibodies, small radionuclides are rapidly cleared from the body, which results 
in better imaging contrast and reduced exposure to ionizing radiation in non-target tissues. 
Scheme 1: Bioorthogonal reactions described in this chapter. 1) Staudinger ligation, 2) copper(I)-
catalyzed azide–alkyne cycloaddition, 3) strain-promoted azide–alkyne cycloaddition, 4) and 5) strain-
promoted inverse electron-demand (4+2) cycloaddition.
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Streptavidin-tagged antibodies combined with radiolabeled biotin have been used for tumor 
pretargeting purposes. However, this system suffers from potential streptavidin immunogenicity, 
which is another important factor one encounters when transferring technologies from in vitro 
cell culture to more complex organisms. Another pretargeting approach involves bispecific 
antibodies that first bind to the tumor and subsequently to the radionuclide-carrier. One 
disadvantage of this method is the need to genetically re-engineer the antibody (Goldenberg et 
al., 2006). Given the disadvantages summarized above, it goes without saying that scientists 
have recently recognized the potential of bioorthogonal chemistry for tumor pretargeting. 
Indeed, Rossin et al. were the first to apply the technique in living animals by using the inverse 
electron-demand Diels–Alder cycloaddition reaction between a TCO-conjugated antibody and 
a [111In]-radiolabeled tetrazine probe (Rossin et al., 2010). Single-photon emission computed 
tomography (SPECT) revealed the specific labeling of the tumor in mice with a good tumor-
to-muscle ratio (13.1:1) three hours after injection of the radiolabeled compound. Further 
tumor pretargeting studies by Devaraj et al. and Zeglis et al. highlighted the value of this 
bioorthogonal reaction for imaging and drug delivery purposes (Devaraj et al., 2012; Zeglis et 
al., 2013). As the bioorthogonal handles are conjugated to the antibody and radionuclide in 
vitro, there is no intrinsic limitation to the type of reactive group that can be installed, and all 
of the reactions mentioned in Scheme 1 therefore are feasible for application in a pretargeting 
approach. It is, however, clear that a pretargeting approach can only be successful if the 
bioorthogonal reaction applied is robust and exhibits fast reaction rates. This issue was well 
exemplified in a comparative study by Van den Bosch et al. who tested the ability of the strain-
promoted alkyne–azide cycloaddition for in vivo pretargeting using the azido-functionalized 
monoclonal antibody rituximab (van den Bosch et al., 2013). They synthesized three different 
[177Lu]-radiolabeled probes, bearing either difluorinated cyclooctynes or a dibenzocyclooctyne 
moiety. Blood retention times of these probes in nude mice were used to assess reactivity. 
Low reaction rates and interaction with serum proteins severely decreased the efficiency of 
the SPAAC reaction in vivo. Conjugating the cyclooctyne moiety to the antibody could serve 
as a potential solution to the problem as the bulkiness of the antibody itself could reduce 
unspecific interactions with serum proteins. Furthermore, reactions rates could be improved 
by using cyclooctynes that display enhanced reactivity, such as dibenzoazacyclooctyne and 
biarylazacyclooctynone (Debets et al., 2010a; Jewett et al., 2010). This was demonstrated by 
Lee et al. who recently utilized the SPAAC reaction with dibenzoazacyclooctyne in tumor 
pretargeting experiments in mice and observed a significantly higher tumor uptake within two 
hours after injection compared to the control group (Lee et al., 2013). Despite some technical 
variations these results are in line with the findings published by Rossin et al., who used 
the reaction between TCO and tetrazine for pretargeting studies (Rossin et al., 2010; Lee et 
al., 2013). More studies are needed to explore the full potential of the SPAAC reaction with 
different cyclooctyne variants for in vivo pretargeting applications. In spite of that, the reaction 
of TCO with 1,2,4,5-tetrazines remains the fastest bioorthogonal reaction to date and is highly 
specific in complex biological systems (Rossin et al., 2013a). The stability of TCO, which can 
isomerize to its unreactive cis form, has also been addressed to further improve this reaction 
for in vivo applications (Rossin et al., 2013b). In light of these studies, it has become clear that 
this pretargeting method can form a viable alternative to traditional approaches and has the 
potential to emerge as the treatment of choice in future clinical settings.
Cellular uptake
of chemical reporter
Incorporation of chemical reporter into 
glycan structure
PROBE
Conjugation to exogenous  probe
Tumor cell
1. Injection of Ab followed by 
accumulation at side of tumor
2. Injection of radiolabeled compound 
followed by binding to Ab  
Tumor cell
(slow clearance
from body)
(fast clearance
from body)
Tumor cell(slow clearance
from body)
Traditional approach
Tumor pretargeting approach
Metabolic Oligosaccharide Engineering
A
B
Figure 1: (A) Two-step protocol of tumor pretargeting in comparison to the traditional approach, which 
is the direct injection of the radionuclide-labeled antibody (Ab) into the organism. (B) The principle of 
metabolic oligosaccharide engineering: an unnatural monosaccharide bearing a reactive handle is first 
incorporated into glycan structures and then functionalized with an exogenous probe. 
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Probing Non-Proteogenic Targets using Metabolic Engineering and 
Bioorthogonal Chemistry
Glycans
Glycans are an important class of carbohydrates which play vital roles in protein stability 
and folding and numerous developmental processes (for a comprehensive review see 
(Haltiwanger and Lowe, 2004)), which are covalently linked to proteins or lipids inside cells as 
well as on cell surfaces. In fact, aberrant glycosylation patterns can serve as a biomarker 
in a number of diseases (Dube and Bertozzi, 2005). In contrast to proteins, glycans are not 
genetically encoded. Standard molecular biology tools commonly used to study proteins or 
nucleic acids are therefore not applicable. Antibodies and other carbohydrate-binding proteins 
(lectins) have been used to visualize and enrich glycoconjugates. However, these methods 
suffer from tissue impermeability, which limits their use in in vivo systems. In the laboratory 
of Bertozzi a new, two-step chemical reporter strategy was developed to label glycans using 
metabolic oligosaccharide engineering (MOE) and bioorthogonal chemistry. It was shown that 
a chemically reactive group can be metabolically incorporated into cellular glycans by feeding 
cells with an unnatural monosaccharide substrate. The reactive group, or chemical reporter, 
has to be small enough to be adopted by the metabolic machinery of a cell, and inert towards 
naturally occurring functionalities. Again, the azide group has proven to be an ideal chemical 
reporter due to its small size, inertness and absence from natural systems. The azide, once 
incorporated into glycans, can be conjugated to an appropriately functionalized, exogenous 
probe using Staudinger ligation or SPAAC for imaging or affinity purification (Figure 1B) 
(Saxon and Bertozzi, 2000; Laughlin and Bertozzi, 2007, 2009b). Glycans following the sialic acid 
biosynthesis pathway were the first to be probed using MOE (Saxon and Bertozzi, 2000). This 
metabolic pathway has proven to be amenable to analogues that carry modifications at the 
N-acetyl position (C5) or the C9 position of sialic acid (Figure 2). The installation of a chemical 
reporter in sialic acids can be achieved by directly feeding the sialic acid analogue or by 
providing an analogue of the natural the precursor for the sialic acid biosynthesis, N-acetyl-
d-mannosamine (ManNAc, Figure 2). ManNAc analogues are easily synthesized and are 
therefore the preferred choice for engineering sialic acids.
The chemical reporter strategy has proven to be an extremely powerful method for the in vivo 
imaging of membrane-bound and intracellular glycans in developing organisms, something 
that cannot be achieved with fluorescently labeled antibodies or carbohydrate-binding proteins 
(Laughlin et al., 2008). For example, zebrafish embryos have been successfully labeled using 
the unnatural peracetylated monosaccharide, N-azidoacetyl-galactosamine (Ac4GalNAz, 
Figure 2). Embryos were treated with Ac4GalNAz 3–72 hours post fertilization (hpf) and 
subsequently conjugated to a fluorescent probe using SPAAC. This enabled visualization of 
regions with active sugar metabolism throughout the embryo. Spatio-temporal resolution of 
these regions could be achieved by an elegant two- and three-step labeling protocol utilizing 
different difluorinated cyclooctyne-bearing (DIFO) Alexa probes, thus allowing for differential 
labeling of old and newly synthesized GalNAz-bearing glycans throughout development 
(Figure 3A). In early post-fertilization, visualization of glycans was also made possible 
by directly microinjecting GalNAz into the yolk sac of the embryo (Baskin et al., 2010). To 
simultaneously image mucin-type O-linked glycans and sialylated glycans in these embryos, 
the peracetylated monosaccharide analogue N-azidoacetyl-mannosamine (Ac4ManNAz, 
Figure 2) was also microinjected into the embryo. However, the relatively high concentrations 
of the monosaccharide analogue required led to developmental defects. Dehnert et al. later 
achieved the visualization of sialic acid as early as 8.5 hpf through direct microinjection of 
azido sialic acid (SiaNAz) into the yolk, averting developmental abnormalities (Dehnert et al., 
2012). The chemical reporter strategy has also been applied to study fucosylated glycans in 
zebrafish, another common posttranslational modification key to development (Dehnert et al., 
2011). The potential of the chemical reporter strategy was even further illustrated by probing 
glycans in the invertebrate roundworm Caenorhabditis elegans (C. elegans), a valuable and 
well-studied model organism used for its easy maintenance and transparency (Laughlin and 
Bertozzi, 2009a). The DIFO-conjugates used in this study mainly labeled GalNAz-containing 
glycans of C. elegans in regions that were accessible to the solution such as pharynx, vulva, 
male tail and anus. The development of new fluorescent probes that can readily penetrate 
into the worm will offer further insight into glycosylation patterns within this model organism.
Besides azides, monosaccharides bearing terminal alkynes have also been used as chemical 
reporters in MOE. An acetylene group is also small in size and does not disturb the cellular 
glycan biosynthesis machinery. The application of terminal alkynes in living organisms was 
initially hindered by the cytotoxicity of the copper catalyst that was needed for conjugation 
to azido-functionalized probes. To circumvent toxicity issues, Wu and coworkers succeeded 
in the preparation of a new, biocompatible copper catalyst that can be used for in vivo 
imaging by applying stronger binding ligands, which prevented copper from complexing with 
biomolecules. They and others demonstrated the in vivo imaging of fucose biosynthesis 
during early zebrafish development at non-toxic concentrations (del Amo et al., 2010; Zheng et 
al., 2011). With this new catalyst formulation, fluorescent signal can be obtained within minutes, 
whereas copper-free labeling with one of the fastest cyclooctyne variants available showed 
only weak labeling of azido-bearing fucose residues in zebrafish (Figure 3B) (Besanceney-
Webler et al., 2011). The laboratory of Ting used a different approach to develop a biocompatible 
version of the CuAAC reaction, by applying copper-chelating azides to label cell-surface 
Figure 2: Structures of sialic acid, ManNAc and unnatural monosaccharides.
O
CO2
OH
HO
AcHN
OH
HO
HO
O
HN
O
N3
AcO
AcO
AcO
OAc
O
1
2
3
9
8
4
6
5
7
AcO
AcO
OAc
HN
O
N3
OAc
O
AcO OAc
OAc
OAc
N3
O
OH
CO2HO
N3
HO
HO O
AcO
OAc
HN
O
N3
OAcAcO
O
NHAc
HO
HO
HO
OH
Sialic acid ManNAc Ac4ManNAz Ac4FucNAz
Ac4GlcNAzAc4GalNAz 8-deoxy-8-azido-KDO
1 1
24 Chapter 1 Introduction 25
proteins on mammalian cells (Uttamapinant et al., 2012). The potential of biocompatible CuAAC 
in more complex organisms such as mice remains to be demonstrated, as both the catalyst 
and the exogenous probe have to reach the target for the reaction to occur. Recently, two 
other promising chemical reporters, a terminal alkene and methylcyclopropene, have been 
introduced into glycans. These studies have added the inverse-electron demand Diels–Alder 
reaction as a new possibility to MOE, but have only been applied in cultured systems so far 
(Cole et al., 2013; Niederwieser et al., 2013). Both reactive groups show lower reaction rates than 
TCO, but are comparable with other bioorthogonal reactions such as the Staudinger ligation 
or SPAAC with a dibenzocyclooctyne (Cole et al., 2013; Niederwieser et al., 2013). 
Two types of bioorthogonal reactions have been used to study polysaccharides in higher 
eukaryotes such as mice. Both the Staudinger ligation and the SPAAC reaction were 
utilized for MOE. In a study by Bertozzi and coworkers mice were administered with 
Ac4ManNAz intraperitoneally for seven days at a concentration of 300 mg/kg, followed by 
in vivo functionalization with a phosphine-conjugated FLAG peptide. Ex vivo analysis with a 
fluorescently labeled anti-FLAG antibody showed a significant increase in fluorescence on 
splenocytes from Ac4ManNAz-treated mice compared to vehicle-treated mice (Prescher et al., 
2004). The same strategy was also used to probe sugars containing N-acetyl-d-galactosamine 
in mice, by using GalNAz as the unnatural monosaccharide analogue (Dube et al., 2006). The 
Staudinger ligation does not appear to be the ideal in vivo reaction as phosphine probes 
suffer from air oxidation, and its reaction rate is much lower than that of SPAAC with one of 
the recently developed cyclooctyne variants. However, Chang and coworkers found some 
remarkable results when they directly compared the efficiency of the SPAAC reaction to that 
of the Staudinger ligation for the probing of azido-bearing glycans in living mice. Different 
FLAG-conjugated cyclooctyne variants were tested for their ability to label ManNAz-bearing 
glycans. Dimethoxyazacyclooctyne (DIMAC) and DIFO displayed the best labeling amongst 
the tested cylcooctyne variants, but were less efficient than the phosphine probe. Although 
the Staudinger ligation is slower, it gave better in vivo labeling. Further analysis revealed 
that the DIFO-probe also bound to mouse serum albumin (MSA) in an azide-independent 
manner. The hydrophobic nature of many cyclooctyne probes could promote non-covalent 
interactions with other proteins, thereby inducing the aspecific reaction. Furthermore, it is 
known that some cyclooctynes can react with thiols (van Geel et al., 2012). Non-covalent binding 
to MSA and subsequent reaction with the thiol of MSA decrease the bioavailability of DIFO 
and may explain the lower SPAAC-mediated labeling efficiency of azido-treated glycans in 
mice. DIMAC is less hydrophobic than DIFO and indeed showed less MSA labeling, but its 
use in in vivo systems is hampered by its low reaction rate. Although other studies described 
the usage of the Staudinger ligation or SPAAC in mice, optimization is still needed (Baskin et 
al., 2007; Chang et al., 2010; Neves et al., 2011; Koo et al., 2012; Neves et al., 2013). Future research 
could, for example, focus on changing the hydrophilic nature of cyclooctynes without losing 
reactivity, something that the laboratory of Boons has been working on recently (Friscourt 
et al., 2012). It would be interesting to test these probes in a living organism as it may be 
that these cyclooctyne variants show decreased MSA binding and thereby increased azido-
specific labeling in more complex environments. Such probes could help broaden future use 
of SPAAC in living organisms. 
MOE has proven useful in the study of glycosylation patterns in multicellular organisms and 
has also been applied to the investigation of the glycan structures in bacteria. This is important 
as it can help to gain fundamental insights into bacterial virulence as well as bacteria-host 
interactions. The peptidoglycan (PG) cell wall of bacteria has gained significant interest as 
a potential target for the treatment of bacterial infections. PG is composed of amino acids 
and sugars, which together form a mesh-like layer surrounding the plasma membrane of 
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Figure 3: (A) Labeling of newly synthesized glycans during zebrafish development. Embryos were 
treated with Ac4GalNAz from 3–61 hpf and reacted with DIFO-647, followed by reaction with DIFO-488 
(61–62 hpf). This double labeling approach allows for spatio-temporal resolution of glycan synthesis. 
The asterisk-labeled section is magnified and shows labeling of ‘old’ and ‘newly’ synthesized glycans 
in the mouth region (Laughlin et al., 2008). Adapted with permission from S.T. Laughlin, J.M. Baskin, 
S.L. Amacher and C.R. Bertozzi, Science, 2008, 320, 664-667. Copyright (2008) American Association 
for the Advancement of Science. (B) Zebrafish embryos were injected with Ac4GalNAz at the single cell 
stage. 24 hpf the embryos were fluorescently labeled for 5 min using CuAAC reaction or SPAAC with 
biarylazacyclooctynone (BARAC). A strong fluorescent signal could be detected when embryos were 
treated with the biocompatible CuAAC, whereas labeling using SPAAC resulted only in a weak fluorescent 
signal (Besanceney-Webler et al., 2011). Adapted with permission from C. Besanceney-Webler, H. Jiang, 
T. Zheng, L. Feng, D. Soriano del Amo, W. Wang, L.M. Klivansky, F.L. Marlow, Y. Liu and P. Wu, Angew. 
Chem., 2011, 50, 8051-8056. Copyright (2011) WILEY-VCH Verlag GmbH&Co.
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bacteria, albeit with differences in composition and thickness between gram-positive and 
gram-negative bacteria. The Nishimura group showed early examples of bacterial cell 
wall engineering using the chemical reporter strategy. They synthesized ketone-bearing 
derivatives of the cell wall precursor UDP-N-acetylmuramic acid (UDP-MurNAc) pentapeptide 
and subsequently demonstrated their incorporation into the cell wall of gram-positive bacteria 
by labeling with a hydrazide-functionalized Alexa probe (Sadamoto et al., 2002; Sadamoto et 
al., 2004). Gram-negative bacteria could also be labeled, but only after solubilization of their 
outer protective lipopolysaccharide (LPS) layer (Sadamoto et al., 2002). The ketone group is 
not an ideal candidate for the specific labeling of biomolecules inside living systems, since 
it can also be found in intracellular metabolites. Not surprisingly, later studies on metabolic 
engineering in bacteria used the azide or alkyne as the reactive handle for functionalization 
with exogenous probes. Instead of synthesizing the whole UDP-MurNAc pentapeptide, Kuru 
et al. and Siegrist et al. used a less cumbersome approach for the labeling of the bacterial cell 
by preparing azido- and alkyne-bearing d-amino acids. d-amino acids are components of the 
UDP-MurNAc pentapeptide and both studies showed that analogues of this building block are 
effectively metabolized and therefore sufficient to label the cell wall of many phylogenetically 
different bacteria. Even gram-negative bacteria could be labeled without prior solubilization of 
the LPS layer. The incorporation of d-amino acid analogues provides an extremely valuable 
tool in the investigation of PG dynamics for a variety of bacterial species (Figure 4A) (Kuru et 
al., 2012). The selectivity of d-amino acid analogues for bacteria was nicely demonstrated by 
Siegrist et al. in a study aimed to label Listeria monocytogenes during macrophage infection 
(Siegrist et al., 2013). The incorporation of alkynes and azides into the bacterial cell wall allows 
for subsequent conjugations to various exogenous probes. Besides fluorescent probes, 
therapeutic or diagnostic probes could also be selectively attached to the bacteria using this 
approach. It is important to note that the universal applicability of this method may become an 
obstacle for therapeutic purposes. For example, non-pathogenic bacteria that belong to the 
normal gut flora may also be affected. This problem is shared with some current antibiotics 
such as the β-lactams, which still have proven to be effective in curing bacterial infections. 
Metabolic engineering approaches may however provide a promising alternative in the 
treatment of bacterial infections given the ever-increasing number of drug-resistant bacteria. 
More selective ways for the labeling of certain types of bacteria have indeed been recently 
developed. The LPS layer is only present in gram-negative bacteria and provides a first level 
of selectivity (Liu et al., 2009; Dumont et al., 2012; Kaewsapsak et al., 2013). The group of Vauzeilles 
prepared an azido-containing analogue of the LPS component 3-deoxy-d-mannooctulosonic 
acid (KDO, Figure 2), which was recognized by the metabolic machinery of several gram-
negative bacteria (Dumont et al., 2012). In addition, Kaewsapsak et al. presented a novel 
MOE-based strategy to treat infections with the gram-negative bacteria Helicobacter pylori 
(H. pylori). Azido-containing peracetylated N-azidoacetylglucosamine (Ac4GlcNAz, Figure 2) 
was incorporated into the LPS of H. pylori followed by conjugation to phosphine-modified 
2,4-dinitrophenyl, an immune stimulant that induces antibody-triggered cell killing. Indeed, 
DNP-covered H. pylori were shown to undergo enhanced cell killing in an in vitro cell viability 
assay, which proves the concept of activating the host’s immune system by means of MOE 
Figure 4: (A) On the left: representation of the PG structure of Listeria monocytogenes (mDAP = meso-
diaminopimelic acid, d-/l-Ala = d-/l-alanine, d-Glu = d-glutamate). On the right: Listeria monocytogenes 
and Myobacterium tuberculosis were first grown in media containing alkyne-bearing d-amino acid, 
followed by labeling with an azido-functionalized fluorescent dye using CuAAC (Siegrist et al., 2013). 
Adapted with permission from M.S. Siegrist, S. Whiteside, J.C. Jewett, A. Aditham, F. Cava and C.R. 
Bertozzi, ACS Chem. Biol., 2013, 8, 500-505. Copyright (2013) American Chemical Society. (B) Illustration 
of the PG engineering strategy using the enzyme sortase A (SrtA), which specifically recognizes and 
incorporates LPETG-bearing proteins and peptides. Administration of an azide-labeled H-LPETG-NH2 
peptide followed by conjugation to Alexa 488 results in specific labeling of PG in Staphylococcus aureus 
(Nelson et al., 2010). Adapted with permission from J.W. Nelson, A.G. Chamessian, P.J. McEnaney, 
R.P. Murelli, B.I. Kazmiercak and D.A. Spiegel, ACS Chem. Biol., 2010, 5, 1147-1155. Copyright (2010) 
American Chemical Society.
and bioorthogonal chemistry (Kaewsapsak et al., 2013). To solely label the surface of gram-
positive bacteria, Spiegel and coworkers utilized the enzyme sortase A, which plays an 
important role in the cell wall synthesis of gram-positive bacteria and is only expressed in this 
type of bacteria. By employing peptides that contained the LPXTG recognition sequence of 
the sortase A enzyme, they were able to engineer the cell wall of Staphylococcus aureus with 
azide-bearing moieties (Figure 4B). The latter were visualized by a copper-free click reaction 
with a DIFO-bearing Alexa probe (Figure 4B) (Nelson et al., 2010).
Lipids
Lipids comprise a second, much less exploited target for metabolic engineering. Cellular 
membranes rely on lipids as they fulfill a barrier function. Lipids also exist as posttranslational 
modifications on proteins and play key roles in cellular signaling (van Meer et al., 2008). Similar 
to glycans, lipids containing bioorthogonal handles can be used as reporters to study key 
biological processes. For example, Salic and coworkers employed propargylcholine to 
metabolically label choline phospholipids, which were then followed by ex vivo imaging using 
a fluorescent azido-dye (Jao et al., 2009). Haberkant et al. also synthesized a 15-carbon long, 
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UV-photoactivatable and clickable fatty acid to identify and visualize protein-lipid interactions. 
C. elegans larvae were fed with this fatty acid analogue, UV-irradiated, fixated and finally 
functionalized with an azido-bearing Alexa probe for imaging. The authors observed prominent 
fluorescent labeling in intestinal epithelial cells and muscle cells in the pharyngeal region and 
thereby demonstrated the utility of this method for investigating fatty acids in their physiological 
context (Haberkant et al., 2013). The preparation of additional surrogates for other classes of 
fatty acids will provide an interesting method for a comprehensive analysis for this type of 
biomolecules during different physiological and pathological stages.
Introducing Bioorthogonal Handles into Proteins using Unnatural Amino Acids
A number of different approaches have been successfully applied to selectively install 
bioorthogonal handles into proteins inside cells without making use of classical ligation 
methods involving lysines and cysteines. Among these, two methods make use of the 
translational machinery to introduce amino acids that provide new functionalities to proteins 
and which will be described in the next section. Two terms can be found in literature to describe 
these amino acids: unnatural amino acids or non-canonical amino acids (ncAA). We will here 
use the former for both protein engineering methods. The first method for introducing new 
functionalities into proteins relies on the addition of a 21st amino acid to the existing pool of 
the 20 canonical amino acids and is referred to as site-specific encoding of UAA. The second 
method replaces either totally or partially one of the 20 amino acids with a new, unnatural 
amino acid and is called the residue-specific method.
Site-specific Incorporation of Unnatural Amino Acids
Expanding the genetic code beyond the 20 canonical amino acids with new functionalities has 
been made possible by the extension of the cell’s translational machinery. In 2001, Schultz 
artfully demonstrated that the translational machinery of E.coli could be supplemented with a 
new tRNA/ aminoacyl-tRNA synthetase (aa-RS) pair to site-specifically incorporate O-methyl-l 
-tyrosine into dihydrofolate reductase (Wang et al., 2001). Two conditions are required to 
genetically encode a 21st amino acid: a) a unique codon, that designates the position for the 
UAA within the protein, and b) an orthogonal tRNA/aa-RS pair, which does not show cross-
reactivity with the endogenous translational machinery (Figure 5A) (Liu and Schultz, 2010). The 
UAG stop (or amber) codon has mainly been used to incorporate unique UAAs into proteins. 
The amber codon does not encode for any of the 20 canonical amino acids and is functionally 
redundant. To achieve orthogonality of the new tRNA/aa-RS pair, scientists imported an 
aa-RS and a tRNA from an evolutionary distinct species into the host organism and further 
engineered them to achieve orthogonality. For example, the tRNATyr/tyrosyl-RS pair from 
Methanococcus jannaschii was used for the expansion of the genetic code in E. coli (Wang 
et al., 2001). The tRNA was further evolved in order to suppress the amber stop codon and 
thereby, incorporate the UAA into the growing peptide chain during protein synthesis (Figure 
5A). Engineering of the corresponding aa-RS was required to selectively recognize the UAA 
and load the suppressor tRNA (tRNACUA) with the UAA. The technique was recently improved 
through the discovery of the tRNACUA/pyrrolysyl-RS pair from Methanosarcina mazei and 
Figure 5: (A) The UAG stop codon (dark green encircled) in the mRNA designates the position of the 
unnatural amino acid (UAA) inside the protein. It can be overwritten by a suppressor tRNA, which has been 
charged with the UAA by the corresponding tRNA synthetase (UAA-RS). (B) Residue-specific incorporation 
of azidohomoalanine into proteins. Methionine can be partially replaced in a concentration-dependent 
manner by the addition of azidohomoalanine to the culture medium. tRNAMet will also be charged with 
azidohomoalanine and incorporates this UAA into proteins in response to the methionine codon. In cells 
are lacking the biosynthesis pathway for methionine, azidohomoalanine can be incorporated in response 
to every methionine codon, resulting in the total replacement of methionines in proteins.
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Methanosarcina bakeri (Mukai et al., 2008; Neumann et al., 2008; Chen et al., 2009). M. mazei and 
M. bakeri naturally incorporate pyrrolysine as a 21st amino acid into their proteins in response 
to the amber stop codon. Since the tRNACUA/pyrrosyl-RS pair functions orthogonally in this 
organism, researchers speculated that this orthogonality was preserved in other organisms 
as well and were proven right, when importing this pair into unicellular organisms (bacteria 
and yeast) and mammalian cells. Besides introduction of the machinery for unnatural amino 
acid incorporation into organisms, Mehl et al. succeeded in bioengineering an E.coli strain 
into a completely autonomous bacterium encoding a 21st UAA along with its own biosynthetic 
machinery (Mehl et al., 2003). Although the site-specific encoding of UAAs provides excellent 
opportunities to perform functional studies in vivo, in bacteria this approach has mainly 
been used for the production of proteins with unnatural functionalities. The incorporation of 
bioorthogonal handles into proteins has also been applied through this methodology in yeast, 
although the proteins were eventually conjugated to the corresponding functionalized probes 
in vitro (Deiters et al., 2003).
The laboratory of Chin took the potential of the site-specific incorporation of UAAs a step 
further by expanding the genetic code of the multicellular organism C. elegans. They used a 
reporter fusion construct encoding the green and red fluorescent proteins GFP and mCherry, 
respectively. The linker region between the sequences encoding these two proteins contained 
an amber codon (Greiss and Chin, 2011). The expression efficiency of this construct was 
initially hampered by nonsense-mediated decay (NMD), a eukaryotic surveillance mechanism 
that destroys mRNA species containing internal stop codons. It has been shown that yeast 
deficient in NMD showed an increase in the production of proteins containing UAAs (Wang and 
Wang, 2008). Accordingly, worms lacking NMD resulted in an increase in expression of proteins 
containing internal amber codons. When these worms were grown in media supplemented 
with UAA, mCherry fluorescence was observed throughout the worm, demonstrating that the 
genetic code can be expanded in multi-cellular organisms (Figure 6). In addition, the authors 
reported a successful incorporation of a terminal alkyne-bearing amino acid, which opens 
the possibility for performing click chemistry in future studies. The site-specific encoding of 
UAAs has also been achieved in the fruit fly Drosophila melanogaster. Tissue-specific UAA 
incorporation was here demonstrated by placing the UAG-codon bearing gene under control 
of an ovary-specific promoter. When flies were fed with an UAA, the expression of UAA-
containing protein was only detected in the fly ovaries and was absent in other parts of the fly 
body (Bianco et al., 2012). Importantly, this study reported the incorporation of UAAs bearing 
bioorthogonal handles. We envision that other bioorthogonal groups such as strained alkyne 
and alkene-functionalized amino acids will soon be genetically encoded inside living organisms 
as well (Borrmann et al., 2012; Lang et al., 2012b; Plass et al., 2012). Future studies could use this 
method to probe various biological processes in model organisms. In this context, labeling 
of proteins with fluorogenic dyes may be highly valuable, since these dyes become only 
fluorescent after a successful cycloaddition, and background fluorescence from unreacted 
probes will be minimal (Shieh et al., 2012). The specific labeling of a protein of interest inside a 
tissue type comes within reach, as long as the reactive probe is able to effectively reach the 
tissue of interest and react with its bioorthogonal reaction partner.
Residue-specific Incorporation of Unnatural Amino Acids
The site-specific incorporation of UAAs into proteins is a valuable tool for the investigation 
of the behavior of an individual protein. In contrast, residue-specific incorporation of UAAs 
allows for the partial or total replacement of a particular amino acid by a synthetic surrogate 
using the natural translational machinery of the cell (Figure 5B) (Johnson et al., 2010). The 
feasibility of this method was demonstrated using a number of methionine analogues that 
were still recognized by the wildtype methionyl-RS, and subsequently incorporated in 
response to the methionine codon (Kiick et al., 2002). Bacterial expression strains that lack the 
metabolic pathway for methionine biosynthesis, enabled high levels of incorporation of non-
canonical analogues into proteins. The technique has been further expanded through the use 
of bioorthogonal non-canonical amino-acid tagging (BONCAT) and fluorescent non-canonical 
amino acid tagging (FUNCAT) (Dieterich et al., 2006; Dieterich et al., 2010). Both methods rely 
on the pulse-labeling of cells (or multicellular organisms) with non-toxic concentrations of 
azido- or alkyne- bearing UAAs. These in turn, allow for a low-level incorporation of the 
reactive handle into newly synthesized proteins (Figure 7A). BONCAT is a powerful technique 
for the selective enrichment of newly synthesized proteins by using the reactive moiety 
for subsequent purification by SPAAC or CuAAC, thus separating these proteins from the 
preexisting pool of cellular proteins. In this way, changes in expression profiles after certain 
stimuli can easily be analyzed by means of mass spectrometry. Dieterich et al. pioneered 
BONCAT by using azidohomoalanine (AHA), a methionine analogue, to identify 195 newly 
synthesized proteins that had been produced in a 2 h time frame following the addition of AHA 
onto cultured HEK293 cells (Dieterich et al., 2006). Another recent example by Hodas et al. used 
the BONCAT technology to study proteomic changes of the nervous system to environmental 
stimuli. The nervous system is a very dynamic entity and changes in its proteome are crucial 
for learning and memory. Hodas et al. investigated the subproteome of hippocampal slices 
Figure 6: Genetic code expansion in C. elegans. Only in the presence of the UAA, full-length protein 
(GFP:mCherry fusion protein) is produced. In the absence of UAA, only GFP fluorescence is detectable 
(Greiss and Chin, 2011). Adapted with permission from S. Greiss and J.W. Chin, J. Am. Chem. Soc., 2011, 
133, 14196-14199. Copyright (2011) American Chemical Society.
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after treatment with the dopamine receptor agonist SKF81297 and identified known and 
unknown candidates involved in the dopaminergic signaling pathway (Hodas et al., 2012). As 
BONCAT can be used for the identification of newly synthesized proteins, FUNCAT enables 
the visualization of newly synthesized proteins. In FUNCAT, cells are first treated with an 
alkyne- or azido-bearing amino acid, which is then followed by the conjugation to a fluorescent 
probe containing the reactive counterpart. Schuman and colleagues introduced FUNCAT in 
a study, in which they visualized newly synthesized proteins in cultured neuronal somata and 
dendrites. The cells were briefly pulse-labeled with AHA (10 min and 20 min, respectively) and 
conjugated to an alkyne-bearing fluorescent probe using CuAAC. Proteins in thicker tissues 
could also be labeled using FUNCAT, as demonstrated by bathing hippocampal slices in AHA-
supplemented buffer, followed by incubation with an alkyne-bearing fluorescent dye (Dieterich 
et al., 2010). Having proven the great potential of the FUNCAT and BONCAT methodologies in 
cell cultures or isolated tissues, Schuman and colleagues have recently applied both methods 
to study new protein synthesis in a whole organism. To this end, 7-day-old larval zebrafish 
were incubated with AHA at a concentration of 4 mM, which did not result in any aberrant 
behaviour. The AHA-containing proteins were subsequently visualized with an alkyne-bearing 
Alexa probe via CuAAC. Newly synthesized proteins could be visualized in an incubation-
time dependent manner with the earliest signal being detected after 12 h (Figure 7B) (Hinz 
et al., 2012). Proteins in deeper lying structures such as the optic tectum, spinal cord and 
cerebellum could also be visualized after a prolonged incubation with AHA. The visualization 
and identification of newly synthesized proteins in an organism will greatly help to understand 
the underlying principles of many biological processes as they allow comparisons between 
normal, pathological, and induced responses. The comprehensive nature of BONCAT and 
FUNCAT makes them powerful tools for analyzing perturbations within the whole organism. 
It should however be noted that the labeling of proteins with AHA is limited to proteins that 
contain at least one methionine residue, as AHA is incorporated into proteins in response to 
the methionine codon. The combined labeling with additional surrogates for amino acids other 
than methionine may result in a broader coverage of newly synthesized proteins. Furthermore, 
AHA competes with methionine for the incorporation into proteins and it may be that not all 
newly synthesized proteins will incorporate AHA.
Scientists in the laboratory of Tirrell developed a method to label proteins with UAA within 
one specific cell population. They used the methionine surrogate azidonorleucine (ANL), 
which is not recognized by the endogenous methionyl-RS. Instead, ANL is recognized 
by an engineered methionyl-RS variant, which loads it onto the cognate methionyl-tRNA. 
Cells expressing the RS mutant for ANL incorporation showed specific protein labeling after 
functionalization with an alkyne-bearing probe, whereas cells lacking this mutant did not show 
any protein labeling (Ngo et al., 2009). Other mutants and methionine surrogates have since 
been developed for cell-selective protein labeling, but have only been applied in co-cultured 
systems thus far (Grammel et al., 2010; Grammel et al., 2012; Truong et al., 2012). The use of 
this cell-selective labeling method could prove immensely useful in the labeling and study of 
substructures found within an entire organism, physiological cellular responses to specific 
stimuli, tissue-specific proteomic changes that occur in diseased states, and even changes 
to the bacterial proteome during infection. The clinical implications of this technique are vast. 
Temporal control of protein labeling within specific tissues may also be achieved in the future 
by using promoter-specific activation of RS mutants (Ngo et al., 2012). 
Conclusion and Outlook
Over the past years bioorthogonal chemistry has reached the next level in both fundamental 
and application-driven research. After the pioneering studies with cultured cells, scientists have 
taken the first steps toward co-cultured systems and multicellular organisms. Bioorthogonal 
chemistry, combined with strategies for the installation of one of the reaction partners into 
biomolecules, holds great promise for a better understanding of many biological processes, 
has also been shown to be an excellent tool for imaging purposes, and may even be suitable 
for targeted drug delivery. 
Among the techniques discussed in this chapter, tumor pretargeting provides the least invasive 
method for performing bioorthogonal chemistry in living organisms. The bioorthogonal group 
Figure 7: (A) Labeling of newly synthesized proteins using azidohomoalanine. Azidohomoalanine-tagged 
proteins can be enriched (BONCAT) for proteomic analysis or functionalized with a fluorescent dye 
(FUNCAT) for visualization. (B) Imaging of newly synthesized glycans in developing zebrafish fish after 
12 h and 48 h. 7-day-old larval zebrafish were incubated with 4 mM azidohomoalanine for 12h and 48h 
and reacted to alkyne-bearing Alexa 488 dye for visualization (Hinz et al., 2012). Adapted with permission 
from F.I. Hinz, D.C. Dieterich, D.A. Tirrell and E.M. Schuman, ACS Chem. Neurosci., 2012, 3, 40-49. 
Copyright (2012) American Chemical Society.
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is conjugated to the antibody in vitro and the bioorthogonal handle will be delivered to the 
tumor due to the specificity of the antibody. No genetic engineering of the organism is needed 
in this method. Comparison of this pretargeting method with the traditional method of using 
directly-labeled antibodies suggests that this technique has the potential of being routinely 
used in future clinical settings. 
As for metabolic engineering, the delivery of a bioorthogonal group into a biomolecule of 
interest is technically relatively simple. Addition of the unnatural substrate to the media or 
injection into the organism is sufficient as the promiscuity of the cellular metabolic machinery 
allows for the subsequent incorporation. It is possible with this method to distinguish between 
certain types of glycosylation such as fucosylation or sialylation. However, specific labeling 
of single glycoproteins or lipids cannot be achieved, because the unnatural monosaccharide 
will be built into all glycans containing the endogenous sugar. Similarly, the residue-specific 
incorporation of UAAs into proteins also results in the partial replacement of the cognate amino 
acid in all proteins and cannot be used for the specific labeling of a single protein. In contrast, 
the site-specific incorporation of UAAs is ideally suited for the study of a single protein, but 
is technically challenging as the translational machinery of the organism has to be extended. 
The residue-specific and metabolic engineering approaches allow for comprehensive 
analyses, which make them invaluable tools for studies in the field of systems biology. As the 
three techniques can answer different biological questions, they also offer a high degree of 
complementarity. Metabolic engineering has already been used in several biological studies 
with different types of living organisms and has matured into a standardized and frequently 
used method. We envision that the protein engineering techniques will also follow this trend 
in forthcoming years, as the major technical hurdles have been taken. We are looking forward 
to the newest advances in this emerging field of chemical biology in living organisms and we 
are sure that an exciting era awaits.
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Introduction
The selective and efficient labeling of biomolecules in living systems has become a focal 
point of attention in the area of chemical biology, as it allows the space- and time-resolved 
investigation of biomolecules in their natural environment. One of the most promising 
bioorthogonal labeling reactions is the strain-promoted azide–alkyne cycloaddition (SPAAC), 
a variant of the copper(I)-catalyzed Huisgen azide–alkyne cycloaddition (CuAAC) that does 
not require the use of this cytotoxic metal (Blomquist et al., 1952; Wittig and Krebs, 1961; Rostovtsev 
et al., 2002; Tornoe et al., 2002). Bertozzi and co-workers were the first to introduce SPAAC 
for in vivo labeling studies, by expressing azide-containing glycans at the cell surface and 
subsequent labeling with functionalized cyclooctyne probes (Agard et al., 2004). Inspired 
by these results, we and others have described the synthesis of cyclooctyne variants with 
improved features, such as increased reactivity, reduced lipophilicity and better synthetic 
accessibility (Baskin et al., 2007; Ning et al., 2008; Debets et al., 2010a; Jewett and Bertozzi, 2010; 
Jewett et al., 2010; Debets et al., 2011; de Almeida et al., 2012). In several cases, significant reaction 
rate enhancement was achieved by dibenzoannulation of the alkyne (Ning et al., 2008; Debets 
et al., 2010a; Jewett et al., 2010). However, the increased hydrophobicity and consequent non-
specific binding to proteins, for instance, stimulated us to develop a novel, less hydrophobic 
strained alkyne called bicyclo[6.1.0]nonyne (BCN). BCN is synthetically readily accessible and 
shows favorable reaction rates during SPAAC due to the fused cyclopropane ring (Dommerholt 
et al., 2010).
In 2001, Wang et al. pioneered a versatile strategy to introduce abiotic functionalities into 
proteins at virtually any position through site-specific genetic encoding of unnatural amino 
acids (UAAs) (Wang et al., 2001; Wang et al., 2009). They genetically encoded O-methyl-l-tyrosine 
into a protein in vivo in response to suppression of the amber stop (TAG) codon by adding 
an orthogonal tyrosyl-tRNA/tRNA-synthetase pair from Methanocaldococcus jannaschii to 
the E. coli translational machinery (Wang et al., 2001). In follow-up reports, this strategy was 
extended to azide- and alkyne-containing UAAs, which could react in a copper(I)-catalyzed 
click reaction (see for example review Liu and Schultz, 2010) (Liu and Schultz, 2010; Hao et 
al., 2011). For copper-free protein labeling, SPAAC requires the installation of either azide or 
cyclooctyne into the protein of interest. Thus, in principle incorporation of the azide allows 
copper-free labeling with strained alkyne-derivatized dyes (Link et al., 2006; Beatty et al., 2010; 
van Hest and van Delft, 2011; Yao et al., 2012). The alternative strategy, that is, encoding a strained 
alkyne, bears two distinct advantages over encoding an azide: 1) azides may be reduced 
during a long-term in vivo expression and purification procedure (Milles et al., 2012), 2) most 
fluorescent and fluorogenic dyes are commercially available or readily synthesized as an 
azide derivative (Brase et al., 2005; Jewett and Bertozzi, 2010). The use of fluorogenic dyes has the 
crucial benefit that the dye will only become fluorescent after a successful cycloaddition has 
taken place, meaning there is no fluorescent background signal present in the cell originating 
from unreacted dye. In 2011, we were the first to genetically encode a cyclooctyne-conjugated 
non-canonical amino acid (compound 1 in Figure 1A) by means of an engineered pyrrolysine 
tRNA-synthetase (pylRSAF) (Mukai et al., 2008; Neumann et al., 2008; Chen et al., 2009; Kaya et 
al., 2009; Plass et al., 2011). To this end, two mutations (Y306A and Y384F) were required to 
Abstract
Visualizing biomolecules by fluorescent tagging is a powerful method for studying their 
behaviour and function inside cells. We prepared and genetically encoded an unnatural amino 
acid (UAA) featuring a bicyclononyne moiety. This UAA offered exceptional reactivity in strain-
promoted azide–alkyne cycloadditions. Kinetic measurements with tetrazine-conjugated dyes 
revealed that the UAA reacted also remarkably fast in the inverse electron-demand Diels–
Alder cycloaddition with tetrazines. Genetic encoding of the new UAA inside mammalian cells 
and its subsequent selective labeling at low dye concentrations demonstrate the usefulness 
of the new amino acid for future imaging studies.
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expand the amino acid binding pocket of the tRNA synthetase in order to enable binding of the 
bulky cyclooctyne moiety (Plass et al., 2011). As higher reactivity is favorable to monitor cellular 
processes, we were prompted to expand the genetic toolbox with a more reactive cyclooctyne 
than 1. 
In this chapter, we prepared and subsequently genetically encoded the BCN-conjugated lysine 
(compound 2, Figure 1A) by amber codon suppression technology. Kinetic measurements with 
azido-dyes were performed and a much higher reactivity than for 1 was observed. Moreover, 
we established that 2 performed extremely well in the strain-promoted inverse electron-
demand Diels–Alder (SPIEDAC) reaction with tetrazines and finally, we demonstrated the 
utility of our new UAA for labeling of proteins inside mammalian cells.
Next, we evaluated whether 2 could be genetically encoded into proteins in response to the 
amber stop codon using the double mutant synthetase pylRSAF and the corresponding amber 
suppressor tRNApyl from Methanosarcina mazei inside E. coli (Plass et al., 2011). In comparison 
to the dibenzoannulated cyclooctynes, 2 is structurally much more similar to the previously 
reported 1 and was therefore expected to fit into the substrate binding pocket of the pylRSAF. 
As a model protein, C-terminally His6-tagged green fluorescent protein that carried a TAG 
mutation at position 39 (GFPY39TAG) was expressed in the presence of 1 mM 2. The protein 
was purified by Ni-NTA chromatography via the C-terminal His6-tag and the expression of 
GFPY39TAG→2 was analyzed by SDS PAGE and Coomassie staining. Figure 1B shows the 
appearance of a protein band when 2 was added to the growth medium. Mass spectrometry 
analysis further confirmed the successful incorporation of 2 into GFPY39TAG→2 (Suppl. Table 
S1). In the absence of 2, no GFP production was observed (Figure 1B, lane 3). This result 
indicates that tRNApyl is specifically charged with 2 by the double mutant pylRSAF and hence, 
2 can be incorporated into the growing peptide chain leading to the production of full-length 
GFP. Judging from the SDS PAGE analysis in figure S1, the expression of GFPY39TAG→2 
was approximately 10 times smaller compared to the expression of wild-type GFP (GFPWT) 
resulting in a typical yield of about 8 mg L-1 culture, which is similar to the previous report on 
the use of 1. One reason for the reduction could be the competition of the peptide translation 
termination factors and the suppressor tRNA for the amber stop codon. Novel E. coli strains 
lacking the release factor 1 as introduced by Johnson et al. (Johnson et al., 2011), as well 
as further evolution of the substrate binding pocket of the pylRSAF could potentially improve 
the yield of the amber suppression. However, expression levels were sufficient for protein 
purification, in vitro as well as in vivo labeling studies.
To test whether 2, once incorporated into GFP, is suitable for SPAAC, we performed a labeling 
experiment by addition of 3-azido-7-hydroxycoumarin (4, Figure 1A) to E. coli expressing 
GFPY39TAG→2 (Figure 1D). For this experiment, GFPY39TAG→1 was used as a positive control, 
while GFPWT and GFP charged with propargyl-functionalized lysine (3, Figure 1A) (Kaya et al., 
2009; Nguyen et al., 2009; Milles et al., 2012) were used as negative controls. GFPY39TAG→3 showed 
a similar expression profile as GFPY39TAG→1 and GFPY39TAG→2 (Figure 1D), but did not react with 
azides in the absence of copper. Cells expressing GFPWT or GFPY39TAG→UAA (UAA = 1, 2, or 3) 
were incubated with 4 for 4-5 h. After rigorously washing out excess dye, the whole cell lysates 
were analyzed on an SDS PAGE gel for fluorescence. As expected, the fluorescent signal was 
restricted to GFPY39TAG→2 and GFPY39TAG→1, demonstrating the specificity of the system (Figure 
1D). This finding shows that 2 is accessible within the protein and functions as a reactive 
handle for SPAAC inside living cells. 
Kinetic studies
Based on earlier kinetic labeling studies with a simple hydroxy-methyl-BCN, we speculated 
that GFPY39TAG→2 would be more reactive towards azides than GFPY39TAG→1 (Dommerholt et al., 
2010). To corroborate this assumption, we performed a time-dependent labeling experiment 
inside cells at 37 °C with 10 µM 4. Samples were taken at various time points and excess dye 
was immediately washed off before analyzing the cell lysate for fluorescence, as described 
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Figure 1: Genetic encoding of 2. (A) Structures of UAAs 1, 2, 3 and fluorogenic azido-coumarin 4. 
(B) Coomassie-stained SDS PAGE gel of GFPY39TAG→UAA in the presence (+) and absence (–) of 2 and 
comparison to wildtype GFP (GFPWT) and (C) GFPY39TAG→1 after purification via Ni-NTA chromatography. 
(D) Fluorescence image and corresponding Coomassie stain of labeling reaction with 4 inside E. coli cells 
expressing GFPY39TAG→1, GFPY39TAG→2, GFPY39TAG→3, and GFPWT (lane 1 to 4, respectively) (arrow indicates 
height of GFP band).
Results and Discussion
Synthesis and genetic incorporation of 2 into GFP through amber suppression 
technology
In order to genetically encode BCN into proteins, compound 2 (Figure 1A) had to be prepared 
first. We synthesized 2 in a practical one-pot reaction sequence. Both the carboxylic acid 
and the α-amino function of l-lysine were protected by an in situ complexation with CuSO4 
(Wiejak et al., 1999). Subsequently, the ε-amino group was acylated with commercially available 
bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate. Copper was simply removed by the 
addition of 8-hydroxyquinoline, affording 2 as a white solid with a yield of 54%. 
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above. Already after 5 min, clear labeling of GFPY39TAG→2 with 4 could be detected, whereas 
only a weak fluorescent band was observed for GFPY39TAG→1 (Figure S2). Within 1 h, the 
labeling reaction for GFPY39TAG→2 had reached completion, whereas labeling of GFPY39TAG→1 did 
not level off even after 6 h of incubation. These results clearly demonstrate that labeling of 
GFPY39TAG→2 by 4 inside E. coli is much faster than for GFPY39TAG→1.
In order to quantify reaction rates for GFPY39TAG→1 and GFPY39TAG→2, a Förster resonance 
energy transfer (FRET)-based assay was applied with GFP serving as FRET-donor and 
tetramethylrhodamine (TAMRA)-azide conjugate as FRET-acceptor (Plass et al., 2012). The 
ligation was performed in phosphate-buffered saline (PBS) and monitored over time for the 
occurrence of energy transfer: Progress of the labeling reaction was thus visualized by a 
decrease in GFP fluorescence and a simultaneous increase of the TAMRA fluorescence 
upon GFP-excitation (Figure 2A). FRET efficiencies were calculated for these data and the 
increase in FRET was fit as described in the Experimental Section. It was found that under 
these circumstances GFPY39TAG→2 reacted faster than GFPY39TAG→1 (Figure 2B, Suppl. Table 
S2). Notably, as seen in Figure 2B neither reaction reached completion under the tested 
conditions. 
In recent years, the strain-promoted inverse electron-demand (4+2) Diels–Alder cycloaddition 
(SPIEDAC) of trans-cyclooctene (TCO) or norbornene dienophiles with 1,2,4,5-tetrazines has 
emerged as another promising bioorthogonal reaction (Blackman et al., 2008; Devaraj et al., 2008; 
Wiessler et al., 2010), and most recently also became available for genetic encoding (Kaya et 
al., 2012; Lang et al., 2012a; Plass et al., 2012; Seitchik et al., 2012). In particular, the reaction of 
TCO with tetrazines is extremely rapid with a reported rate constant of up to 35,000 M-1s-1 
(Plass et al., 2012). Interestingly, cyclooctynes can also react with 1,2,4,5-tetrazines, as has 
been reported by Sauer et al. (Sauer et al., 1998) and most recently also by Chen et al (Chen 
et al., 2012). In the latter study, the reaction of diphenyltetrazine with BCN was demonstrated 
to be 47-fold faster than with plain cyclooctyne. These results encouraged us to investigate 
the reaction rate constants for GFPY39TAG→1 and GFPY39TAG→2 with a tetrazine-conjugated dye 
by means of FRET as outlined in figure 2A. Accordingly, a tetrazine-functionalized TAMRA 
(Figure S3) was used and FRET between GFPY39TAG→UAA and TAMRA was monitored over time 
as a measure of UAA-tetrazine ligation. As shown in figure 2C, when no TAMRA-tetrazine was 
added only GFP fluorescence was observed (Figure 2C, black line).After adding tetrazine-
functionalized TAMRA, an increase in TAMRA fluorescence (575 nm) and a simultaneous 
decrease in GFP fluorescence (506 nm) could be detected due to FRET (Figure 2C). Analysis 
of the FRET data (Figure 2) revealed a rate reaction constant of k = 29000 ± 7500 M-1s-1for 
2, which is around 80-fold higher than the rate reaction constant for 1 (k = 370 ± 80 M-1s-1), 
and surprisingly close to that reported for the reaction of TCO with tetrazines (Plass et al., 
2012). Summarizing these findings, incorporating 2 leads to an improvement of the rate of the 
SPAAC reaction and enables exceptionally fast labeling with tetrazine-conjugated dyes (Lang 
et al., 2012b). Gratifyingly, the potential competitive reaction of 2 with endogenous thiols was 
not observed at any instance (see also Table S1) (van Geel et al., 2012). 
Genetic encoding into mammalian cells
We next explored the genetic incorporation of 2 inside mammalian cells. For this purpose, 
we co-transfected a mammalian expression vector carrying the tRNApyl/pylRS
AF and a vector 
containing a nuclear localization signal (NLS)-maltose binding protein (MBP) -GFPY39TAG into 
HeLa Kyoto cells and cultures were grown in the presence of 250 µM 2 for 24-36 h before 
cells were washed and fixed. The cells were then incubated with tetrazine-functionalized 
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Figure 2: Determination of reaction kinetics of GFPY39TAG→UAA using Förster resonance energy transfer 
(FRET). (A) Reaction scheme illustrating the reaction between GFPY39TAG→UAA with TAMRA-azide (upper 
row) or -tetrazine (lower row) (grey spheres). Upon reaction TAMRA will become fluorescent (red spheres) 
due to FRET. (B) Development of FRET as function of time for the reaction of GFPY39TAG→1 (red line) and 
GFPY39TAG→2 (blue line) with TAMRA-azide. (C) (left) Fluorescence spectrum of GFPY39TAG→2 (black line 
= without dye) with TAMRA-tetrazine over time showing a decrease in GFP fluorescence (around 506 
nm) and simultaneously an increase in TAMRA fluorescence around 575 nm (dark to light blue). (right) 
Development of FRET as function of time for the reaction of GFPY39TAG→1 (red curve) and GFPY39TAG→2 (blue 
curve) with TAMRA-tetrazine.
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Cy5 dye (Figure S3) and washed excessively after incubation (Plass et al., 2012). As shown 
in figure 3, already after 10 min of labeling, cells expressing GFPY39TAG→2 in the nucleus 
were red fluorescently labeled with Cy5-tetrazine dye, whereas cells expressing GFPY39TAG→1 
showed labeling only after 2 h of incubation with elevated dye concentration (Figure S4). 
The latter experiment shows that GFPY39TAG→1 is still intact and hence, that co-localization of 
red Cy5 fluorescence with green GFP fluorescence within 10 min after dye addition (Figure 
3) in cells expressing GFPY39TAG→2 is due to the higher reactivity of 2 compared to 1. (Figure 
3). Depending on the biological question, the inverse electron-demand Diels–Alder reaction 
can be of particular use, for example for instant monitoring of newly synthesized proteins or 
proteins having a short lifetime within the cell. Due to the selectivity and fast reactivity of the 
Diels–Alder reaction, low dye concentrations (in our case 100 nM) suffice for efficient protein 
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Figure 3: Fluorescence images of HeLa Kyoto cells expressing tRNApyl/pylRSAF and GFPY39TAG→1 (upper 
row) or GFPY39TAG→2 (lower row) after incubation for 10 min with 100 nm Cy5-tetrazine. Pictures show 
from left to right fluorescence from Hoechst staining (DNA stain), GFP, Cy5-tetrazine and colour overlay, 
respectively. Red co-localization of Cy5 is only observed when using 2. Scale bar 50 µm.
labeling inside cells. Furthermore, lower concentrations of labeling dye will also result in a 
decrease of non-specific adhesion of dye molecules as can be seen in figure 3 and figure 
S4. UAA 2 shows a much higher reactivity towards tetrazine-dyes than previously reported 
norbornene-conjugated amino acids, which are only converted within hours after large excess 
dye addition (Plass et al., 2012). However, tetrazine-conjugated dyes are not yet commercially 
available and their synthesis is more labor-intensive when compared to fluorescent and 
fluorogenic azide-based dyes, although progress has most recently been made by Yang et al. 
(Yang et al., 2012). If selective labeling and accessibility of the labeling agent is more important 
than reaction rate, UAA 2-labeled proteins are also suitable for cellular conjugation with azido 
compounds. Figure S5 shows that GFPY39TAG→2 expressing HeLa cells can also selectively be 
labeled with TAMRA-azide (10 µM) within 2 h of incubation without a significant increase in 
background fluorescence. The labeling experiments with azide- or tetrazine-conjugated dyes 
reveal the versatility of UAA 2 compared to other compounds (Kaya et al., 2012; Lang et al., 
2012a; Plass et al., 2012; Seitchik et al., 2012). 
Conclusion 
We have genetically encoded a new UAA 2 based on bicyclononyne, readily accessible 
from l-lysine in a one-pot procedure, and have demonstrated its utility in two types of 
bioorthogonal reactions, involving either SPAAC (with azide) or SPIEDAC (with tetrazine). 
We have demonstrated that the ligation reactions readily take place both in vitro and in vivo. 
Labeling studies with azido-dyes showed that the reaction is around ten times faster than for 
the previously encoded cyclooctyne variant 1. Furthermore, the BCN-based UAA 2 performs 
remarkably well in the inverse electron-demand Diels–Alder reaction with tetrazine. One clear 
advantage of the methodology presented by us is that it is a viable, alternative strategy to the 
fluorescent labeling of proteins in their native habitat by fluorescent proteins, a commonly 
used procedure to track proteins inside cells. In such cases, the (bulky) fluorescent protein 
that is fused to the C- or N-terminus of the protein of interest may negatively interfere with the 
protein function. In addition, genetically encoding 2 into proteins allows for fluorescent tagging 
with small chemical probes that display better photophysical properties.
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Experimental Section
Materials: 
Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate (BCN-OSu), l-(+)-lysine 
monohydrochloride, 8-hydroxyquinoline and copper(II) sulfate pentahydrate were 
purchased from Synaffix, Merck and Acros, and used without further purification. 3-azido-
7-hydroxycoumarin and TAMRA-azide were purchased from Baseclick GmbH (Tutzing, 
Germany). Azide-fluor 545 for the labeling experiment described in Figure S5 was purchased 
from Jena Bioscience GmbH (Jena, Germany). Solvents were purchased from J.T. Baker and 
Fisher Scientific and used as received. Thin layer chromatography was performed on silica 
gel-coated plates (Kieselgel 60 F254, Merck, Germany) with the indicated solvent mixture, 
and spots were detected by ninhydrin (300 mL butanol, 9.3 mL AcOH, 243 mg ninhydrin) 
staining. Compound 1 and 3 were synthesized according to previously published work by 
Plass et al. and Milles et al, respectively (Plass et al., 2011; Milles et al., 2012). TAMRA-tetrazine 
and Cy5-tetrazine were synthesized as described by Plass et al and Wießler et al (Wiessler et 
al., 2010; Plass et al., 2012).
Instrumentation: 
NMR spectra were recorded on a Varian 400 (400 MHz) and an Advance III Bruker 500 (125 
MHz) spectrometer. High resolution mass spectra (HRMS) for 2 were recorded on a JEOL 
AccuTOF (electrospray ionization, ESI).
Synthesis of N-ε-((1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-methyloxy)carbonyl)-l-lysine (2): 
Copper(II) sulfate pentahydrate (205 mg, 0.82 mmol) was dissolved in H2O (30 mL) and added 
to a solution of l-(+)-lysine HCl salt (300 mg, 1.64 mmol) in saturated NaHCO3 (30 mL). The 
resulting mixture was stirred for 30 min at room temperature (rt). A solution of BCN-OSu (620 
mg, 2.13 mmol) in acetonitrile (60 mL) was added to the reaction mixture and stirring was 
continued for 2 h at rt. Acetonitrile was evaporated in vacuo resulting in a blue precipitate. The 
precipitate was filtered off and was washed with H2O (3 × 50 mL). The precipitate was taken 
up in H2O (50 mL) and 8-hydroxyquinoline (310 mg, 2.13 mmol) was added. The resulting 
mixture was again stirred for 2 h at rt and then filtered off. The solid was washed with H2O 
(3 × 50 mL). The filtrate was washed with CH2Cl2 (3 × 200 mL), concentrated in vacuo and 
finally lyophilized to afford pure 2 (287 mg, 0.89 mmol, 54% yield) as a white powder. TLC: RF 
= 0.40 (CHCl3/MeOH/ammonium hydroxide, 60:45:10); 
1H NMR (D2O, 400 MHz): δ 4.23 (d, 
2H, J=7.9Hz), 3.77 (t, 1H, J=6.1Hz), 3.18 (t, 2H, J=6.6Hz), 2.24-2.38 (m, 6H), 1.84-1.99 (m, 
2H), 1.56-1.69 (m, 4H), 1.38-1.53 (m, 3H), 0.99-1.07 (m, 2H) ppm; 13C NMR (D2O/CD3CN, 75 
MHz): δ 175.8, 159.2, 100.7, 64.0, 55.4, 40.6, 31.1, 26.3, 29.2, 22.4, 21.4, 20.4, 17.9 ppm; 
HRMS (ESI) m/z calculated for C17H26N2O4 (M + H+) 323.1908, found: 323.1970.
Protein expression: 
An N-terminally FLAG-tagged and C-terminally His-tagged green fluorescent protein (GFP) 
was expressed from a pBAD plasmid. Bacteria were grown in Terrific Broth (TB) medium with 
ampicillin at 37 °C until OD 0.4-0.6, when expression was induced with 0.02% arabinose. 
Growth was continued for at least 12 h at 37 °C. Bacteria expressing GFPY39TAG→UAA contained 
a plasmid encoding for the tRNApyl/pylRS
AF pair (pEvol tRNApyl/ pylRS
AF) in addition and were 
grown in TB medium with ampicillin and chloramphenicol (Plass et al., 2011). The UAA was 
added to the expression culture 20 min prior to induction at a final concentration of 1 mm. 
Bacteria were harvested by centrifugation, resuspended in 4x phosphate buffered saline 
(PBS, pH 8.0) with 10 mm imidazole, and lysed by sonication. The lysate was centrifuged at 
14.000xg at 4 °C for 30 min and the supernatant was incubated with Ni-NTA beads (Qiagen, 
Duesseldorf, Germany) for 2 h at 4 °C. Ni-NTA beads were washed and the purified protein 
was eluted from the beads with 4xPBS supplemented with 20 and 500 mm imidazole, 
respectively. All purification buffers contained in addition 1 mm phenylmethanesulfonylfluoride 
(PMSF) and 0.2 mm tris(2-carboxyethyl)phosphine (TCEP). Proteins were further purified on 
a Superdex-200 in 1xPBS supplemented with 0.2 mm TCEP.
Mass spectrometry analysis: 
For mass determination of intact GFPY39TAG→UAA and GFPY39TAG→UAA, TAMRA-azide/tetrazine, protein 
samples were acidified using 1% TFA prior to injection onto the Acquity UPLC System 
(Waters, Saint-Quentin, France). Approximately 10 µg of each sample were loaded onto a 
protein separation column (Phenomenex Discovery Bio Wide Pore C5, 5 µm 1x150 mm). The 
outlet of the analytical column was coupled directly to a quadrupole time of flight (Q-TOF) II 
electrospray tandem mass spectrometer (Waters/Micromass) using the standard ESI source 
in positive ion mode. Solvent A was water, 0.1% formic acid, and solvent B was acetonitrile, 
0.1% formic acid. The samples were loaded in 96% A, 4% B at a constant flow of 0.2 mL min-1. 
The column was held at 4% B for 5 min before ramping to 25% B by 6 min. A linear gradient 
to 80% B was then applied until 17 min.
For the Q-TOF, a spray voltage of 3.5 kV was applied with a cone voltage of 35 V and extraction 
cone at 5 V. The desolvation temperature was set at 350 °C, with source temperature 120 °C. 
Desolvation gas was nitrogen at a flow rate of 500 L min-1. Collision energy was set at 5 eV 
with argon in the collision cell at a pressure of 4.5∙10-5 mbar. Data were acquired in continuum 
mode over the mass range 500–3500 m/z with a scan time of 0.5 s and an interscan delay 
of 0.1 s. Data were externally calibrated against a reference standard of intact myoglobin, 
acquired immediately prior to sample data acquisition. Spectra from the chromatogram protein 
peak were then summed and intact mass was calculated using the MaxEnt1 maximum entropy 
algorithm (Waters/Micromass) to give the zero charge deconvoluted molecular weight.
Labeling inside E.coli:
Cell pellets from 5 mL E. coli cultures expressing either GFPY39TAG→1, GFPY39TAG→2, GFPY39TAG→3, 
or GFPWT were resuspended in 5 mL 1xPBS and incubated for 1 h shaking at 37 °C, followed 
by two short washes in 1 mL 1xPBS to remove excess of unincorporated amino acid. 
Cells were resuspended in 1 mL 1xPBS and coumarin-azide was added to the cells at a 
final concentration of 10 µM, followed by incubation in the dark at 37 °C. For the qualitative 
determination of reaction kinetics, at indicated time points 100 µL cells were taken out from 
the cell suspension, pelleted and frozen at -20 °C. After incubation, samples were washed 
2 2
48 Chapter 2 Genetic Encoding of  BCN-lysine 49
once in 200 µL 1xPBS, subsequently pelleted and resuspended in 1 mL 1xPBS before 
incubating for 2 h on a nutator in the dark at 4 °C to remove excess of unreacted dye. Next, 
cells were washed another two times with 200 µL 1xPBS and finally the whole cell lysate was 
loaded on an SDS PAGE gel. The gel was analyzed for fluorescence using a commercially 
available gel documentation system (Alpha Innotech, CA) by exciting the sample at λ= 365 
nm and detecting the emission with an ethidium bromide filter setting and protein expression 
by Coomassie staining (coumarin absorbs in the UV-range).
FRET measurements: 
FRET measurements were performed on a PTI Quantamaster spectrometer (Ontario, 
Canada). Purified GFPY39TAG→1 and GFPY39TAG→2 were diluted to 500 nM using 1xPBS and 
TAMRA-azide dye was added to a final concentration of 20 µM. Fluorescence spectra (470-
650 nm) were recorded upon excitation of the GFP chromophore at 450 nm at various time 
points. For evaluation of the corresponding time traces, all data were corrected for values of 
direct excitation (i.e. excitation of TAMRA by the excitation light) and leakage (emission of 
GFP into the acceptor signal) that were obtained from measurements with GFPWT and the 
corresponding dye concentration. FRET efficiencies were calculated as:
FRET = Em(581 nm)/[Em(581 nm)+Em(506 nm)],
where Em(XXX nm) corresponds to the fluorescence intensity at XXX nm (corrected values). 
FRET data were fitted under the assumption of a constant dye concentration (B) throughout 
the entire reaction – a valid assumption due to 40x excess of TAMRA-azide using the following 
equation:
Due to the comparatively slow reaction kinetics of GFPY39TAG→1 and GFPY39TAG→2 with TAMRA-
azide, the reaction does not reach completion within the measured time frame and the 
amplitude was fixed to 0.2 as extracted from the GFPY39TAG→1 and GFPY39TAG→2 with TAMRA-
tetrazine.
Labeling reactions with TAMRA-tetrazine, on the other hand, proceeded very fast under pseudo 
first order conditions and were close to completion already during mixing the two reactants. 
In order to be able to follow this very fast labeling reaction we reduced the concentration of 
TAMRA-tetrazine to 1 µM in the case of labeling GFPY39TAG→1, and to 550 nM in the case of 
labeling GFPY39TAG→2. FRET efficiencies were calculated as described above.
For rate constant fitting we used the following, second-order equation:
where A0 and B0 correspond to the initial GFP
Y39TAG→UAA and TAMRA-tetrazine concentrations, 
respectively, and k denotes the rate constant. Rate reaction constants were determined at rt 
and are listed in Table S2. The rate constants were obtained from independent measurements 
and the error shows the standard deviations from three independent fits.
Transfection of mammalian cells and in vivo labeling: 
HeLa Kyoto cells were grown in DMEM low glucose medium (1 g/L) (Sigma, Munich, Germany) 
with 10% FBS (Sigma) and 1% L-Glutamine (Gibco Life Technologies GmbH, Darmstadt, 
Germany). Cells were seeded in 4-well chambers (glass bottom, Lab-Tek, Thermo Fisher 
Scientific, Langenselbold, Germany). Next day the growth medium was exchanged to fresh 
one supplied with 250 µM of the UAA, and cells were co-transfected (1:1 ratio) with plasmids 
carrying NLS-MBP-GFPY39TAG (NLS= nuclear localisation signal; MBP= maltose-binding 
protein; GFP= green fluorescent protein) and pylRSAF (tRNApyl/pylRS
AF pair) using jetPRIME 
transfection reagent following the manufacturer protocol (PEQLAB Biotechnologie GmbH, 
Erlangen, Germany). 24-36 h after transfection, the UAA-containing transfection medium was 
replaced by normal growth medium without UAA and incubated for 1-3 h in order to wash off 
excess UAA. Cells were washed once with 1xPBS and subsequently treated with -20°C cold 
acetone for 4 min to fix and permeabilize the sample. After washing once with 1xPBS, cells 
were incubated with either 100 nM Cy5-tetrazine for 10 min (Figure 3), 200 nM Cy5-tetrazine 
for 2 h (Figure S4), or 10 µM 5-,6-carboxytetramethylrhodamine-PEG3-azide (Azide-Fluor 545, 
Jena Bioscience, Jena, Germany) for 2 h (Figure S5). To stop the labeling reaction, cells were 
simply washed three times with 1xPBS, stained with Hoechst 33342 (1 µg/mL, 10 min, Sigma) 
and kept in 1xPBS at 4 °C in the dark until imaging. Cells were then mounted on a Leica SP5 
confocal fluorescence microscope employing a 1.2NA 40x oil objective (Leica, Mannheim, 
Germany) and imaged in three channels (Hoechst, GFP, TAMRA or Cy5, respectively). 
Images were analyzed using ImageJ Fiji. The right channel shows a false colour overlay of all 
three fluorescent channels with the corresponding DIC image. Scale bar 50 µm for all images.
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Supplementary Tables and Figures
Figure S1: SDS PAGE analysis of crude lysate for the protein expression from GFPY39TAG→1, GFPY39TAG→2 and 
GFPWT expressing E.coli cells (arrow indicates height of GFP band). GFPWT expression is approximately 
10 times higher compared to GFPY39TAG→1 and GFPY39TAG→2.
Table S1: For mass spectroscopic validation, GFPY39TAG→2 samples were analyzed in comparison to GFPWT 
which exhibits a tyrosine residue instead of the UAA. The results verifying the successful incorporation 
of 2 are summarized in the table. In addition, masspectrometric proof of dye reacted with GFP is given. 
Purified GFPY39TAG→2 at a final concentration of 50 µm was separately reacted with TAMRA-tetrazine 
(molecular weight (MW)= 599.64 Da) or TAMRA-azide, (molecular weight (MW)= 512.56 Da) at a final 
concentration of 500 µm (= 10 eq) by 16 h shaking in the dark at 37 °C. Purification was done using Ni-NTA 
chromatography. Under the chosen reaction conditions, unlabeled GFPTAG→UAA was not observed.
Figure S2: Labeling of GFPY39TAG→1, GFPWT and GFPY39TAG→2inside E. coli cells and analysis of whole cell 
lysate for fluorescence (left panel) and the corresponding Coomassie stain (right panel). After already 
5 min, a clear fluorescent signal is visible at the expected height of the GFP band in the lysate from 
GFPY39TAG→2 expressing cells (middle row), whereas only a faint fluorescent signal is present in lysate 
from GFPY39TAG→1 expressing cells (upper row) and no signal in lysate from GFPWT expressing cells (lower 
row) demonstrating the orthogonality of the system. After 2 h, the labeling reaction of GFPY39TAG→2 has 
reached completion. In contrast, after more than six hours the intensity of the fluorescent band is still 
increasing in GFPY39TAG→1 expressing cells indicating that the reaction is not complete yet. There is also a 
faint fluorescent band (upper and middle panel) visible at around 50 kDa, which is very likely the pylRSAF 
that is also overexpressed in the cells. Longer incubation times also result in increased non-specific dye 
sticking (lower panel), since mass spectrometry analysis did not show any covalent labeling of GFPWT with 
dye after 16 h of incubation (see Table S1).
Figure S3: Structures of TAMRA-tetrazine (right structure) and Cy5-tetrazine (left structure) (Wiessler et 
al., 2010; Plass et al., 2012).
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GFPY39TAG      2 ~1.7 ± 0.3 29000 ± 7500→
Table S2: Reaction rate constants for GFPY39TAG→1 and GFPY39TAG→2.
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Figure S4: Fluorescence images of HeLa Kyoto cells expressing tRNApyl/pylRSAF and NLS-MBP-
GFPTAG→1 and NLS-MBP-GFPTAG→2 (upper and lower row, respectively). Pictures show from left to right 
fluorescence from Hoechst staining, GFP, TAMRA-tetrazine and colour overlay, respectively. At longer 
incubation times and higher dye concentration (200 nm Cy5-tetrazine), we observed also some red 
fluorescent labeling of NLS-MBP-GFPTAG→1, but also increased background fluorescence indicating dye 
adhesion or degradation.
Figure S5: Fluorescence images of HeLa Kyoto cells expressing tRNApyl/pylRSAF and NLS-MBP-
GFPTAG→2 after labeling with TAMRA-azide. Pictures show from left to right fluorescence from Hoechst 
staining, GFP, TAMRA-azide and colour overlay. Incubation with 10 µm TAMRA-azide gave signal in the 
TAMRA channel due to labeling for NLS-MBP-GFPTAG2 which is clearly above background (upper panel), 
while at 50 µm dye concentration also background labeling could be observed (lower panel).
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Introduction
The modification of proteins is key to many (bio)technological and diagnostic applications, 
including surface immobilization and conjugation of proteins to specific reporter molecules 
such as fluorophores, radioisotope labels or chelators. A well-known example of tailoring of 
protein properties for clinical application involves the covalent attachment of a polyethylene 
glycol chain (PEGylation) to increase the circulation half-life of a protein (Pasut and Veronese, 
2012). Proteins have also been conjugated to drugs and have been used as drug-delivery 
systems for therapy or diagnostic purposes (Kratz, 2008; Flygare et al., 2013). In this respect, 
a high level of control over the site of modification is particularly relevant, since a structural 
change can have direct impact on protein function. Amide bond formation with lysine side-
chains or thiol-maleimide chemistry for the reaction with cysteines generally lack site-
selectivity, because either amino acid is typically present multiple times in a given protein. 
An elegant strategy to enable chemoselective conjugation under mild conditions entails the 
site-specific generation of non-proteinogenic keto- or aldehydo-functionality, followed by 
oxime ligation (Chen et al., 2005; Wu et al., 2009; Agarwal et al., 2013). Selective protein labeling 
can also be achieved via azide-chemistry, i.e. Staudinger ligation (Saxon and Bertozzi, 2000), 
Cu(I) catalyzed azide–alkyne cycloaddition (CuAAC) (Link and Tirrell, 2003; Wang et al., 2003), 
or strain-promoted cycloaddition of cyclooctynes (SPAAC) (Kiick et al., 2002; Agard et al., 2004; 
Plass et al., 2011). Alternative 1,3-dipoles, such as nitrones (SPANC) (McKay et al., 2010; Ning et 
al., 2010), nitrile oxides (SPANOC) (Sanders et al., 2011), diazo compounds or sydnones have 
also been found suitable for this purpose (Sanders et al., 2011; Wallace and Chin, 2014). Many 
different technologies have been developed to site-specifically introduce the appropriate 
chemical handle into a protein, involving genetic, enzymatic and chemical approaches (Sletten 
and Bertozzi, 2009; van Hest and van Delft, 2011; Borrmann and van Hest, 2014). The strain-promoted 
inverse electron-demand Diels–Alder cycloaddition (SPIEDAC) of cyclooctynes or trans-
cyclooctenes with tetrazines has recently been developed as a particularly fast procedure 
to site-selectively label proteins (Blackman et al., 2008; Borrmann et al., 2012; Lang et al., 2012b; 
Plass et al., 2012). One shortcoming of the above conjugation strategies is the lack of temporal 
control of activation. 
Two elegant exceptions in this regard include the cycloaddition of alkenes and nitrile imines, 
generated in situ by UV irradiation (300 nm) of tetrazoles (Yu et al., 2012; An et al., 2013; Yu 
et al., 2013; Yu and Lin, 2014), and a photo-triggered click reaction upon in situ generation 
of cyclooctynes from a cyclopropene precursor with 350 nm light (Poloukhtine et al., 2009). 
However, short-wavelength conditions may not always be compatible with light-sensitive 
molecules. Controllable, site-specific reactions are highly valuable for multiplexing of (bio)
molecules and expansion of labeling diversity. Early studies during the 1970s and 1980s 
described the reaction of plain cyclooctyne with various 1,2-quinones in organic solvents 
(Sakanishi et al., 1975; Verboom and Bos, 1981; Meier et al., 1982). It has also been shown that 
1,2-quinones can be generated on proteins by selective periodate oxidation of genetically 
incorporated 3,4-dihydroxy-l-phenylalanine (l-DOPA), leading to slow (5 hours) conjugation 
with a polysaccharide (Ayyadurai et al., 2011). We aimed to explore the facile catechol-to-quinone 
conversion as a fast, chemically activatable bioconjugation by strain-promoted chemistry. In 
Abstract
A main challenge in the area of bioconjugation is to devise reactions that are both activatable 
and fast. Here, we introduce a temporally controlled reaction between cyclooctynes and 
1,2-quinones, induced by facile oxidation of 1,2-catechols. This so-called strain-promoted 
oxidation-controlled cyclooctyne–1,2-quinone cycloaddition (SPOCQ) shows a remarkably 
high reaction rate when performed with bicyclononyne (BCN), outcompeting the well-known 
cycloaddition of azides and BCN by three orders of magnitude, thereby allowing a new level 
of orthogonality in protein conjugation.
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this chapter, we describe the potential of 1,2-quinone cycloadditions with a highly reactive 
cyclooctyne variant, i.e. bicyclo[6.1.0]non-4-yne (BCN), as a novel bioconjugation tool. We 
show that the reaction of 1,2-quinone with BCN is highly suitable for extremely fast and 
selective in vitro labeling of proteins. Moreover, the cycloaddition can be selectively activated 
by the oxidation of the catechol moiety to 1,2-quinone providing temporal control over the 
reaction (Scheme 1).
(Figure 1B) a large difference in absorbance between 1 and 3, most notably at 384 nm. We 
therefore monitored the (exponential) decay of the absorbance of 1 at 384 nm over time upon 
reaction with BCN in 1:1 methanol/water (Figure 1, S1). Based on these measurements, the 
reaction rate constant for SPOCQ was calculated to be 496 ± 70 M-1s-1, roughly the same 
order of magnitude as the reaction of BCN with tetrazines (400-1200 M-1s-1) (Lang et al., 2012b) 
and the reaction of spirocyclopropene with nitrile imines (890 M-1s-1) (Yu and Lin, 2014), but 
orders of magnitude faster than the strain-promoted cycloaddition of azides and cyclooctynes 
(typical values 0.01-1 M-1s-1) (Sletten and Bertozzi, 2011). Furthermore, the cycloaddition of 1 
with BCN outperforms the SPANC reaction (highest values up to 39 M-1s-1) or the recently 
identified reaction of BCN with sulfenic acid (12 M-1s-1) (Ning et al., 2010; Poole et al., 2014). Taken 
together, only the strain-promoted inverse electron-demand Diels–Alder cycloaddition of 
tetrazine with trans-cyclooctene (SPIEDAC) shows a significantly higher reaction rate constant 
(> 5000 M-1s-1) than SPOCQ (Lang et al., 2012b). We also investigated the cycloaddition of 1 
with cyclooctyne derivative dibenzoazacyclooctyne (DBCO, also known as DIBAC), earlier 
developed by us as well as by others (Debets et al., 2010a; Kuzmin et al., 2010). While DBCO is 
known to react faster with (aliphatic) azides than BCN, surprisingly, the reaction rate constant 
for cycloaddition with 1,2-quinone was found to be 1000 × slower (0.19 M-1s-1) than that for 
the reaction with BCN, as determined by NMR, and is comparable to the rate constants 
for previously described SPAAC reactions (Figure S2). The latter finding is in line with the 
Scheme 1: Strain-promoted Azide–Alkyne Cycloaddition (SPAAC) with BCN and Strain-Promoted 
Oxidation-Controlled Cyclooctyne–1,2-Quinone Cycloaddition (SPOCQ)
Results and Discussion
To assess the scope and limitations of the cyclooctyne–1,2-quinone reaction, first a model 
system was studied in detail. We selected the monosubstituted 4-tert-butyl substituted 
quinone (1) as a (relatively) stable and simple model substrate to investigate the reaction 
kinetics for cycloaddition with BCN (Dommerholt et al., 2010). Hence, 4-tert-butyl-1,2-quinone (1) 
was prepared by oxidation of 4-tert-butyl-1,2-catechol with sodium periodate and isolated as 
a pure solid without column chromatography (Takata et al., 1983; Mure and Klinman, 1995). Next, 
cycloaddition was investigated by adding 1.5 equiv. BCN (2) to a solution of 1 in methanol/
water (1:1) (Figure 1). As anticipated, a rapid reaction took place as indicated by the immediate 
color change from red to yellow, and the formation of a new product based on TLC analysis. 
Purification by silica column chromatography led to the isolation of product 3 as a mixture 
of stereoisomers with a combined isolated yield of 80%, along with a small amount of an 
aromatic compound, formed by a retro-Diels–Alder reaction resulting in decarbonylation of 3 
(see Supporting Information).
The apparent fast reaction of 4-tert-butyl-1,2-quinone with BCN stimulated us to investigate 
in detail the second order rate reaction constant of this cycloaddition, which we termed 
strain-promoted oxidation-controlled cyclooctyne–1,2-quinone cycloaddition (SPOCQ). Initial 
attempts in this respect were focused on monitoring of the reaction progress with NMR, by 
integrating the disappearance/formation of the representative peaks. However, the reaction 
was too fast to monitor, i.e. (near) complete conversion was already observed at the first time 
point. Therefore, we turned our attention to UV-spectroscopy as a potential tool for measuring 
reaction conversion, based on the assumption that the highly conjugated 1,2-quinone system 
would display much enhanced absorbance with respect to the non-conjugated product 3 
(Poloukhtine et al., 2009). Indeed, UV-spectroscopy of the respective components indicated 
Figure 1: Reaction kinetics of SPOCQ. (A) Cycloaddition of 4-tert-butyl-1,2-quinone (1) with BCN (2). (B) 
UV/Vis spectrum of 1 and SPOCQ product 3 and determination of the reaction rate constant in MeOH/
H2O (1:1) at room temperature using the decay in absorbance of 1 at 384 nm. Due to the high rate of this 
reaction, there is a small variation in the time from mixing the reactants until starting the measurement, 
which causes the deviation at the beginning of the fitting line.
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observation that 1,2,4,6-tetrazines, another type of electron-deficient diene-reagents, as well 
as electron-poor aromatic azides (Dommerholt et al., 2014), react quickly with BCN, but not with 
DBCO (Chen et al., 2012; Karver et al., 2012).
Next, we explored the feasibility of SPOCQ for bioconjugation. First, we turned our attention 
to the selective labeling of peptides containing a catechol moiety. Model peptide 4, readily 
generated and purified by standard (solid phase) peptide synthesis, was first oxidized for 
30 min with sodium periodate (1 equiv.) to generate the corresponding 1,2-quinone in situ, 
followed by incubation with BCN-biotin (5). The progress of reaction was analyzed by high 
performance liquid chromatography (HPLC) using a reverse phase C-18 column. A new 
peak was identified with a retention time of 9 min (Figure S3). Mass spectrometry analysis 
of the newly formed product revealed a corresponding mass matching that of the anticipated 
cycloadduct product 6 (Figure S3). When peptide 4 was not oxidized prior to incubation with 
5, no reaction product was detected (Figure S3). These results show that the catechol moiety 
is inert towards BCN and can be controllably activated by oxidation to undergo reaction with 
BCN. The large difference in reaction rate constants of BCN with azide and 1,2-quinone 
triggered us to further investigate whether mutually orthogonal labeling could be achieved 
by the combination of SPOCQ and SPAAC. Thus, a competition experiment was designed 
with peptide 4 and N-terminally azide-functionalized peptide 7. HPLC and MS analysis of 
the reaction of oxidized peptide 4 and 7 with 5 revealed the formation of the cycloaddition 
product of 4 and 5, whereas the mass of the product from the SPAAC reaction between 5 and 
7 (anticipated product 8) was not detected (Figure 2, S4). However, when we repeated the 
experiment without adding the oxidized peptide, mass spectrometry confirmed the presence 
of the expected SPAAC product (Figure 2, S4). These findings show that the higher reaction 
rate of SPOCQ outcompetes SPAAC and can be used for selective labeling. Moreover, since 
the catechol moiety is inert towards BCN and only reacts after oxidation, it can be used as an 
activatable handle in conjugation studies. 
With these exciting findings in hand, we speculated that it should be possible to use SPOCQ 
for protein labeling. Although it is known that 1,2-quinones react with naturally occurring 
functionalities such as amines and thiols, chemoselective labeling with SPOCQ may still be 
feasible, since the reaction of BCN with 1,2-quinone displays such a high reaction rate (Horner 
and Sturm, 1955; Liu et al., 2006; Ayyadurai et al., 2011; Martinez et al., 2012). For protein labeling 
purposes, BCN can be readily incorporated into proteins via genetic code expansion as has 
been described in Chapter 2 (Borrmann et al., 2012; Lang et al., 2012b). Thus, we used a C-terminally 
His6-tagged green fluorescent protein (GFP
BCN) that carried an amber codon (TAG) mutation 
at position 39 as a model protein and genetically encoded BCN-lysine using a previously 
engineered version of the pyrrolysine tRNA-synthetase (pylRS) from Methanosarcina mazei 
and its corresponding suppressor tRNACUA (Figure 3A) (Plass et al., 2011). After recombinant 
expression, GFPBCN was purified by means of Ni-NTA chromatography. A catechol-containing 
fluorescent dye (9), synthesized in three steps from sulforhodamine B acid chloride and 
dihydroxyphenyl acetic acid (see SI), was then oxidized (10) and subsequently incubated 
(4 equiv.) with GFPBCN at room temperature for 1 h (Figure 3B). Wild-type GFP (GFPWT), that 
contains a tyrosine residue at position 39, was used as a negative control. Gratifyingly, in-
gel fluorescence analysis revealed that GFPBCN selectively reacts with 10 (Figure S5). Mass 
spectrometry analysis further confirmed the formation of a single product peak even when 
the oxidizing agent was directly added to a mixture containing GFPBCN and 9 (Figure S6). 
No ligation product was observed in the absence of oxidizing agent, (Figure S6). Based on 
mass spectrometry analysis, quantitative labeling was observed with small peptides (Figure 
S7) and labeling efficiency of proteins was estimated to be 90%. Moreover, co-incubation 
of GFPBCN with bovine serum albumin and 10 showed that reaction with GFPBCN was much 
faster than the reaction of other nucleophiles such as amines or thiols present in proteins, 
which limits undesired non-specific labeling with lysine or free cysteine (Figure S8). If cross-
reactivity becomes a problem for future in vitro applications, thiols can potentially be capped 
using sulfhydryl-reactive chemical groups such as iodoacetamide or maleimide.
Next, we followed the reaction of GFPBCN with 10 as a function of time to estimate whether 
the high reaction rate of SPOCQ, observed for small molecules, also translates into fast 
labeling of proteins. Samples were taken at various time points and subsequently quenched 
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7, respectively) with BCN-biotin (5). Competition experiment with and without oxidized peptide 4 was 
analyzed by HPLC followed by ESI-MS. R1 = PEG3-(+)-biotin.
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with an excess of BCN alcohol. We also performed the experiment with an azido-dye (11) 
to directly compare the labeling kinetics of 1,2-quinone cycloaddition to that of SPAAC. In-
gel fluorescence analysis showed that already after 1 min, GFPBCN was clearly fluorescently 
labeled with 10 and reached saturation within a few minutes (Figure 3B). In contrast, only faint 
labeling of GFPBCN with 11 was observable and did not reach completion within 1 h. To prove 
that the reaction of 10 with GFPBCN was indeed oxidation-controlled, we incubated GFPBCN 
with 9 and did not observe any fluorescent labeling (Figure 3B). As expected from previous 
cycloaddition studies with GFPBCN and absorbance/fluorescence measurements, structural 
integrity of GFP was also not influenced by the SPOCQ reaction (Figure S9) (Borrmann et al., 
2012; Lang et al., 2012b).
As a first attempt towards multiplexing, we sought to use the orthogonality of SPOCQ and 
SPAAC to form protein dimers. We synthesized a bifunctional linker 12 (Figure 3C) containing 
both an azide and a catechol moiety. A small excess of the linker (5 equiv.), after oxidation with 
periodate, was then incubated with GFPBCN for 1 h at room temperature. Subsequently, the 
excess of linker was removed by spin filtration and another equivalent of GFPBCN was added, 
leading to the desired formation (20-30%) of protein dimer, as analyzed by gel electrophoresis 
and Coomassie staining (Figure 3C). As expected, no dimer formation was observed without 
prior oxidation of the linker. Although other studies using bifunctional linkers to form protein 
dimers reported slightly higher yields (up to 50%) (Hutchins et al., 2011; Schoffelen et al., 2013), we 
envisage that further optimization of dimer formation could be achieved e.g. by use of a longer 
linker or incubation at higher concentrations. Nevertheless, these experiments demonstrate 
the feasibility of selective activation-conjugation by a combination of SPOCQ and SPAAC 
for multiplexing. Finally, it must be noted that the formed dimers were readily separated from 
the unreacted monomers with size exclusion chromatography, yielding a population of well-
defined protein dimers (Figure S10).
Conclusion
We have described a new bioconjugation reaction based on cycloaddition of bicyclo[6.1.0]-
nonyne and 1,2-benzoquinone derivatives. This new cycloaddition, named SPOCQ (strain-
promoted oxidation-controlled cyclooctyne 1,2-quinone cycloaddition) shows an extremely 
high reaction rate constant, several orders of magnitude faster than for SPAAC. We think that 
SPOCQ will add a new temporally controlled and fast reaction to the bioconjugation toolbox, 
since a variety of catechol derivatives as well as BCN-derivatives are readily accessible and, 
furthermore, both BCN and catechol-bearing amino acids can be genetically incorporated into 
proteins (Alfonta et al., 2003) and periodate treatment is a broadly applied tool for chemoselective 
oxidation of proteins (Geoghegan and Stroh, 1992). Although direct application of SPOCQ as a 
bioorthogonal tool for in vivo labeling is obviated due to the requirement of periodate, it is not 
excluded that for future applications, the oxidation of the catechol could also be mediated by 
an enzyme (e.g. catechol oxidase) (Claus and Decker, 2006) providing better compatibility of 
the latter oxidation step. Research along those lines is currently ongoing in our laboratories.
Figure 3: SPOCQ for bioconjugation. (A) Site-specific incorporation of BCN into GFP. (B) In-gel 
fluorescence assay and corresponding Coomassie stained protein gels of fluorescently labelled GFPBCN 
using SPOCQ and SPAAC. (C) Protein gel showing controlled dimer formation of GFPBCN using bifunctional 
linker 12 after oxidation. Dimers were separated from monomers using size exclusion chromatography (full 
chromatogram in Supporting Information). Elution fractions containing dimer and monomer are indicated.
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Experimental Section
Materials: 
Sulforhodamine B acid chloride, 4-tert-butyl-catechol and 2,2′-(ethylenedioxy)bis(ethylamine) 
were purchased from Sigma Aldrich and 3,4-dihyroxyphenylacetic acid and sodium periodate 
were purchased from Acros. All BCN-compounds and diazo-transfer reagent were purchased 
from SynAffix. N-(3-Aminopropanoyl)-dibenzoazacyclooctyne (DBCO-NH2) was a kind gift 
from SynAffix. Solvents were purchased from J.T. Baker, Sigma Aldrich or Fisher Scientific 
and used as received. Thin layer chromatography was performed on silica gel-coated plates 
(Kieselgel 60 F254, Merck, Germany) with the indicated solvent mixture, spots were detected 
by KMnO4 staining (1.5 g KMnO4, 10 g K2CO3, 2.5 mL 5% NaOH-solution, 150 mL H2O) and 
UV-detection. The pEvol plasmid encoding the mutant pylRS/suppressor tRNACUA and the 
plasmids encoding GFP were kindly provided by the laboratory of Dr. E.A. Lemke (EMBL, 
Heidelberg, Germany).
Instrumentation:
NMR spectra were recorded on a Varian 400 (400 MHz) or an Advance III Bruker 500 (125 
MHz) spectrometer. High-resolution mass spectra (HRMS) were recorded on a JEOL AccuTOF 
JMS-T100CS (Electrospray Ionization (ESI) time-of-flight) or a JEOL AccuTOF JMS-100GCv 
(Electron Ionization (EI), Chemical Ionization (CI)).
Synthesis of 4-tert-butyl-1,2-benzoquinone (1):
To a solution of 4-tert-butyl-catechol (1.0 g, 6 mmol) in 30 mL of THF/H2O (1:1) 
was added 6 mL of MeOH until the solution turned clear. Upon the portion wise 
addition of NaIO4 (1.28 g, 6 mmol, 1 eq.) the solution turned into a dark reddish 
suspension, which was allowed to stir at room temperature for approximately 30 min. The 
reaction mixture was extracted with DCM (2 × 100 mL). The organic layers were combined, 
dried (Na2SO4), filtered and concentrated in vacuo to yield 1 as a brownish/reddish solid 
(0.98 g, 5.97 mmol, 99% yield). RF 0.35 (heptane/EtOAc, 2:1). 
1H NMR (CDCl3, 400 MHz): δ = 
7.22 (dd, J =10.4, 2.4 Hz, 1H), 6.40 (dd, J = 10.4, 0.8 Hz, 1H), 6.28 (dd, J = 2.4, 0.8 Hz, 1H), 
1.25 (s, 9H). 13C NMR (CDCl3, 125 MHz): δ = 180.5, 180.4, 162.2, 140.2, 129.6, 124.0, 35.8, 
27.9. HRMS (EI) for C10H12O2: ([M]
+•), calcd: 164.0837, found: 164.0839
Synthesis of compound 3:
To a solution of 4-tert-butyl-1,2-
benzoquinone (51 mg, 0.31 mmol) in 
MeOH/H2O (1:1) was added endo-
bicyclo[6.1.0]non-4-yn-9-ylmethanol 
(endo-BCN, 2) (70 mg, 0.46 mmol, 1.5 
eq.). The reaction mixture was stirred at rt for 30 min. During the reaction the color changed 
from dark red to yellow. The reaction mixture was concentrated in vacuo. The residue was 
dry-loaded with silica and purified by column chromatography (1% triethylamine in EtOAc/
pentane (1:2 → 1:1) to afford 3 as a yellow, glassy solid (77 mg, 0.24 mmol, 79% yield) 
as a mixture of exo,endo and endo,endo diastereoisomers (3a + 3b). RF 0.10 (heptane/
EtOAc, 2:1). 1H NMR (CDCl3, 400 MHz): δ = 6.08-6.05 (m, 2H, diastereoisomer a+b), 3.89-
3.88 (m, 2H, diastereoisomer a + b), 3.73 (d, J = 6.4 Hz, 1H, diastereoisomer a), 3.73 (d, J 
= 6.4 Hz, 1H, diastereoisomer b), 3.69-3.67 (m, 4H, diastereoisomer a + b), 2.87-2.72 (m, 
4H, diastereoisomer a + b), 2.30-2.21 (m, 4H, diastereoisomer a + b), 2.13-2.01 (m, 4H, 
diastereoisomer a + b), 1.80-1.68 (m, 4H, diastereoisomer a + b), 1.13 (s, 9H, diastereoisomer 
a), 1.12 (s, 9H, diastereoisomer b), 1.14-1.04 (m, 2H, diastereoisomer a + b), 0.89-0.68 (m, 
4H). 13C NMR (CDCl3,125 MHz): δ = 182.6, 182.5, 181.5, 181.3, 154.1, 153.8, 136.6, 136.4, 
136.2, 135.7, 118.5, 118.4, 60.8, 60.4, 59.9, 59.9, 58.1, 58.0, 34.9, 34.9, 32.3, 32.2, 32.1, 
31.64, 31.5, 28.3, 28.2, 22.7, 22.4, 22.3, 22.3, 20.2, 20.1, 17.9, 17.6, 17.3, 16.7. HRMS (CI) 
for C20H26O3: (M + H
+−CO), calcd: 287.2006, found: 287.1996; (M +CH2CH3
+), calcd: 343.2273, 
found: 343.2290; (M + CH2CH3
+−CO) calcd: 315.2319, found: 315.2297.
Retro-Diels–Alder product:
1H NMR (CDCl3,400 MHz): δ = 7.12 (dd, J = 2.2 Hz, 7.7 Hz, 1H), 7.10 (d, J = 1.9 Hz, 1H) 
7.02 (d, J = 7.7 Hz, 1H), 2.97-2.88 (m, 1H) (the rest of the peaks overlaps with the major 
compound). 13C NMR (CDCl3,125 MHz): δ = 148.8, 141.7, 139.1, 129.9, 127.2, 122.7. HRMS 
(CI) for C18H26O: (M + H
+−OH), calcd: 241.1956, found: 241.1936; (M + H+−OH − t-Butyl), 
calcd: 185.1330, found: 185.1326.
Synthesis of 3,4-O-isopropylidene-3,4-dihydroxyphenylacetic acid (13):
This compound was synthesized according to a previously published 
procedure (Geiseler and Fruk, 2012) with an overall yield of 57%. 1H NMR 
(CDCl3, 400 MHz): δ = 6.68-6.67 (m, 3H), 3.54 (s, 1H), 1.66 (s, 6H). 
13C NMR (CDCl3, 125 MHz): δ = 177.7, 147.8, 146.9, 126.2, 122.1, 118.2, 109.7, 108.3, 40.8, 
26.0, HRMS (EI) for C11H12O4: ([M]
+•), calcd: 208.0736, found: 208.0741.
General Peptide Synthesis: 
2-Chlorotrityl resin was purchased from Bachem, Fmoc-l-amino acids were purchased 
from Novabiochem or Bachem and coupling reagents were purchased from Biosolve and 
Sigma Aldrich. Lyophilization was achieved using an ilShin Freeze Dryer (ilShin, Ede, The 
Netherlands). Analytical HPLC was performed on a Shimadzu LC-20A Prominence system 
(Shimadzu) equipped with a C18 ReproSil column, 150 × 3 mm, particle size 3 µm (Screening 
Devices). Elution of the peptides was achieved using an CH3CN/H2O gradient containing 
0.1% TFA (5-100%, 1-30 min, flow 0.4 mL/min). LC-MS was performed on a Thermo Finnigan 
LCQ-Fleet ESI-ion trap (Thermo Fischer, Breda, The Netherlands) equipped with an Alltima 
C18 column (50 mm, 2 mm, particle size 3 µm) (Alltech Applied Sciences BV). An CH3CN/H2O 
gradient containing 0.1% HCO2H was used for elution (5-100%, 1-10 min). 
Peptides were synthesized from 1.0 g 2-chloro-trityl resin using Fmoc solid-phase peptide 
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synthesis (SPPS). The resin was swollen in DCM for 20 min prior to use. Functionalization of 
the resin with the first amino acid was performed for 30 min with 2 eq. of the required amino 
acid and 3 eq. N,N-diisopropylethylamine (DIPEA). After the coupling reaction, capping of the 
resin was performed with 2 eq. DIPEA in MeOH. Deprotection of the Fmoc-groups was carried 
out with piperidine in DMF (20%, v/v) for 20 min. Subsequent couplings were performed for 
45 min with 3 eq. of the required amino acid, 3.3 eq. of N,N’-diisopropylcarbodiimide (DIPCDI) 
and 3.6 eq. of N-hydroxybenzotriazole (HOBt) in DMF. After each coupling and deprotection 
step, a Kaiser test (Kaiser et al., 1970) was done to ensure completion of the reaction. The 
peptides were cleaved from the resin by treatment with a mixture of TFA: triisopropylsilane 
(TIS):1,2-ethanedithiol (EDT):H2O (92.5: 2.5: 2.5: 2.5) for 3 h. Peptides were afforded by 
precipitation in Et2O, followed by freeze-drying from water.
Synthesis of peptide 4: 
The general procedure was followed for synthesis of the peptide. Compound 13 (2.5 eq.) was 
coupled as the final residue for 4 h using DIPCDI (2.75 eq.) and HOBt (3.0 eq.) in DMF. The 
peptide was cleaved from the resin and obtained as a white solid. 
LC-MS: m/z for C38H48N6O10: (M + H
+), calcd: 701.34, found: 701.3, Retention time = 6.43 min, 
analytical HPLC: Retention time = 12.58 min.
Synthesis of peptide 7: 
Bromoacetic acid (13.9 g, 100 mmol) and sodium azide (13.0 g, 200 mmol, 2 eq.) were dissolved 
in water (60 mL) and stirred for 48 h at rt (Pfeiffer et al., 2009). Concentrated hydrochloric acid 
(50 mL) was added to the reaction mixture after which extraction was performed with Et2O (4 
× 100 mL). The combined organic phases were dried over MgSO4 and evaporated in vacuo. 
The product was obtained as yellow oil and was dried under vacuum (9.86 g, 98%).
The general procedure was followed for synthesis of the peptide. As the final residue, 
azidoacetic acid (5 eq.) was coupled for 2 h using DIPCDI (5.5 eq.) and HOBt (6.0 eq.) in 
DMF. The peptide was cleaved from the resin and obtained as a white solid. LC-MS: m/z for 
C28H43N9O8: (M + H
+), calcd: 634.32, found: 634.6, Retention time = 6.40 min, analytical HPLC: 
Retention time: 15.10 min.
Synthesis of catechol-functionalized dye 9:
To a solution of 8 (50 mg, 0.070 mmol) in 
MeOH (4 mL) was added 10% Pd/C (10 
mg) and H2 was passed through for 4 h. 
The catalyst was filtered off over hyflo and 
the filtrate was concentrated in vacuo. 
The crude amine was dissolved in DMF 
(5 mL) and subsequently benzotriazol-1-
yloxy-tris(dimethylamino)phosphonium 
hexafluorophosphate (BOP, Sigma Aldrich) (31 mg, 0.070 mmol), DIPEA (25 µL, 0.140 mmol), 
and 3,4-dihydroxyphenylacetic acid (12 mg, 0.070 mmol) were added. After stirring for 16 h at 
rt the mixture was concentrated in vacuo. The residue was purified by column chromatography 
(H2O/ MeCN 1/20) to afford 9 (24 mg, 41%) as a dark red/purple solid. RF 0.37 (H2O/ MeCN 
1/12). 1H NMR (CDCl3 + CD3OD, 400 MHz): δ 8.79 (d, J = 1.8 Hz, 1H), 8.1 (dd, J = 7.9, 1.9 Hz, 
1H), 7.27 (d, J = 7.9 Hz, 1H), 7.15 (d, J = 7.9 Hz, 2H), 7.04 (t, J = 5.5 Hz, 1H), 6.77-6.68 (m, 
6H), 6.58 (dd, J = 8.1, 2.1 Hz, 1H), 3.57-3.51 (m, 16H), 3.38-3.34 (m, 2H), 3.32 (s, 2H), 3.25 (t, 
J = 5.3 Hz, 2H), 1.29 (t, J = 7.1 Hz, 12H). 13C NMR (CD3OD, 125 MHz): δ 174.8, 159.4, 157.8, 
157.1, 147.2, 146.4, 145.3, 144.2, 135.4, 133.7, 132.5, 129.3, 128.2, 127.7, 121.5, 117.3, 
116.4, 115.3, 115.0, 97.0, 71.3, 71.3, 70.7, 70.5, 46.8, 44.1, 43.3, 40.5, 12.8. HRMS (ESI) m/z 
for C41H51N4O11S2: (M + H
+), calcd: 839.2996, found: 839.2974.
Synthesis of azido-functionalized dye 11:
To a solution of sulforhodamine B sulfonylchloride 
(364 mg, 0.631 mmol) in DMF (5 mL) was added at 
0 °C DIPEA (169 µL, 0.947 mmol, 1.5 eq.) and O-(2-
aminoethyl)-O’-(2-azidoethyl)ethylene glycol (110 mg, 
0.631 mmol, 1eq.). After stirring for 16 h at rt the mixture 
was concentrated in vacuo and the residue was purified 
by column chromatography (column 1: MeOH/acetone/
DCM, 1/4.5/4.5, column 2: MeOH/DCM, 1/9) which 
afforded 11 (180 mg, 40%) as a dark red/purple solid. RF 0.21 (MeOH/DCM, 1/9). 1H NMR 
(CDCl3, 400 MHz): δ 8.84 (d, J = 1.6 Hz, 1H), 7.98 (dd, J = 7.9, 1.9 Hz, 1H), 7.29 (d, J = 9.5 
Hz, 2H), 7.21 (d, J = 7.9 Hz, 1H), 6.81 (dd, J = 9.5, 2.5 Hz, 2H), 6.67 (d, J = 2.5 Hz, 2H), 5.56 
(t, J = 5.9 Hz, 1H), 3.75-3.72 (m, 2H), 3.71-3.64 (m, 6H), 3.61-3.50 (m, 8H), 3.47-3.45 (m, 
2H), 3.30 (dd, J = 10.6, 5.6 Hz, 2H), 1.30 (t, J = 7.2 Hz, 12H). 13C NMR (CD3OD + CDCl3, 125 
MHz): δ 159.1, 157.7, 156.9, 147.1, 143.8, 135.1, 133.5, 132.1, 129.0, 127.6, 115.1, 114.8, 
96.8, 71.3, 71.2, 70.9, 70.7, 51.5, 46.7, 43.9, 12.8. HRMS (ESI+) m/z for C33H43N6O8S2: (M + 
H+), calcd: 715.2584, found: 715.2571.
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Synthesis of bifunctional linker 12:
To a solution of 3,4-dihydroxyphenylacetic acid 
(200 mg, 1.19 mmol) in DMF (2 mL) was added 
subsequently BOP (526 mg, 1.19 mmol), DIPEA (414 
µL, 2.38 mmol) and O-(2-aminoethyl)-O’-(2-azidoethyl)ethylene glycol (249 mg, 1.43 mmol). 
After stirring for 16 h at rt the mixture was concentrated in vacuo and the residue was purified 
by column chromatography (column 1: MeOH/acetone/DCM/toluene, 0.1/2/8/1, column 2: 
MeOH/EA, 1/19) which afforded the product (281 mg, 73%) as an oil. RF 0.32 (MeOH/EA, 
1/19). 1H NMR (CDCl3, 400 MHz): δ 6.76-6.72 (m, 2H), 6.58 (d, J = 7.9 Hz, 1H), 6.37 (t, J = 
5.1 Hz, 1H), 3.64-3.57 (m, 6H), 3.52 (t, J = 5.0 Hz, 2H), 3.44-3.41 (m, 4H), 3.37-3.35 (m, 2H). 
13C NMR (CDCl3, 125 MHz): δ 173.3, 144.7, 144.0, 126.5, 121.4, 116.4, 115.8, 70.5, 70.2, 
70.0, 69.6, 50.7, 42.8, 39.7. HRMS (ESI) m/z for C14H20N4NaO5: (M + Na
+), calcd: 347.1331, 
found: 347.1340.
Synthesis of N-(3-N’-acetyl-3-aminopropanoyl)-dibenzoazacyclooctyne (DBCO-NHAc) 
(14):
To a solution of DBCO-NH2 (80% purity, 90 mg, 0.33 mmol) in DCM 
(5 mL) was added Ac2O (46 µL, 0.49 mmol, 1.5 eq.), TEA (91 µL, 
0.652 mmol, 2 eq.) and a catalytic amount of 4-dimethylaminopyridine 
(DMAP). After stirring for 16 h at rt water (5 mL) was added and the 
mixture was extracted with DCM (3 × 10 mL). The organic layer 
was dried (Na2SO4), filtered and concentrated in vacuo. The residue was purified by column 
chromatography (MeOH/DCM, 1:19) to afford 14 (93 mg, 90%) as a white solid. RF 0.32 
(MeOH/DCM, 1/19). 1H NMR (CDCl3, 400 MHz): δ 7.68 (d, J = 7.5 Hz, 1H), 7.42-7.26 (m, 7H), 
6.07-6.02 (m, 1H), 5.14 (d, J = 13.9 Hz, 1H), 3.70 (d, J = 13.9 Hz, 1H), 3.38-3.30 (m, 1H), 
3.24-3.16 (m, 1H), 2.46 (ddd, J = 16.6, 7.7, 4.0 Hz, 1H), 1.96 (ddd, J = 16.6, 7.3, 3.7 Hz, 1H), 
1.81 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 172.5, 170.0, 151.2, 148.1, 132.2, 129.2, 128.7, 
128.6, 128.5, 128.0, 127.4, 125.7, 123.1, 122.7, 114.9, 107.9, 55.7, 35.4, 34.9, 23.3. HRMS 
(ESI) m/z for C20H18N2NaO2: (M + Na
+), calcd: 341.1266, found: 341.1275.
Preparation of 15 by reaction of DBCO-NHAc (14) and 1:
To a solution of 14 (30 mg, 0.094 mmol) in DCM (2 mL) was 
added 1 (23 mg, 0.094 mmol, 1 eq.).The mixture was stirred 
for 3 h at rt in the dark. The solvent was evaporated and 
the residue was purified by column chromatography (MeOH/
DCM, 1:19 →1:9) to afford 15 (as a mixture of endo/exo-
diastereomers and regioisomers, total 4 stereoisomers) (36 
mg, 79%). RF 0.13-0.29 (MeOH/DCM, 19/1). 
1H NMR (CDCl3, 400 MHz) and 
13C NMR (CDCl3, 
125 MHz) were recorded, but interpretation was impossible due to the overlap of signals 
for the 4 stereoisomers. HRMS (ESI) m/z for C30H31N2O4: (M + H
+), calcd: 483.2284, found: 
483.2290.
Retro-Diels–Alder products, mixture of regioisomers, HRMS (ESI) m/z for C28H31N2O2: (M + 
H+), calcd: 427.2386, found: 427.2401.
Kinetic measurements:
UV/Vis measurements were performed on a Varian Cary-50 spectrophotometer using a 1 cm 
quartz cuvette. A stock solution of BCN was prepared in MeOH/H2O (1:1) and filtered through 
an Acrodisc® 13 mm Syringe Filter (0.2 μm nylon membrane, Life Sciences). 4-tert-butyl-1,2-
benzoquinone was also dissolved in MeOH/H2O (1:1) to a final concentration of 100 μM. For 
a total volume of 1 mL 20 μL of the BCN solution (final concentration 190 μM) was added to 
the quartz cuvette followed by the addition of 980 μL of the 4-tert-butyl-1,2-benzoquinone 
solution. Since the product also slightly absorbs at 384 nm, we used the following equation: 
with Abs = total absorbance at 384 nm, εA and εP = extinction coefficients of substrate A and 
product P, respectively, and [A] and [P] = the concentrations of substrate A and product P, 
respectively (mol/L). 
The concentration of the product was then calculated using the following equation:
with [P] = concentration of product (mol/L), Abs = total absorbance at 384 nm, [A]0 = the initial 
concentration of substrate A (mol/L) and εA and εP = extinction coefficients of substrate A and 
product P, respectively.
The reaction was followed at a wavelength of 384 nm with a scanning interval of 0.5 sec and 
was done in triplo. From the conversion plots thus obtained, second order rate constants were 
calculated according to this equation:
with k = 2nd order rate constant (M-1s-1), t = reaction time (s), [A]0 = the initial concentration of 
substrate A (mol/L), [B]0 = the initial concentration of substrate B (mol/L).
1H NMR monitoring of the cycloaddition of DBCO-NHAc 14 with 1 was performed by rapid 
mixing (t=0) of stock solutions A and B (350 µL each) in an NMR tube and immediate insertion 
into a 400 MHz NMR spectrometer. NMR spectra were measured at preset time-intervals. The 
experiment was performed in triplo.
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Stock solution A: 14 was dissolved in a mixture of CD3OD and D2O (ratio 1:1, 1 mL) to give 
a 20.0 mM solution. Stock solution B: 1 was dissolved in a mixture of CD3OD and D2O (ratio 
1:1, 2 mL) to give a 24.0 mM solution. Kinetics of the reaction of 14 with 1 were determined 
by measuring the decrease of the integral of the signal at δ 3.72 caused by one DBCO-NHAc 
methylene proton, compared to the integral of the CD3OD solvent-peak as internal standard. 
A starting value for the integral of the methylene signal was estimated, due to the fact that 
cycloaddition had already proceeded significantly by the time of the first measurement.
HPLC analysis:
Peptide stock solutions (10 mM) and a NaIO4 stock solution (10 mM) were prepared in MilliQ, 
the BCN-biotin stock solution (10mM) was prepared in a mixture of acetonitrile and MilliQ (1:2). 
Peptide 4 and 7 were treated with sodium periodate (1 eq.) for 15 min at room temperature. 
Reactions were carried out in MilliQ with a final concentration of 750 µM peptide and 250 µM of 
BCN-biotin. The mixtures were incubated at room temperature for 1 h with moderate shaking 
and analyzed by LC-MS. 10 uL of the reaction mixtures were injected on a reverse-phase C18 
column (50 mm, 2 mm, particle size 3 µm) and analyzed using a linear CH3CN/H2O gradient 
with 0.5% HCO2H (5-100%, over 15 min). The corresponding mass spectra were acquired on 
a LCQ Fleet Ion Trap Mass Spectrometer (Thermo Scientific). 
Protein expression:
TOP10 cells (Life technologies) were transformed with a pBAD plasmid carrying the 
sequence for an N-terminally FLAG-tagged and C-terminally His-tagged amber mutant green 
fluorescent protein (GFP) and a pEvol plasmid encoding for the tRNACUA/mutant-pylRS pair, 
that has been reported by Plass et al (Plass et al., 2011). The protein expression was performed 
as described in Chapter 2 with minor changes (Borrmann et al., 2012). Briefly, bacteria were 
grown in 2xYT medium with ampicillin and chloramphenicol at 37 °C until OD 0.4-0.6, 
when expression was induced with 0.02% arabinose. BCN-lysine was dissolved in 0.1 M 
NaOH and added to the culture medium right before the induction with arabinose at a final 
concentration of 1 mM. Bacteria were grown for 16 h and harvested by centrifugation. The 
pellet was resuspended in 4x phosphate buffered saline (PBS, pH 8.0) with 10 mM imidazole 
and 1 mM phenylmethanesulfonyl fluoride (100 mM solution from Sigma Aldrich), and lysed by 
sonication. The lysate was centrifuged at 14.000xg at 4 °C for 25 min and the supernatant was 
incubated with Ni-NTA beads (Qiagen) for 2 h at 4 °C. Beads were washed and protein was 
eventually eluted using 4 × PBS, pH 8.0 and 500 mM imidazole. The buffer was exchanged for 
1 × PBS, pH 7.4 using a HiPrep 26/10 desalting column (GE healthcare). The eluted fractions 
were combined and concentrated and stored at -20 °C in 15% glycerol until further usage.
Protein mass spectrometry:
Protein samples were desalted with MilliQ (3 × with 400 µL) using 10 kDA MWCO centrifugal 
filter units (Millipore) and analysed by ESI-TOF on a JEOL AccuTOF. Samples were acidified 
with formic acid (0.1%) upon injection. Deconvoluted spectra were obtained using MagTran 
1.03 b2. Settings: charge range 1-100, peak width (Da) (isotope envelope) 1-50, max numbers 
of species 4, S/N 5, mass accuracy (Da) 0.05.
Protein labeling experiments:
To determine the selectivity of SPOCQ, 9 (10 mM stock solution) was oxidized for 30 min 
at rt using 1 eq. of NaIO4 (10 mM sock solution). 4 eq. of oxidized 9 was then incubated 
with GFPBCN (20 µM) and GFPWT (20 µM) at rt for 1 h with moderate shaking. Samples were 
then analyzed by SDS-polyacrylamide gel electrophoresis, in-gel fluorescence detection and 
Coomassie staining. In-gel fluorescence was measured on a G:BOX Chemi XT4 Fluorescent 
& Chemiluminescent Imaging System (Syngene) using 520 nm as excitation wavelength and 
emission was detected using the UV06 filter (572-625nm). To follow the labeling of GFPBCN 
as a function of time, 9 was oxidized as described earlier. For the control experiment, NaIO4 
was replaced by MilliQ. GFPBCN (final conc. 5 µM) was then incubated with 4 eq. of 9 (oxidized 
and not oxidized) and 11 and incubated at rt with moderate shaking. Samples were taken at 
indicated time points and were directly quenched with a 200-fold excess of BCN. Samples 
were eventually analyzed by SDS-polyacrylamide gel electrophoresis, in-gel fluorescence 
detection and Coomassie staining. 
Cysteine crossreactivity experiment:
9 (10 mM stock solution in DMSO) was oxidized by adding 1 eq. of NaIO4 (10 mM stock 
solution in MilliQ) for 10 min at rt and subsequently diluted to 500 µM with MilliQ. The oxidized 
dye was then added to a solution of BSA (500 µM stock solution, final concentration in reaction 
mixture 10 µM) and GFPBCN (530 µM stock solution, final concentration in reaction mixture 
10 µM) in PBS at final concentration of 10 µM and incubated at rt with moderate shaking. 
Samples were taken at indicated time points and a large excess of BCN was added to quench 
the reaction. The samples were analyzed by SDS-polyacrylamide gel electrophoresis, in-gel 
fluorescence detection and Coomassie staining.
Protein dimerization experiment:
Linker 12 was oxidized at rt for 30 min using NaIO4 (1 eq.). GFPBCN (final concentration 50 µM) 
was incubated with the oxidized linker (5 eq.) for 1 h at rt, with moderate shaking. The reaction 
mixture was transferred to a spin filter (10 K device, Amicon Ultra-0.5 mL, Millipore) and buffer 
was exchanged by the addition of 1 × PBS (3 × 15 min, at 4°C, 13000 × g). After spin-filtration, 
new GFPBCN was added (1 eq.) and incubated overnight at 37°C, with moderate shaking. Next 
day, the reaction mixture was analyzed using size exclusion chromatography (Superdex 75, 
Pharmacia), followed by SDS-polyacrylamide gel electrophoresis and Coomassie staining. 
For the control experiment linker 9 was used without prior oxidation.
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Supplementary Figures
Figure S1: UV/Vis measurement of compound 1 at 384 nm: Over the course of the kinetic experiment 
compound 1 does not show a decrease in the absorbance at 384 nm, when 2 has not been added.
Figure S2: Kinetics of the cycloaddition of 14 with 1 using 1H NMR, measurements were done in triplo: 
(A) Plots on the left-hand side show the decrease of the integral at δ 3.72 originating from one DBCO-
NHAc methylene proton during the reaction with 1. (B) Determination of the rate reaction constant for 
each measurement.
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Figure S3: HPLC spectra and corresponding m/z spectra for the reaction of BCN-biotin (m/z = 551.6) 
with 3 eq. of peptide 4 (m/z = 701.4) with (A) and without prior oxidation (B). (A) When peptide 4 was 
oxidized, a new peak (retention time: 9 min) with the expected mass of the anticipated product (m/z = 
1250, hydrate: m/z = 1268) was detected. (B) No reaction of BCN-biotin with peptide 4 was detected 
without prior oxidation. The peak with a retention time of 9.25 min in the right HPLC trace is an impurity 
from the peptide synthesis and can also be detected when only peptide 4 is injected.
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Figure S4: (A) HPLC spectra and corresponding m/z spectra for the reaction of BCN-biotin (m/z = 
551.6) with 3 eq. of azido-functionalized peptide 7 (m/z = 634.6) in the presence of NaIO4. The SPAAC 
reaction proceeded and two new peaks were detected with m/z values matching the anticipated products 
(m/z = 1201.0 (oxidation of biotin) and 1185.0 for peak 2 and 3, respectively). (B) HPLC spectra and 
corresponding m/z spectra for the reaction of BCN-biotin (m/z = 551.6) with 3 eq. of oxidized peptide 4 
(m/z = 701.4) and azido-functionalized peptide 7. A new peak (retention time: 9 min) with the expected 
mass of the anticipated product of the SPOCQ reaction was detected (m/z = 1250, hydrate: m/z = 1268), 
whereas the SPAAC product was not formed, showing that SPOCQ outcompetes SPAAC due to its high 
reaction rate.
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Figure S5: Protein gel (top): SDS-PAGE and in-gel fluorescence analysis: GFPBCN and GFPWT (final 
concentration 20 µM) were incubated with 10 (4 eq.) for 1 h at rt, with moderate shaking. In-gel 
fluorescence analysis revealed that only GFPBCN was fluorescently labeled, showing the selectivity of 
the SPOCQ reaction. Graph (bottom): Mass spectrometry analysis: To a solution of GFPWT (30 µM), 10 
(90 µM) was added, followed by incubation at rt for 60 min with moderate shaking. Mass spectrometry 
analysis revealed no formation of additional product peaks demonstrating the specificity of SPOCQ. The 
expected mass of GFPWT was found (calcd: 28713 Da, found: 28711 Da).
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Figure S6: Upper graph: To a solution of GFPBCN (30 μM), 9 (90 μM) was added, followed by NaIO4 (90 
μM) and the reaction mixture was incubated at rt for 60 min with moderate shaking. Mass spectrometry 
analysis revealed the formation of one single product with the expected mass of the ligation product 
(calcd: 29690 Da, found: 29689 Da). A small peak corresponding to starting material was also detected. 
The mass of 839.3 corresponds with the single charged mass of 9. Lower graph: To a solution of GFPBCN 
(30 µM), 9 (90 µM) was added, followed by incubation at rt for 60 min with moderate shaking. Mass 
spectrometry analysis revealed no formation of the SPOCQ product peak. Only the mass of GFPBCN was 
found (calcd: 28854 Da, found: 28853 Da) showing that SPOCQ is oxidation-dependent.
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Figure S7: (A) HPLC spectra and corresponding m/z spectra for the reaction of oxidized peptide 4 
(250 µM) with 2 (750 µM, 10 mM stock solution was prepared in CH3CN). First, a solution of 2 and 4 
was prepared and NaIO4 (250 µM) was subsequently added to this solution. The reaction mixture was 
incubated at rt for 1h and then analyzed by LC/MS. The formation of a new product was observed at 8.5 
with an m/z value of the anticipated product (calcd: 849.6 found: 849.6), whereas the peak of peptide 4 
(RT = 7.7 min) had disappeared. (B)When no oxidation agent was added, only peptide 4 was observed 
(m/z = 701.4). The asterisk denotes an impurity that was already present in the starting material.
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Figure S8: GFPBCN (10 µM) and bovine serum albumin (BSA) (10 µM) were incubated with 10 (10 µM) 
for 5 min and 30 min at rt. In-gel fluorescence analysis revealed that the labeling of GFPBCN with 10 was 
much higher than the labeling of BSA. In the absence of GFPBCN, strong labeling of BSA was observed 
already after 5 min. When the exposure time of the gel was increased, low labeling of BSA was visible in 
the sample that also contained GFPBCN.
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Figure S9: The characteristic GFP absorbance at 490 nm (red line) did not change after conjugation with 
10 (conjugate, blue line). Furthermore, fluorescence could also be detected after conjugation (intensities: 
10*103 a.u. for conjugate and 13*103 a.u. for GFPBCN). By interpreting the fluorescence data, it should be 
kept in mind that GFP and rhodamine are FRET pairs, which might explain the small differences observed 
in fluorescence.
Figure S10: Dimerization experiment with GFPBCN and linker 12 with and without prior oxidation, as 
analyzed by size exclusion chromatography. The upper UV-chromatogram shows the presence of a new 
peak (elution time: 9 mL, marked with asterisk) that is absent in the control experiment (no oxidation of 
the linker, lower chromatogram). SDS-PAGE analysis of the corresponding fractions revealed that indeed 
the peak at 9 mL contained covalently formed GFPBCN dimer, whereas the peak with an elution time of 10 
mL contained the GFP monomer.
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Introduction
Hydrogels are water-swollen networks, formed by cross-links between the polymeric 
constituents. In the past years, they have received increasing attention as injectable drug 
deliverables, as scaffolds for the immobilization of biomolecules and as matrix materials in 
regenerative medicine. Poly(ethylene glycol) (PEG) is often applied as the polymeric basis, 
because it has excellent biocompatibility, is hydrophilic, shows low toxicity and is non-
adhesive towards proteins and cells. Typically, the PEG-based polymers contain terminal 
mutually reactive groups that form a cross-linked network upon reaction (Peppas et al., 2006; 
Hoare and Kohane, 2008; Lin and Anseth, 2008; Zhu, 2010; Hoffman, 2012; Jonker et al., 2012; Kharkar 
et al., 2013). A variety of reactions have been successfully used to form gels via chemical 
cross-linking (Nimmo and Shoichet, 2011; Jiang et al., 2014). The Cu(I)-catalyzed azide–alkyne 
cycloaddition (CuAAC; commonly known as click reaction), as introduced by Meldal and 
Sharpless (Rostovtsev et al., 2002; Tornoe et al., 2002), has proven to be very promising to form 
PEG-based hydrogels as it is fast, high-yielding and modular, but most importantly orthogonal 
towards naturally occurring functionalities (Malkoch et al., 2006; Dijk et al., 2010). However, the 
cytotoxicity associated with the Cu(I)-catalyst limits the usage of CuAAC for the preparation of 
hydrogels for biomedical applications. Other conjugation strategies have also been reported 
for hydrogel formation such as thiol-ene photoclick reactions (Aimetti et al., 2009; Gupta et al., 
2010; Shih and Lin, 2012), Michael-type additions (Lutolf et al., 2003; Phelps et al., 2012), thiol-
norbornene reactions (Fairbanks et al., 2009), oxime chemistry (Grover et al., 2012), Diels–Alder 
cycloadditions (Wei et al., 2009; Nimmo et al., 2011; Alge et al., 2013) and strain-promoted azide–
alkyne cycloadditions (SPAAC) (DeForest et al., 2009; Xu et al., 2011; Zheng et al., 2012). Especially, 
Diels–Alder reactions and SPAAC form viable alternatives to CuAAC as cross-linking method 
due to their bioorthogonal character and spontaneous reactivity (Agard et al., 2004; Codelli et al., 
2008; Devaraj et al., 2008; Borrmann and van Hest, 2014). The Anseth group was the first to exploit 
SPAAC for hydrogel formation by using star-shaped PEG-azide and cyclooctyne-containing 
peptides. By incorporation of an alkene group, hydrogels could be post-modified with thiol-
containing compounds using UV-light (DeForest et al., 2009). However, an important aspect the 
above-mentioned cross-linking methods are lacking is a coupling strategy that is both fast 
and can be activated. Both are highly desired properties for injectable hydrogels and for other 
biomedical applications where spatiotemporal control of hydrogel formation is demanded. An 
interesting activatable and bio-inspired cross-linking method was reported by Messersmith 
and co-workers, whom functionalized 4-armed PEG (Mn = 10 kDa) with the unnatural amino 
acid 3,4-dihydroxyphenylalanine (DOPA). Subsequent oxidation of the DOPA groups to the 
corresponding 1,2-quinone with sodium periodate resulted in hydrogel formation (Lee et al., 
2002). In recent years, more groups have developed DOPA-inspired hydrogels as potential 
adhesive materials in tissue engineering (Brubaker and Messersmith, 2011; Ryu et al., 2011; Cencer 
et al., 2014). Apart from covalent cross-linking, the catechol moiety is also capable of forming 
strong complexes with metal ions like Fe3+. This property was recently used as a non-covalent 
cross-linking method to rapidly form pH-induced reversible hydrogels (Holten-Andersen et al., 
2011; Lee and Konst, 2014). However, strategies to form covalently cross-linked hydrogels are 
still hampered by slow reaction kinetics.
Abstract
Strain-promoted oxidation-controlled cyclooctyne–1,2-quinone cycloaddition (SPOCQ) was 
used as a fast and activatable cross-linking strategy for hydrogel formation. Gelation is induced 
by oxidation, which is performed either chemically with sodium periodate or enzymatically 
using mushroom tyrosinase. Due to the fast reaction kinetics, SPOCQ-formed hydrogels can 
be functionalized in one-pot with an azide-containing moiety using the strain-promoted azide–
alkyne cycloaddition.
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In this study, we report how the strain-promoted oxidation-controlled cyclooctyne–1,2-quinone 
cycloaddition (SPOCQ), as reported in chapter 3 (Borrmann et al., 2015) can be used as cross-
linking method for hydrogel formation. We show that the formation of hydrogels out of 4-armed 
star PEG, functionalized with cyclooctyne derivative bicyclo[6.1.0]non-4-yne (BCN), and the 
catechol derivative DHPA (3,4-dihydroxyphenylacetic acid), proceeds extremely fast upon 
chemical or enzymatic oxidation of the catechol moiety to a 1,2-quinone (Figure 1). Since 
both BCN and DHPA are readily accessible, making this a user-friendly cross-linking method 
for hydrogel formation. Furthermore, we demonstrate that SPOCQ and SPAAC can be used 
in concert, due to the large difference in reaction rates. The SPOCQ reaction thus offers a 
versatile, fast and activatable alternative to current hydrogel cross-linking strategies.
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Figure 1: Hydrogel formation using SPOCQ. (A) A mixture of star-PEG-BCN and star-PEG-DHPA is 
oxidized with sodium periodate or mushroom tyrosinase, to yield a stable hydrogel network. (B) SPOCQ 
cross-linking between BCN and DHPA upon oxidation.
Results and Discussion
In order to form hydrogels from 4-armed poly(ethylene glycol) (Mn = 10 kDa, star-PEG) as 
building block, functionalization of star-PEG with cyclooctyne derivative bicyclo[6.1.0]non-
4-yne (BCN) or with DOPA analogue 3,4-dihydroxyphenylacetic acid (DHPA) was required 
first. The functionalization could be readily achieved in one step by acylation of star-PEG-
amine with respectively BCN-succinimidyl ester or 3,4-dihydroxyphenylacetic acid (Figure 
S1-3). Sodium periodate was used to oxidize the catechol moieties and hydrogel formation 
was studied at polymer concentrations of 10, 20 and 30 mg mL–1 (1–3 wt%). The oxidizing 
agent (1 eq) was added to an equimolar mixture of polymers star-PEG-BCN and star-PEG-
DHPA. Hydrogels were formed almost instantaneously, due to the fast reaction kinetics of the 
SPOCQ reaction (Figure 1) (Borrmann et al., 2015). Varying the polymer concentration (10, 20 
or 30 mg mL–1) did not influence the gelation time. The mechanical properties of the hydrogels 
were measured using rheology. The storage (G’) and loss modulus (G’’) were determined with 
an oscillatory time sweep test. Due to fast gelation of our periodate-induced hydrogels, the 
gelation point (where G’ exceeds G’’) could not be determined. Stable G’ and G’’ values were 
already found from the start of the measurement and remained constant in an overnight time 
sweep study showing that gels quickly obtained their final strength (Figure 2A). Gels appeared 
to be soft at all studied polymer concentrations (10, 20 and 30 mg mL–1), as expected at these 
low percentages, while stronger gels were formed with increasing polymer content. G’ values 
of 65 Pa (10 mg mL–1), 454 Pa (20 mg mL–1) and 1375 Pa (30 mg mL–1) were obtained for the 
periodate-induced gels. The PEG material displayed typical hydrogel behaviour, as G’ values 
were much larger than G’’ values. Frequency sweep measurements were conducted on all 
cured hydrogels and G’ and G’’ values were found to be independent of frequency (Figure 
S4), which corresponds to a predominantly elastic composition of the hydrogels. Magic angle 
spinning (MAS) 1H-NMR was performed on 30 mg mL–1 hydrogels with an equimolar polymer 
ratio in order to study cross-linking efficiency. We focused on the peak at δ = 2.2 ppm, resulting 
from alkyne’s α-protons, which all shift upon reaction with the quinone. As expected, a small 
peak was still detectable in the gel, revealing the presence of dangling ends in the network 
(Figure S5). Next, we investigated the stability of star-PEG-BCN and star-PEG-DHPA upon 
storage. Solutions of both polymers were stored at room temperature and at 4 °C for one 
week. Hydrogels could still be formed in both cases, however gels made with polymers stored 
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Figure2: Rheological analysis of SPOCQ-induced cross-linked hydrogels. (A) Representative time 
sweep measurement (t = 5 min) of a hydrogel formed upon NaIO4 oxidation. Gels instantenously obtained 
their final G’ (red line) and G’’ (blue line) values. (B) Gelation time of mushroom tyrosinase cross-linked 
hydrogels as estimated via the inverted vial test. The gelation time was approximately 1 min with 2000 
units mL–1 and decreased with increasing enzyme concentration. (C) Representative time sweep mea-
surement (t = 2 h) of tyrosinase-induced cross-linking (500 units mL–1).
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at room temperature appeared to be less stiff, resulting in lower G’ values (Experimental 
Section).
Besides chemical activation of the catechol moiety, it can also be oxidized by certain enzymes 
such as mushroom tyrosinase (Lee et al., 2002). Other gelation systems have been described 
in previous reports that utilize an enzymatic reaction for gel formation, including horseradish 
peroxidase (Lee et al., 2002; Park et al., 2011), phosphatase (Yang et al., 2004) and transglutaminase 
(Sperinde and Griffith, 1997; Hu and Messersmith, 2003). Enzymatic cross-linking is advantageous 
due to the high substrate-specificity of the enzyme. Furthermore, by tuning the enzyme 
concentration, the overall cross-linking rate can be controlled (Ko et al., 2013). We set out to 
investigate enzymatically induced gel formation with SPOCQ. To this end, we studied gelation 
of an equimolar mixture of star-PEG-DHPA and star-PEG-BCN with the enzyme mushroom 
tyrosinase. We first investigated 20 mg mL–1 solutions at different enzyme concentrations 
(100–2000 units mL-1) (Figure 2B). Gelation times of the resulting enzymatically cross-linked 
hydrogels were estimated using the inverted vial test. Gelation was found to be fast and the 
time to gelation decreased, as expected, with increasing enzyme concentration. Samples 
of 20 mg mL–1 already led to gelation in approximately 1 min with an enzyme concentration 
of 2000 units mL–1. Lowering the enzyme concentration to 100 units mL–1 still resulted in gel 
formation after approximately 20 min (Figure 2B). The gelation time of the hydrogels can 
thus easily be controlled by adjusting the enzyme concentration. In order to follow gelation 
with rheology, we decided to perform these measurements with an enzyme concentration of 
500 units mL–1 on hydrogel solutions with a total polymer content of 10, 20 and 30 mg mL–1. 
Time sweep measurements were carried out for 2 h and showed that G’ began to increase 
rapidly after addition of the enzyme (Figure 2C). The mechanical properties of enzymatically 
cross-linked hydrogels were comparable to periodate-induced gels, as G’ values of 35 Pa 
10 mg mL–1 20 mg mL–1 30 mg mL–1
NaIO4
MT
65 Pa ± 10
35 Pa ± 3
454 Pa ± 19
921 Pa ± 37
1375 Pa ± 21
476 Pa ± 28
Table 1: Hydrogel strength G’ (Pa) measured by rheology. Values were recorded after 5 min for sodium 
periodate (n = 5) and after 2 h for mushroom tyrosinase (MT (500 units mL–1), n = 3).
(10 mg mL–1), 476 Pa (20 mg mL–1) and 921 Pa (30 mg mL–1) were acquired (Table 1). 
Hydrogels induced by tyrosinase also mainly had an elastic composition (Figure S6).
These data show that the high reaction rate constant of SPOCQ also translates into fast 
hydrogel formation after enzymatic or chemical oxidation of the DHPA groups. A similar study 
that solely used 4-armed PEG-DOPA constructs (130 mg mL-1) for gelation showed much 
slower kinetics, with gelation occurring only after 18 min with NaIO4. Enzymatic cross-linking 
with 25,000 units mL–1 mushroom tyrosinase resulted in hydrogel formation after 2 days (Lee et 
al., 2002). Another study that used SPAAC for cross-linking obtained a gelation point (G’ > G’’) 
within 5 min, using a polymer concentration of 13.5 wt% (135 mg mL–1) (DeForest et al., 2009). 
To be able to make a direct comparison with SPOCQ, we also performed the SPAAC reaction 
with our low polymer concentrations. For this purpose, star-PEG-N3 was first synthesized by 
coupling of azidoacetic acid to star-PEG-amine. Cross-linking of star-PEG-BCN and star-
PEG-N3 with SPAAC resulted in gelation points of 20 min for 30 mg mL
–1 up to 6 h for the 
10 mg mL–1 hydrogel Figure S7). The latter finding strongly corroborates the high reaction 
rate of SPOCQ for hydrogel formation compared to the SPAAC reaction. Furthermore, the 
mechanical properties of SPOCQ-formed PEG-hydrogels are also comparable to other 
previously reported PEG-hydrogels. For instance, measured moduli of 10 wt% SPOCQ gels 
(G’ = 11.7 ± 0.6 kPa, (Figure S8)) were similar to the reported moduli for 13.5 wt% SPAAC 
cross-linked gels (G’ = 12.0 ± 0.6 kPa) (DeForest et al., 2009) and to 13 wt% DOPA-DOPA cross-
linked gels (G’ = 13 kPa) (Lee et al., 2002). Moreover, Waite and co-workers recently introduced 
non-covalently cross-linked hydrogels with a more stable catechol analogue (3-hydroxy-4-
pyridinone, HOPO). Gels formed via the coordination of Fe3+ to HOPO appeared to have 
similar mechanical properties (10 wt%, G’ = 12 kPa) as our SPOCQ-formed hydrogels (Menyo 
et al., 2013).
Now that we showed that the SPOCQ reaction can be applied as an efficient, activatable and 
fast cross-linking method for hydrogel formation, we wanted to further explore the possibilities 
to functionalize these hydrogels. In chapter 3, we demonstrated that the 1,2-quinone and 
the azide moieties can be utilized as an orthogonal reaction pair due to their large difference 
in reactivity towards BCN (Borrmann et al., 2015). In this respect, it was hypothesized that 
we could utilize this property to post-functionalize our SPOCQ-formed hydrogels using the 
SPAAC reaction. To this end, we first tested if gels could be formed with non-equimolar 
amounts of star-PEG-DHPA and star-PEG-BCN. We chose to study gels with a final polymer 
concentration of 20 mg mL–1 (2 wt%) containing star-PEG-DHPA and star-PEG-BCN in a 
ratio of 0.8:1.0 (Figure 3A). Oxidation with sodium periodate still resulted in rapid gelation, 
corroborated by the inverted vial test. For subsequent functionalization, we utilized 3-azido-7-
coumarin, a dye that shows a strong increase in fluorescence upon cycloaddition to an alkyne. 
We added azido-coumarin to already formed hydrogels containing an excess of BCN-groups. 
Illumination with UV-light showed fluorescence at the site of addition, proving that the BCN-
groups are accessible for the SPAAC reaction with azido-coumarin (Figure 3B).
Next, we evaluated whether SPOCQ and SPAAC can also be performed orthogonally in one 
pot. For this experiment, hydrogels were prepared by adding a mixture of azido-coumarin and 
sodium periodate to a polymer mixture containing an imbalanced ratio of star-PEG-DHPA 
(0.8 eq) and star-PEG-BCN (1.0 eq). Immediate gelation was observed indicating that the 
presence of azido-coumarin did not interfere with the curing of the gel. Hydrogels containing 
a balanced ratio of star-PEG-DHPA (1.0 eq) and star-PEG-BCN (1.0 eq) were also prepared, 
which contained the same amount of azido-coumarin as for the imbalanced gel (0.8:1.0). The 
gels were subsequently analyzed for coumarin fluorescence under UV-light and a marked 
difference in fluorescence was observed. As expected, the hydrogel with the imbalanced 
polymer ratio showed a much higher fluorescence than the hydrogel with the balanced 
polymer ratio (Figure 3C-E). In order to quantify the observed differences in fluorescence, we 
prepared hydrogels in microwell plates and measured the fluorescence using a microplate 
reader. As seen in figure 3, the fluorescence of the imbalanced gels (DHPA:BCN = 0.8:1.0) 
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was significantly higher (40 ×) than the intensity of the balanced hydrogel (DHPA:BCN = 1:1). 
Moreover, the same trend was seen in MAS NMR, where a larger fraction of unreacted alkyne 
was present in imbalanced gels compared to the balanced hydrogel, further exemplifying 
the possibility to use the unreacted BCN groups for functionalization with azido-compounds 
(Figure S5). These findings show that SPOCQ and SPAAC can be used in one pot for the 
preparation of hydrogels (via SPOCQ) and subsequent post-modification (via SPAAC). In 
addition, incorporation of azido-coumarin did not change the mechanical properties of the 
network, since non-functionalized imbalanced hydrogels showed the same moduli (Figure 4). 
Using the same reactive group for cross-linking and functionalization can result in decreased 
hydrogel stiffness, as was shown for gels formed via the inverse electron-demand Diels–Alder 
reaction (Alge et al., 2013).
The advantage of using SPOCQ for hydrogel formation and SPAAC for simultaneous hydrogel 
functionalization was further exemplified when we prepared hydrogels with a lower polymer 
concentration of 10 mg mL–1 (1 wt%). We again used an imbalanced polymer ratio (0.8: 
1.0) and added azido-coumarin (1.5 eq, based on excess BCN) to the samples. SPOCQ-
induced cross-linked samples composed of star-PEG-DHPA (0.8 eq), star-PEG-BCN (1.0 eq) 
and azido-coumarin still formed hydrogels almost instantaneously after addition of sodium 
periodate. Similarly, we also prepared hydrogels cross-linked with SPAAC, to compare those 
Figure 3: Upon incorporation of a functional group (azido-coumarin), fluorescence increases after re-
action with alkynes in SPOCQ-formed gels using SPAAC. (A) Schematic overview. (B) Azido-coumarin 
added on pre-formed gels with an imbalanced polymer ratio, showing fluorescence at the side of addition. 
Gels were prepared by adding NaIO4 (1.0 eq per DHPA group) to a mixture star-PEG-DHPA (0.8 eq) and 
star-PEG-BCN (1.0 eq). On top of the gel was added 0.5 eq azido-coumarin (based on the excess of 
BCN-groups). (C) Gels with an imbalanced polymer ratio (excess star-PEG-BCN, 1) and a balanced ratio 
(2; top: picture under UV-light, bottom: regular picture. (C) Fluorescence measurements showing that 
imbalanced hydrogels (1, red) display a 40 × higher fluorescence intensity than balanced gels (2, blue). 
(E) Emission at 468 nm of gels with an imbalanced (2.9·× 104 ± 1.7·103)) and balanced ratio (7.4 × 102 ± 
3.4 × 102)) and a background measurement of only azido-coumarin (46 ± 3).
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star-PEG-BCN (1.0 eq) was reacted in the presence of azido-coumarin, hydrogel formation 
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Figure 4: Rheology of imbalanced hydrogels (20 mg mL–1) containing star-PEG-BCN and star-PEG-
DHPA in a ratio of 1.0:0.8. Red: time sweep measurement of non-functionalized imbalanced hydrogels 
(G’ = 285 ± 23 Pa, n = 5) Blue: time sweep measurement of azido-coumarin-functionalized hydrogels (G’ 
= 285 ± 48 Pa, n = 5). Incorporation of azido-coumarin does not change the mechanical properties of the 
hydrogel network.
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Figure 5: Competition experiment between SPOCQ and SPAAC, using a total polymer content of 
10 mg mL–1. (A) Sample containing 0.8 eq star-PEG-DHPA, 1.0 eq star-PEG-BCN and azido-coumarin, 
cross-linked by SPOCQ. (B) Sample containing 0.8 eq star-PEG-N3, 1.0 eq star-PEG-BCN and azido-
coumarin. No cross-linking occured. Excess azido-coumarin hampered the formation of a hydrogel. Left: 
reacted samples; middle: inverted vial test (sample B did not form a hydrogel, marked with an asterisk); 
right: under UV-light irradiation to detect coumarin fluorescence. (C) Hydrogels (polymer content of 
10 mg mL–1) are cross-linked using SPAAC in the absence of azido-coumarin.
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cross-linked hydrogels were formed (Figure 5 & Table S1). These findings show that azido-
coumarin interferes with gel formation when SPAAC is used as chemical cross-linking method. 
Due to the high reaction rate of SPOCQ, one-pot functionalization is possible, even at low 
polymer concentrations.
Conclusion
In conclusion, we have shown that strain-promoted oxidation-controlled cyclooctyne–1,2-
quinone cycloaddition (SPOCQ) is a fast and efficient cross-linking method for hydrogel 
formation. Cross-linking is activable and was achieved by addition of either a chemical 
oxidizing agent (NaIO4) or an enzyme (mushroom tyrosinase) catalysing the oxidation of 
DHPA. We have also shown that SPOCQ can be regarded as an orthogonal reaction pair 
with SPAAC, which allows us to easily incorporate a second functionality during or after 
the curing process. We think that the combined usage of an imbalanced ratio of BCN and 
catechol groups for gel formation and SPAAC will provide a straightforward method to modify 
hydrogels with other functionalities or biomolecules, such as peptides for cell adhesion 
or biomineralization. Hydrogel modification can either be achieved directly in one pot or 
sequentially on pre-formed gels. We expect these hydrogels to be ideal in those applications, 
where fast or spatiotemporally controlled gel formation is required.
Experimental Section 
Materials: 
4-Armed poly(ethylene glycol)-NH2 (10 kDa) salt was obtained from JenKem Technology 
(USA). (1R,8S,9S)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate was purchased 
from SynAffix (Oss, The Netherlands). 3-Azido-7-hydroxycoumarin (N3-coumarin) was kindly 
provided by Jan Dommerholt. All other chemicals were purchased from Sigma-Aldrich, Baker 
or Fluka and utilized as received. 
Instrumentation: 
1H NMR spectra were recorded on a Varian Mercury (400 MHz). Chemical shifts are given 
using TMS as reference (δ = 0 ppm). Mass spectra were recorded on a Bruker Biflex MALDI-
TOF (Bruker Daltronik, Bremen, Germany). As matrix, α-cyano-4-hydroxycinnamic acid 
was used. Column chromatography was performed with Silica gel 60 (particle size 0.040 
– 0.063 mm Merck) or aluminum oxide (basic activated, pore size 58 Å, Sigma-Aldrich). Thin-
layer chromatography (TLC) was performed on silica gel coated plates (Merck 60, F-254). 
Visualization was accomplished with UV-light and/or ninhydrin or permanganate staining. 
Lyophilization was achieved using an ilShin Freeze Dryer (ilShin, Ede, The Netherlands). 
Rheology measurements were performed on an AR2000ex rheometer (TA instruments, New 
Castle, USA). UV irradiation was performed with a CAMAG UV-lamp (366 nm). Fluorescence 
measurements were performed on a Tecan Infinite M200 Pro plate reader. 
Synthesis of star-PEG-BCN: 
To a dry reaction flask was added 4-armed poly(ethylene glycol)-NH2 HCl salt (600 mg, 0.06 
mmol), (1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate (BCN-OSu; 
87.4 mg, 0.30 mmol) and 100 µL triethylamine (100 µL, 0.72 mmol) in dry DCM (25 mL). The 
reaction mixture was stirred at rt overnight under N2 atmosphere and then washed with 2M 
NaOH (3 × 25 mL). The organic layer was dried over Na2SO4 and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (MeOH:DCM 2:98, followed by 
10:90) to afford the product after freeze-drying from dioxane. The obtained white powder was 
stored at -20°C until further usage (406 mg, 63%) (Dommerholt et al., 2010). (REF) RF = 0.36 
(MeOH:DCM, 10:90); 1H NMR (400 MHz, CDCl3, δ): 0.86-1.01 (m, 4H), 1.25-1.43 (m, 8H), 
1.52-1.66 (m, 8H), 2.18-2.34 (m, 16H), 3.38 (m, 16H), 3.51-3.86 (m, [CH2CH2O]n), 4.15 (d, J = 
8.0 Hz, 8H); MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure S1.
Synthesis of star-PEG-DHPA: 
To star-poly(ethylene glycol)-NH2 HCl salt (500 mg, 50 µmol) in DMF (13 mL) was added 
subsequently benzotriazol-1-yl-oxy-tris dimethylaminophosphonium hexafluorophosphate 
(BOP; 133 mg, 0.30 mmol), 3,4 dihydroxy phenylacetic acid (51 mg, 0.30 mmol), and DiPEA 
(210 µL, 1.2 mmol). The reaction mixture was stirred overnight at r.t., after which the DMF was 
evaporated in vacuo. The residue was dissolved in DCM and washed with 1 M KHSO4 (3 × 40 
mL) and brine (1 × 40 mL). The organic layer was dried over Na2SO4. The product was purified 
with column chromatography on basic aluminum oxide (MeOH: DCM; 10:90). Lyophilization 
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from dioxane afforded the product as a white powder, which was stored at 4°C. (445 mg, 84%) 
RF = 0.25 (MeOH:DCM, 10:90); 
1H NMR (400 MHz, CDCl3, δ): 3.36-3.86 (m, [CH2CH2O]n, CH2-
Ar-CH), 6.61-7.03 (m, Ar-CH); MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure S2.
Synthesis of star-PEG-N3: 
To star poly(ethylene glycol)-NH2 HCl salt (800 mg, 80 µmol) in DCM (25 mL) was added 
subsequently BOP (283 mg, 0.64 mmol), azido acetic acid (Pfeiffer et al., 2009) (65 mg, 0.64 
mmol) and DiPEA (328 µL 1.92 mmol). The reaction mixture was stirred overnight at r.t and 
extracted with 1 M KHSO4 (5 × 50 mL) and brine (1 × 50 mL). The organic layer was dried over 
MgSO4 and concentrated in vacuo. The compound was purified by column chromatography 
on basic aluminum oxide, using MeOH:DCM  (10:90) as eluent. Freeze-drying from dioxane 
afforded the product as a white powder (760 mg, 92%). RF = 0.38 (MeOH:DCM, 10:90); 
1H 
NMR (400 MHz, CDCl3, δ): = 3.41 (s, 8H), 3.45-3.55 (m, 16H), 3.57-3.70 (m, [CH2CH2O]n), 
3.96 (s, 8H); MALDI-TOF (α-cyano-4-hydroxycinnamic acid): Figure S3; IR = 2103.52 cm-1 
(N3).
Hydrogel formation: 
Hydrogels were formed by addition of NaIO4 or mushroom tyrosinase to an equimolar 
mixture of star-PEG-BCN and star-PEG-DHPA. Hydrogels were prepared in total polymer 
concentrations of 10, 20 and 30 mg mL–1 (1–3 wt%) in water (NaIO4) or in PBS (tyrosinase). 
For a typical hydrogel, equal volumes of the polymer mixture and the oxidizing agent were 
mixed to the final concentration. For the polymer mixture, stock solutions of 20, 40 and 60 
mg L–1 of star-PEG-BCN and star-PEG-DHPA were first freshly prepared and then mixed in 
a 1:1 fashion. For hydrogels formed by sodium periodate, a stock solution containing 1 eq 
NaIO4 (based on amount of DHPA groups, 4 eq NaIO4 per star-PEG-DHPA) was prepared 
in MilliQ. Hydrogels formed by mushroom tyrosinase were formed in 1xPBS (pH 7.5), which 
was purged with O2 for 15 min prior to use. A tyrosinase stock solution was prepared in PBS 
containing twice as many units mL–1 as needed in the final gel sample.
Determination of gelation time: 
Gelation time was determined qualitatively using the inverted vial test. The test was not applied 
for hydrogels formed by sodium periodate, due to almost instant gel formation as soon as all 
components were mixed. For the enzymatically cross-linked hydrogels, the gelation times 
were determined using a tyrosinase concentration series: 100–2000 units mL–1. For this, a 
4000 units mL–1 stock solution in PBS was first prepared, of which a dilution series was made. 
Hydrogels (20 mg mL–1) were formed using the typical procedure. As soon as the enzyme 
solution was added to the polymer mixture, the time measurement was started. When the 
material stopped flowing, and the vial could thus be inverted, the measurement was ended. 
Gelation time measurements were performed in triplo (Figure 2).
Rheology: 
The storage (G’) and loss modulus (G’’) of the hydrogels were measured using an AR2000ex 
rheometer (TA instruments) (Table 1). All measurements were performed using a flat steel 
plate geometry (20 m, gap size 500 µM) and were performed at a temperature of 20 °C. 
Hydrogels were prepared by loading 100 µL of a star-PEG-BCN/star-PEG-DHPA mixture 
directly on the testing platform. After addition of 100 µL NaIO4 or mushroom tyrosinase stock 
solution, the upper plate was immediately lowered and the measurement was started. Initially, 
a strain sweep measurement was conducted to determine the linear viscoelastic range of the 
hydrogels, by measuring between 0.1 and 1000% strain at an angular frequency of 10 rad/s. 
Within this range, a strain percentage (1%) was chosen to perform further measurements. 
The values of G’ and G’’ for periodate-induced gels (10, 20 and 30 mg mL–1) were determined 
using an oscillatory time sweep test for 5 min at a constant strain of 1% and an angular 
frequency of 10 rad/s. Time sweep measurements for enzyme-induced gels were performed 
for 2 h, using a final enzyme concentration of 500 units mL–1. To minimize evaporation, a 
solvent trap was utilized which was filled with water. For frequency sweep measurements, 
the angular frequency was measured between 0.1 and 100 rad/s and a constant strain of 
1%. All measurements were performed at least in triplicate (Table 1, Figure S4, S6). SPAAC 
cross-linked hydrogels were measured by loading an equimolar mixture of star-PEG-BCN 
and star-PEG-N3 on the rheometer. Time sweep measurements were conducted for 16 h for 
10 mg mL–1 hydrogels and for 2.5 h for 30 mg mL–1 gels, using the same settings as above 
(Figure S7).
Stability measurements: 
Star-PEG-DHPA and star-PEG-BCN solutions of 40 mg mL–1 were prepared in MilliQ and 
stored at 4°C and at room temperature for 1 week. In order to determine the stability of the 
polymers in solution, hydrogels of 20 mg mL–1 were prepared with the aged solutions using 
sodium periodate as oxidizing agent. Time sweep measurements of hydrogels formed with 
polymers stored at 4°C resulted in comparable moduli (G’ = 468 ± 26 Pa, n = 3) as obtained 
for freshly prepared gels (G’ = 454 ± 19 Pa, Table 1). Hydrogels prepared with polymers left 
at room temperature were less stiff, resulting in slightly lower G’ values (G’ = 361 ± 16 Pa, n 
= 2). For long term storage it is therefore advisable to store the polymers as solids at lower 
temperatures. 
Magic angle spinning (MAS) 1H NMR: 
Hydrogels were prepared in final polymer concentrations of 30 mg mL–1 using the standard 
procedure with sodium periodate as oxidizing agent. Gels were prepared with three different 
ratios of star-PEG-BCN : star-PEG-DHPA of 1:1 (balanced), 1:0.8 and 1:0.5. The total sample 
volume used was 200 µL. NMR experiments were performed on a Varian 300 MHz solid 
state NMR spectrometer. Single pulse 1H NMR experiments were performed using a 9.5 mm 
Chemagnetics probe, with magic angle spinning at a frequency of 1605 Hz. The gels were 
prepared in a Teflon sample insert that fit snugly into the 9.5mm rotor. T1 measurements were 
performed to ensure that the repetition delay of 10s was sufficiently long so that measurements 
were quantitative. For each preparation 256 scans were accumulated (Figure S5).
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Supplementary Tables and Figures
Figure S1: MALDI –TOF spectrum star-PEG-BCN.
Figure S2: MALDI-TOF spectrum star-PEG-DHPA.
Figure S3: MALDI-TOF spectrum star-PEG-N3.
Fluorescence measurements: 
For post-functionalization: see Figure S9. Imbalanced hydrogels contained a polymer ratio of 
0.8: 1.0 of star-PEG-DHPA and star-PEG-BCN. For example, a 200 µL hydrogel (20 mg mL-1) 
contained 1.78 mg star-PEG-DHPA (0.8 eq) and 2.22 mg star-PEG-BCN (1.0 eq). Hydrogels 
were oxidized by sodium periodate, using 1 equivalent of NaIO4 per DHPA group. Gels 
contained 1.5 equivalents 3-azido-7-hydroxycoumarin (N3-coumarin) per BCN-group, based 
on the excess of star-PEG-BCN (in the example: 0.44 mg). Balanced hydrogels contained an 
equimolar polymer ratio (1:1, for example 2.0 mg star-PEG-DHPA and 2.0 mg star-PEG-BCN). 
The amount of N3-coumarin remained equal for balanced hydrogels. For a typical hydrogel, a 
star-PEG-DHPA/star-PEG-BCN mixture (100 µL) was prepared, to which a N3-coumarin/NaIO4 
mix (100 µL) was added. This N3-coumarin/NaIO4 mixture was prepared using a stock solution 
of N3-coumarin in DMSO, in such a way that the maximum DMSO concentration in the mixture 
was 5%. Hydrogels were irradiated under UV-light (366 nm) using a UV-lamp (CAMAG). The 
fluorescence of N3-coumarin containing hydrogels was measured using a Tecan Infinite M200 
Pro plate reader. Hydrogels were prepared in a 96-wells plate, with a sample volume of 80 µL. 
Hydrogels were left for 15 min before the measurement was started. An emission scan was 
performed between 400 and 600 nm, using an excitation wavelength of 360 nm. To determine 
the background fluorescence, a mixture of star-PEG-DHPA, N3-coumarin and NaIO4 was 
measured. All fluorescence measurements were performed with n = 9. 
Competition reaction SPOCQ and SPAAC: 
Hydrogels with a total polymer content of 10 mg mL–1 were prepared with three different 
polymer compositions (Table S1). The first sample contained 0.8 eq star-PEG-DHPA, 1.0 eq 
star-PEG-BCN, 1.5 eq N3-coumarin (based on the excess of BCN) and 1 eq NaIO4 (per DHPA 
group), and was prepared in a similar manner as before. The second sample contained 0.8 eq 
star-PEG-N3, 1.0 eq star-PEG-BCN and an equal amount of N3-coumarin (1.5 eq), and was 
prepared by making a polymer mixture in MilliQ, to which a stock solution of N3-coumarin in 
DMSO (2.5%) was added. The third sample only contained the star-PEG-N3 (0.8 eq) – star-
PEG-BCN (1.0 eq) polymer mixture in MilliQ (Figure S11). Sample 2 and 3 were left overnight 
to allow gel formation to occur. The inverted vial test was utilized to check gel formation of 
the samples. The gels or solutions were examined under UV-light (366 nm) using a UV-lamp. 
Samples were prepared in triplicate.
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Figure S4: Rheological analysis of periodate-induced gels. G’ is represented by closed symbols, G’’ by 
open symbols. Left: Representative frequency sweeps of 10, 20 and 30 mg mL–1 hydrogels oxidized by 
sodium periodate. Right: Strain sweep measurement of a 20 mg mL–1 hydrogel to determine the linear 
viscoelastic region.
Table S1: Overview sample composition for the SPOCQ/SPAAC competition experiment. Total sample 
volume: 400 µL. Total polymer concentration: 10 mg mL-1. N3-coumarin: from stock solution: 24.6 mM (in 
DMSO, 1.5 eq based on excess of BCN groups). NaIO4: from stock solution: 3.54 mM (1 eq based on 
amount of DHPA groups). * = added together to a solution of star-PEG-DHPA and star-PEG-BCN.
Sample 1 Sample 2 Sample 3
Star-PEG-BCN 2.22 mg 2.22 mg 2.22 mg
Star-PEG-DHPA 1.78 mg - -
Star-PEG-N3 - 1.78 mg 1.78 mg
N3-coumarin 10 µL* 10 µL -
NaIO4 190 µL* - -
MilliQ 200 µL 390 µL 400 µL
δ 1H (ppm)
 
 
1.81.922.12.22.32.4
2:1
5:4
1:1
Figure S5: MAS 1H NMR spectrum showing the region where the alkyne signal resonates (δ = 2.2 ppm, 
protons next to the triple bond). Three different ratios of star-PEG-BCN: star-PEG-DHPA were measured. 
With an excess of star-PEG-BCN, more unreacted alkyne is present, with the most intense signal for the 
1:0.5 mixture.
Figure S6: Rheological analysis of enzymatically oxidized gels. G’ is represented by closed symbols, G’’ 
by open symbols. Left: Representative frequency sweeps of 10, 20 and 30 mg mL–1 hydrogels oxidized 
by mushroom tyrosinase (500 units mL-1). Right: Strain sweep measurement of a 20 mg mL–1 hydrogel to 
determine the linear viscoelastic region.
Figure S7: Rheology of SPAAC-cross-linked hydrogels; composed of star-PEG-BCN and star-PEG-N3. 
G’ is represented by closed symbols, G’’ by open symbols. Left: time sweep measurement (16 h) for a 
10 mg mL–1 polymer concentration, with the gelation point after approximately 6 h. Right: time sweep 
measurement (2.5 h) for a 30 mg mL–1 hydrogel, with the gelation point after approximately 20 min.
Figure S8. Rheological analysis of 100 mg mL–1 (10 wt%) SPOCQ cross-linked hydrogels, oxidized by 
periodate. G’ is represented by closed symbols, G’’ by open symbols. Gels obtained a G’ value of 11.7 ± 
0.6 kPa. Left: representative time sweep test (10 min). Right: frequency sweep measurement.
99
5Chapter
Annika Borrmann
Elles R. Simonetti
Elisabeth S. Pierson
Christa E. van der Gaast-de Jongh
Dimitri A. Diavatopoulos
Marien W.C. de Jonge
Jan C. M. van Hest
A Bioorthogonal Approach towards Fc-coated 
Bacteria for Vaccination
5 5
100 Chapter 5 Designing a Vaccine using Bioorthogonal Chemistry 101
Abstract
Vaccination is one of the most effective ways in preventing infectious diseases and has led 
to global eradication of some pathogens. Vaccines are usually administered by injection, 
which often results in less efficient protection at mucosal surfaces, the first defense line of the 
human body. Because most infections start at the mucosal surface, it is therefore important 
to induce local immunity specifically at this site. The neonatal Fc receptor mediates uptake of 
mucosal antigens bound to IgG, i.e. immune complexes, across the mucosa, which results 
in effective mucosal immunity. In this chapter, we aimed to develop a generic mucosal 
vaccination strategy for whole bacterial pathogens using bioorthogonal chemistry. Bacterial 
cell walls were modified with azides via the incorporation of the appropriate d-amino acids in 
the bacterial peptidoglycan structure. Although Fc fragments were selectively functionalized 
with a cyclooctyne group and were subsequently reacted with the azido-modified bacteria, we 
have not yet observed conjugation of the Fc fragment to the bacterial cell walls. More research 
is needed to study the effect of steric hindrance on the conjugation efficiency.
Introduction
Vaccination has been one of the most successful medical interventions to reduce morbidity 
caused by infectious pathogens. Delivering a live-attenuated or killed pathogen or subunits of 
the disease-causing organism has proven extremely effective in conferring protection against 
viral and bacterial infections (Delany et al., 2014). Most vaccines are administered by injection, 
i.e. parenteral vaccination. For many pathogens, e.g. polio and influenza, this induces efficient 
systemic immunity and protection against disease (Delany et al., 2014; Zens and Farber, 2015). 
However, for other important pathogens, such as Shigella, human immunodeficiency virus 
(HIV), pathogenic E.coli, Chlamydia or Staphylococcus aureus (S.aureus), vaccination 
remains a challenge. Mucosal protection is an important component of protection against these 
pathogens and in many cases experimental vaccines that induce local, mucosal immunity 
show improved efficacy over parenteral vaccination (Neutra and Kozlowski, 2006; Fujkuyama et al., 
2012). Different types of immune effector cells such as T-cells, B-cells, dendritic cells (DCs) and 
macrophages, are located close to the mucosa in the so-called mucosa-associated lymphoid 
tissue (MALT) (Wang et al., 2015). Moreover, some studies have shown that vaccination at the 
mucosa induces not only mucosal, but also systemic immunity against pathogens (Herremans 
et al., 1999; Fujkuyama et al., 2012). 
A promising strategy to achieve mucosal immunity involves the engagement of Fcγ receptors 
(FcγR) and neonatal Fc receptor (FcRn) (Heijnen et al., 1996; Keler et al., 2000). FcγRs are 
membrane-bound receptors, that are constitutively expressed by antigen-presenting cells 
(APCs) like dendritic cells and macrophages and mediate antigen uptake by binding to the 
constant region of IgG called Fc fragment (Gosselin et al., 2009). The neonatal Fc receptor is also 
a membrane-bound receptor that got its name because of its role in transporting maternal IgG 
across the placenta to the fetus. In spite of its name, FcRn is expressed at mucosal surfaces 
in adults and is involved in IgG homeostasis and in antigen-bound IgG immune complex 
phagocytosis (Dickinson et al., 1999; Roopenian and Akilesh, 2007). Human FcRn is a heterodimer 
consisting of the glycosylated class I major histocompatibility complex-like protein (α-FcRn) 
and a β2 microglobulin (β2m) subunit (Kuo et al., 2010). FcRn binds to a site in the CH2-CH3 
region of the Fc region and two FcRn molecules can bind to the Fc region simultaneously 
(Burmeister et al., 1994; Sanchez et al., 1999; West and Bjorkman, 2000). The affinity between FcRn 
and Fc is strongly pH-dependent (Ober et al., 2004).
Recently, Zhu and coworkers fused a model antigen of the herpes simplex virus type-2 (HSV-
2) pathogen to a mouse IgG Fc fragment, thereby targeting FcRn as well as Fcγ receptors. 
Intranasal vaccination with this construct resulted in mucosal and systemic immunity against 
HSV-2 (Ye et al., 2011). Immunity was also observed in a subsequent study in which they used 
this strategy for intranasal vaccination against HIV Gag protein (Lu et al., 2011). Both studies 
show the great potential of FcR-mediated immunization. Vaccination with a single antigen 
fused to the Fc fragment can be disadvantageous, because the resulting immune response 
relies on a single antigen and mutation of this antigen can result in immune escape of the 
pathogen. Rawool et al. used monoclonal antibodies (mAbs) against the bacteria Francisella 
tularensis to target whole bacteria to FcγRs and FcRn. Intranasal immunization with the mAb-
coated inactivated bacteria showed improved protection compared to non-coated bacteria, 
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when mice were challenged with the infectious agent (Rawool et al., 2008). This vaccination 
strategy has the advantage that it induces protection against many antigens, since whole 
bacteria present a mixture of antigens.
In this study, we aimed to develop a novel bacterial vaccination strategy by conjugating Fc 
fragments to the whole bacterial surface using bioorthogonal chemistry, which does not 
require prior knowledge and/or modification of the antigens. Bioorthogonal reactions are 
chemical reactions that are biocompatible and extremely specific in the presence of naturally 
occurring functionalities such as amines and thiols (Sletten and Bertozzi, 2009; Borrmann and 
van Hest, 2014). A good example is the so-called strain-promoted azide–alkyne cycloaddition 
(SPAAC), a highly specific reaction between an azide and a cyclooctyne, which may be 
applied in cellular systems as well as whole organisms (Agard et al., 2004). In order to obtain 
full control over the position of the conjugation site and prevent modification of binding sites 
crucial for FcR binding, either an azide or a cyclooctyne had to be introduced in a highly 
selective manner. Recently, it was shown that the peptidoglyan layer of a variety of bacteria 
can be functionalized with azides, when cells were cultured in the presence of the appropriate 
azido-d-amino acid (Kuru et al., 2012; Siegrist et al., 2013). In order to conjugate Fc fragments 
covalently to the surface of bacteria for selective targeting of these bacteria to Fc receptors, 
modification with a cyclooctyne moiety was required (Figure 1A).
Here, we desribe two different methods to selectively functionalize the Fc fragment with the 
cyclooctyne azadibenzocyclooctyne (DBCO) (Debets et al., 2010a; Kuzmin et al., 2010). The first 
approach involves an enzyme called sortase A, a transpeptidase that recognizes the LPXTG 
motif and ligates this motif to N-terminal glycine-containing peptides and proteins (Popp and 
Ploegh, 2011). As a second method, maleimide-thiol chemistry was used. For this purpose the 
Fc fragment was site-selectively mutated to contain one cysteine for functionalization, which 
subsequently reacted with maleimide-functional DBCO. This method resulted in the generation 
of DBCO-modified Fc, which was then used for coupling Fc protein to azido-labeled S. aureus. 
Results and Discussion
Fc fragment functionalization using SrtA
To site-specifically functionalize the Fc fragment with a DBCO-moiety, we first focused on an 
enzymatic approach. Strategies involving enzymes are promising methods for site-selective 
protein modification due to the substrate specificity of the enzyme. The gram-positive bacterial 
cell wall enzyme sortase A (SrtA) has become a popular tool for N-terminal and C-terminal 
labeling of proteins (Ton-That et al., 1999; Popp and Ploegh, 2011; Ritzefeld, 2014). SrtA is a 
transpeptidase that recognizes the LPXTG motif and cleaves the peptide bond between the 
threonine and glycine with the active site cysteine forming a thioester intermediate (Figure 
2A). An N-terminal glycine-containing peptide or protein can subsequently react with this 
acyl enzyme intermediate forming a native peptide bond between the carboxyl group of the 
threonine and the N-terminal amino group of the peptide or protein. To test the feasibility of 
the SrtA reaction for N-terminal labeling of the Fc fragment with DBCO-containing LPETG 
peptides, we first genetically introduced a triglycine sequence to the N-terminus of the Fc 
Figure 1: Schematic representation of the strategy to develop a whole-cell vaccine based on bioorthogonal 
chemistry. (A) Conjugation of a cyclooctyne-charged Fc fragment to the surface of azido-bearing bacteria 
with SPAAC. (B) Uptake of bacteria by the FcRn receptor upon binding to the interface of the CH2 and CH3 
regions of the Fc protein, and transport across the mucosa. Immune effector cells can subsequently be 
taken up the bacteria by phagocytosis.
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fragment. Although only one N-terminal glycine is required for the SrtA reaction, we chose 
to add a triglycine motif to the Fc protein in order to increase the efficiency of the reaction as 
was reported earlier by Pollok and coworkers (Mao et al., 2004). The triglycine sequence was 
introduced at the N-terminus of the Fc protein following the interleukin 2 signal sequence 
(IL2ss). The IL2ss is a stretch of 20 amino acids and is intracellularly cleaved after the 
C-terminal serine resulting in the secretion of the GGG-tagged Fc protein into the culture 
media. HEK293T cells, which are frequently used mammalian cells for the production of 
exogenous proteins, were transiently transfected with the GGG-Fc fragment carrying plasmid. 
The Fc protein was purified from the media using protein A affinity chromatography (Figure 
2B). SDS-polyacrylamide gel electrophoresis (PAGE) analysis showed a single band at 
the expected height of the protein and mass spectrometry analysis of the purified protein 
confirmed the presence of the triglycine motif. We also found a second species with a mass 
matching the expected mass of the Fc fragment monomer without the triglycine (Figure 2B, 
S1A). Interestingly, N-terminally truncated forms were also earlier observed for the IL2 protein, 
suggesting that the cleavage is not solely restricted to the serine at position 20 of the IL2 
signal sequence. (Robb et al., 1984). 
With the N-terminally GGG-tagged Fc in hand, we wanted to test whether the GGG-Fc could 
be modified using SrtA. For this purpose, a model LPETG peptide containing N-terminal 
fluorescein was synthesized (1, Figure 2C). After two hours of incubation at 37 °C of the 
model peptide with the GGG-Fc fragment and SrtA, the reaction was analyzed by SDS-PAGE 
and in-gel fluorescence detection. A fluorescent band could be detected at the expected 
height of the Fc fragment monomer (Figure 2B). The fluorescent acyl-SrtA intermediate was 
also observed in the protein gel. Incubation with the wildtype Fc fragment (WT-Fc) did not 
result in fluorescent labeling (Figure 2B). These results show that the N-terminal triglycine is 
accessible for SrtA modification and that the SrtA reaction is specific towards the N-terminal 
glycine, since no labeling was observed for wildtype Fc. 
To estimate the efficiency of the SrtA reaction, a protein gel shift assay was used. Bicyclononyne 
(BCN)-modified PEG5000 was coupled to azide-containing LPETG peptide yielding conjugate 
2 (Figure 2D). 2 was subsequently incubated with the GGG-Fc fragment and SrtA. The 
reaction was followed as a function of time and analyzed by immunoblotting with an anti-
IgG Fc fragment antibody coupled to a fluorescent infrared dye. Already after 30 min 50% of 
the GGG-Fc monomers were functionalized with the PEG-conjugate (Figure 2D). Increasing 
the incubation time did not result in the formation of more PEG-coupled Fc fragment. One 
explanation for the incomplete conversion is the presence of the species that did not contain 
an N-terminal triglycine motif, which we identified earlier using mass spectrometry analysis. 
Also, the modification of one N-terminus in the intact Fc fragment dimer could sterically hinder 
the modification of the adjacent N-terminus by SrtA, resulting in a lower labeling efficiency. 
Finally, it is likely that the fusion product formed after enzymatic ligation itself serves as a 
substrate for SrtA again, with reformation of the enzyme-protein complex followed by 
hydrolysis. Nevertheless, 50% functionalization is comparable to a recent study that also 
modified the N-terminus of Fc proteins using oxidation (Netirojjanakul et al., 2013). Overnight 
incubation resulted in a slight decrease of the formed product, which is likely caused by the 
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Figure 2: (A) SrtA reaction. (B) SDS-PAGE analysis of the purified GGG-Fc mutant and mass spectrometry 
analysis of the purified protein (mass for GGG-Fc monomer after reduction with dithiothreitol: calculated: 
25632.0 Da, found: 25629.4 Da; mass without triglycine: calculated: 25460.8 Da, found: 25458.7 Da). (C) 
Fluorescent labeling of the GGG-Fc mutant using SrtA reaction. No labeling was detected for the WT-
Fc. (D) Immunoblot analysis to assess labeling efficiency of GGG-Fc using SrtA and a PEG5000-LPETG 
conjugate (2). (E) Structure of DBCO-modified SrtA peptide (3) and purification of DBCO-functionalized 
Fc protein using protein A and subsequent reaction of the eluted Fc with azido-PEG5000. Fractions were 
analyzed by SDS-PAGE and Coomassie staining. Protein gel was also silver stained to increase the 
intensity of the asterisk-marked band.
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competing hydrolysis of the LPETG peptide (Huang et al., 2003). As the SrtA reaction proved to 
be effective for Fc fragment functionalization, we next synthesized a DBCO-modified LPETG 
peptide 3 and coupled it to the Fc fragment using SrtA. However, as shown in figure 2E, when 
we purified the Fc fragment from the reaction mixture using protein A and reacted it with a 
large excess of azido-PEG5000 to assess the reactivity of DBCO, we only observed a faint 
band at the expected height of the product on a protein gel (Figure 2E, marked with asterisk). 
However, when azido-PEG5000 was first conjugated to 3 and then used in the Srt reaction as 
substrate, we observed 50% functionalization of the Fc fragment (Figure S2). These results 
suggest that the low degree of Fc protein PEGylation shown in figure 2 results from an 
inefficient reaction of the DBCO group with the azide. Increassing the concentations of both 
reactants could increase the efficiency of SPAAC, however based on previous bioconjugation 
experiments a higher degree of functionalization was expected with the used concentrations 
than was observed. The DBCO moiety might be partially inaccessible after coupling to the Fc. 
Hydrophobic interactions of the DBCO moiety with the Fc protein could hinder the reaction 
with the azide. The low degree of functionalization as well as the presence of two Fc protein 
species, one containing a triglcyne motif and one missing this motif, urged us to find a more 
efficient method to generate DBCO-modified Fc protein. 
Chemical modification of Fc Fragment
In order to develop an alternative strategy to site-specifically functionalize the Fc fragment, 
we focused on a chemical approach involving thiol-maleimide chemistry. Modification of 
antibodies with small molecules using maleimides and thiols is a commonly used technique. 
For example, free thiols were generated by the reduction of the interchain disulfide bridges 
of the antibody, which were subsequently used to generate antibody-drug conjugates using 
maleimide chemistry (Sochaj et al., 2015). One disadvantage of reducing interchain disulfide 
bridges for subsequent coupling reactions is the generation of more than one reactive thiol. To 
circumvent this, cysteines can also be engineered at defined sites of the antibody (Junutula et 
al., 2008; Sochaj et al., 2015). To generate an Fc-Cys mutant, we selected a previously reported 
site, serine at position 222 (Ser222), which was shown to be accessible for conjugation (Stimmel 
et al., 2000). Moreover, Ser222 is in close proximity to the C-terminus of the Fc fragment and 
thereby outside of the FcRn and FcγR recognition sites (Burmeister et al., 1994; West and 
Bjorkman, 2000; Lu et al., 2015). Therefore, binding of this Fc-Cys mutant to Fc receptors should 
still be possible after its conjugation to the surface of bacteria. SrtA could also be utilized to 
selectively functionalize the C-terminus of proteins (Popp and Ploegh, 2011). However, to test 
whether modification of Fc protein with DBCO via the C-terminus results in a higher degree of 
functionalization, we decided to use a more pragmatic approach that involves thiol-maleimide 
chemistry and requires no protein A purification to remove SrtA.
We introduced the cysteine at position 222 by site-directed mutagenesis. The mutant was again 
expressed in HEKT293 cells and purified with protein A affinity chromatography. SDS-PAGE 
analysis showed a single band at the expected size of the Fc monomer after purification. Mass 
spectrometry analysis of the purified protein revealed the presence of three protein species. 
The first mass matched the expected mass of the Fc-Cys mutant without the first three amino 
acids after the IL2 signal sequence, the second mass corresponded to the expected mass 
for the Fc-Cys protein missing the first two amino acids and the third mass matched the full-
length Fc-Cys protein (Figure 3A, S1B). Since all protein species contain the mutated cysteine 
residue, a higher degree of functionalization than for the GGG-Fc was expected. In contrast 
to the study by Stimmel et al., we did not observe any degree of aggregation of Fc protein 
(Figure 3A, right lane showing non-reduced Fc dimer) (Stimmel et al., 2000). 
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Figure 3: (A) SDS-PAGE analysis of the purified Fc-Cys mutant (left: reduced and right: non-reduced) 
and mass spectrometry analysis of the purified protein calculated (mass for full-length Fc-Cys: calculated: 
26021.6 Da, found: 26018.2 Da; mass calculated for Fc protein missing the first two amino acids: 
calculated at the N-terminus: 26221.8, found: 26218.7; mass calculated for Fc protein missing the first 
three amino acids at the N-terminus: 25950.5 Da, found: 25947.6 Da). (B) Functionalization of Fc-Cys 
with mal-PEG3500. (C) Two-step functionalization of Fc-Cys with mal-DBCO followed by azido-PEG5000.
Next, we reacted the Fc-Cys mutant with maleimide-PEG3500 (mal-PEG3500) and assessed the 
labeling efficiency of this mutant using a gel shift assay. The reaction was performed at room 
temperature in phosphate buffer (20 mM, pH 7) for 1 and 2 h and samples were quenched 
by the addition of SDS sample buffer. Approximately 80–90% of the Fc monomers were 
labeled with mal-PEG3500 after 2 h and labeling was specific for the Fc-Cys mutant (Figure 
3B). However, this could also generate reactive thiols from interchain disulfide bridges and 
therefore, prior reduction was not performed. In order to generate a DBCO-functionalized 
Fc fragment, Fc-Cys was incubated with a 10-fold excess of mal-DBCO (4, Figure 3C) and 
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subsequently coupled to azido-PEG5000. Judging from the SDS-PAGE analysis, 50% of the 
individual Fc-Cys monomers could be coupled to PEG (Figure 3C). These results show that 
an engineered thiol in combination with maleimide chemistry can be used to selectively modify 
the Fc fragment with a DBCO moiety, followed by a subsequent SPAAC reaction with azido-
PEG5000, which led to a good overall labeling yield.
Metabolic incorporation of d-azidoalanine into bacterial peptidoglycan
To incorporate azido moieties into the bacterial peptidoglycan (PG) structure, we used 
a previously established method that utilizes unnatural d-amino acids. Kuru et al. showed 
that d-alanine residues, which are naturally present in the PG structure of bacteria, could be 
replaced by d-amino acids containing different fluorophores or bioorthogonal groups (Kuru et 
al., 2012; Siegrist et al., 2013). The PG was easily remodeled by culturing bacteria in the presence 
of the corresponding d-amino acid analogue. We used S. aureus as a model organism to 
decorate the cell surface with azido-groups. Bacteria were therefore cultured for 2.5 h at 
37 °C in the presence of 0, 1 or 2 mM d-azidoalanine, for which the growth rates were similar. 
Cells were then washed with PBS and subsequently labeled with a cyclooctyne-conjugated 
dye (BCN-495) at room temperature for 70–80 min. Excess of dye was removed by washing 
with PBS and cells were fixated prior to analysis by flow cytometry using 70% ethanol. A 
dose-dependent increase of fluorescent signal was observed with increasing concentrations 
of d-azidoalanine, showing successful incorporation of the unnatural d-amino acid (Figure 4A), 
consistent with previous studies (Kuru et al., 2012; Siegrist et al., 2013). Incubation of bacteria with 
2 mM d-azidoalanine resulted in a significant shift in fluorescence intensity compared to the 
control population (Figure 4A). As shown in figure 4B, fluorescence microscopy analysis also 
showed successful incorporation of the azido-group into the surface of bacteria. Furthermore, 
non-specific binding of BCN-495 dye to the bacteria was negligible. We also detected actively 
dividing cells showing a high fluorescent signal in the middle plane (Figure 4B), which was also 
recently reported by Kuru et al (Kuru et al., 2012). Taken together, these results demonstrate 
the facile incorporation of d-azidoalanine into the surface of S. aureus, in agreement with 
previously published data on the incorporation of unnatural d-amino acids into the bacterial 
cell wall. 
After establishing the procedures to functionalize both the bacterial cell wall and the Fc 
fragments with the complementary reactive groups for the SPAAC reaction, we explored 
the coupling of the Fc-Cys mutant to the surface of the bacteria. To this end, bacteria were 
first grown in the presence of 2 mM d-azidoalanine, followed by incubation with DBCO-
functionalized Fc protein or wildtype Fc protein for 2.5 h at room temperature. Detection 
of bound Fc fragment was performed with an FITC-conjugated anti-IgG antibody and flow 
cytometry analysis. Unfortunately, no specific binding for the DBCO-modified Fc fragment 
could be detected (Figure 5). Furthermore, the small increase in fluorescence intensity that 
was observed, was likely caused by binding of the Fc fragment to endogenous protein A, 
which is a surface protein in S. aureus. This was further confirmed by pre-incubation of soluble 
protein A with DBCO-modified or wildtype Fc, which diminished the fluorescence signal 
(Figure 5). The DBCO moiety was still shown to be functional, when the same Fc fragment 
was successfully conjugated to azido-PEG5000 (Figure S3). The most plausible explanation 
for the lack of functionalization is the steric hindrance a protein such as the Fc fragment 
experiences when it penetrates the bacterial cell wall, as small dye molecules react effectively 
with the azido-groups in the PG. There are a number of options to circumvent this problem. 
Elongation of the linker between the azide and the α-carbon of the d-amino acid could result 
in higher  surface accessibility of the azido-groups for labeling with larger molecules. A study 
by Fura et al. showed that when bacteria were cultured in the presence of d-amino acids with 
longer side chains, such as dinitrophenyl-modified d-amino acids (DNP), an increase in anti-
DNP antibody recruitment was observed (Fura et al., 2014). Moreover, increasing the length 
of the linker between the maleimide and the DBCO moiety could even further improve the 
conjugation of Fc to the surface. Fc fragment penetration into the PG could also be hindered 
by wall teichoic acids, which are peptidoglycan-linked phosphate-rich polymers on the surface 
of gram-positive bacteria. It was previously demonstrated that culturing bacterial cells in the 
presence of tunicamycin, which selectively inhibits the first enzyme in the biosynthesis of wall 
teichoic acids in S. aureus (Campbell et al., 2011), drastically increased the recruitment of anti-
DNP antibodies to the surface of bacteria compared to untreated cells (Fura et al., 2014).
Another important factor to consider in the design of Fc-coated bacteria using maleimide 
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chemistry is the position of the engineered cysteine and the stability of the maleimide-thiol 
conjugate. A study by Junutula and coworkers investigated the effect of the conjugation site 
on the stability of the antibody-drug conjugate. A solvent-accessible position was more prone 
to exchange with other thiols present in plasma than a partially solvent-accessible site within 
a positively-charged environment (Shen et al., 2012). This shows that the stability of the thiol-
maleimide adduct can be optimized by analyzing the structural and chemical environment 
of the conjugation site. Eventually, high stability of the Fc-coated bacteria is also desired for 
vaccination studies in mice to ensure binding and transport across the mucosa. 
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Figure 5: Flow cytometry analysis of S. aureus after incubation with DBCO-functionalized Fc-Cys. WT-
Fc was used as control. To fluorescently label bacteria, cells were incubated with FITC-labeled anti-Fc 
antibody. Left histogram shows labeling without preincbuation with protein A and right histogram shows 
labeling after preincubation with protein A.
Conclusion
In conclusion, we have been able to show site-selective C-terminal functionalization of the Fc 
protein with a DBCO moiety using maleimide-thiol chemistry, while earlier efforts using SrtA did 
not result in efficient preparation of DBCO-modified Fc fragments. We also demonstrated the 
successful functionalization of the surface of S. aureus with d-azidoalanine and the conjugation 
of these surface azides to small dye molecules. In an attempt to couple the DBCO-modified Fc 
fragment to the surface of azido-labeled bacteria, we did not observe conjugation. It is likely 
that steric hindrance plays an important role in the reaction of the Fc fragment with the surface 
azides. More studies are needed to investigate this effect and to find optimal conditions for the 
coupling. Although we worked with S. aureus as model organism, this strategy is potentially 
applicable to a variety of bacteria, since many different types, both gram-positive and gram-
negative bacteria, can be labeled with azides using the same approach (Kuru et al., 2012; 
Siegrist et al., 2013). Vaccination studies in mice with Fc-covered bacteria need to be conducted 
eventually to investigate whether the strategy will induce efficient and long-lasting mucosal 
and systemic immunity. 
Experimental Section
Materials: 
Plasmids for transient transfections were purified using the Plasmid Maxiprep kits from 
Qiagen or JetStar™. Poly(ethylene imine) (linear, MW 25,000) for transfection was purchased 
from Polysciences, Inc. Primers for cloning or site-directed mutagenesis were obtained from 
Biolegio (The Netherlands) or Integrated DNA Technologies, Inc. DBCO-PEG5-NHS and mal-
DBCO were purchased from Click Chemistry Tools. Fluorescein isothiocyanate (FITC) isomer 
I, azido-PEG5000 and Boc-protected l-lysine were obtained from Sigma. d-Azidoalanine and 
mal-PEG3500 were purchased from Iris Biotech GmbH (Germany) and JenKem Technology, 
respectively. PierceTM Recombinant Protein A was purchased from Thermo Scientific. BCN-
495 was obtained from SynAffix BV. Solvents were purchased from J.T. Baker, Sigma Aldrich 
or Fisher Scientific and used as received. The sortase plasmid was a kind gift of Prof. Geerten 
Vuister.
Methods: 
Thin layer chromatography was performed on silica gel-coated plates (Kieselgel 60 F254, 
Merck, Germany) with the indicated solvent mixture, spots were detected by KMnO4 staining 
(1.5 g KMnO4, 10 g K2CO3, 2.5 mL 5% NaOH-solution, 150 mL H2O) and UV-detection. NMR 
spectra were recorded on a Varian 400 (400 MHz). High resolution mass spectra (HRMS) 
were recorded on a JEOL AccuTOF JMS-T100CS (Electrospray Ionization-Time-Of-Flight 
(ESI-TOF)).
Insertion of N-terminal triyglycine motif to Fc fragment:
The trigylcine motif was inserted at the N-terminus of the Fc protein and directly after the 
IL2 signal sequence. The pFUSE-hIgG1e1-Fc2 plasmid (InvivoGen) carrying the human IgG 
Fc fragment was used as the DNA template to generate the triglycine-tagged Fc protein. 
PCR was performed using primers 1 and 2 (Table 1) and Phusion Hot Start II High-Fidelity 
DNA polymerase (Thermo Scientific) according to the manufacturer’s protocol. The PCR 
product was analyzed on a 1% agarose gel and purified using the Wizard® SV Gel and 
PCR Clean-Up System (Promega). The PCR product and the pFUSE-hIgG1e1-Fc2 plasmid 
were digested using EcoRI and NheI (New England BioLabs) for 1 ½ h at 37°C. The ligation 
of the PCR product and the “empty” pFUSE vector was performed overnight at 16°C using 
T4 DNA ligase (New England BioLabs). Next day, the ligation mixture was transformed into 
TOP10 cells by electroporation and incubated for 45 min at 37°C shaking at 200 rpm in 
1 mL S.O.C. medium before being spread on a low salt Luria Broth agar plate containing 
ZeocinTM (Life Technologies). Colonies were selected and inoculated into 5 mL low salt LB 
medium containing ZeocinTM and grown overnight at 37°C shaking at 200 rpm. Plasmids were 
purified using the Wizard® Plus SV Minipreps DNA Purification System. The construction of 
the anticipated DNA construct was confirmed by sequencing using primer 3. 
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Site-directed mutagenesis to replace Ser222 by Cys:
The gene encoding the Fc fragment of human IgG1e1-Fc2 was in a pcDNA3.1(+) plasmid 
(inserted between restriction sites BamHI and XhoI). The Cys mutation was introduced into 
the gene encoding the Fc fragment by PCR using primers 4 and 5 (Table 1) and Phusion 
Hot Start II High-Fidelity DNA polymerase (Thermo Scientific). The whole plasmid was 
amplified according to the manufacturer’s protocol. Next, the PCR reaction mixture (20 µL) 
was incubated for 2h at 37°C with 1 µL of DpnI (New England BioLabs). DH5α cells were 
transformed with 5 µL of the PCR reaction mixture by heat-shock and incubated for 45 min 
at 37°C shaking at 200 rpm in 1 mL LB medium, before being spread on an LB agar plate 
containing ampicillin. Colonies were selected and inoculated into 5 mL LB medium containing 
ampicillin and grown overnight at 37°C shaking at 200 rpm. Plasmids were purified using the 
Wizard® Plus SV Minipreps DNA Purification System (Promega). The insertion of the Cys 
mutation was confirmed by sequencing with the recommended T7 forward and BGH reverse 
primer. 
Protein Purification: 
Purification of the Fc fragment from the culture medium was done using fast protein liquid 
chromatography (FPLC). The HiTrap Protein A HP (GE Healthcare) column was first 
equilibrated with 20 mM phosphate buffer solution, pH 7.5. Subsequently, the medium was 
filtered and loaded onto the column o/n at 4°C. The column was then washed with 20 mM 
phosphate buffer solution, pH 7.5 before the protein was eluted from the column using 0.1 
M citrate buffer solution, pH 3, and 1 mL fractions were collected and directly neutralized by 
adding 150 μL tris(hydroxymethyl)aminomethane (Tris) pH 8.8 buffer solution to the collected 
fractions. The fractions containing protein were combined, concentrated and the buffer was 
simultaneously exchanged using spin filters (Amicon® Ultra 4 mL or 0.5 mL, 10 kDa, Merck 
Millipore) to either sortase A buffer (50 mM Tris, 150 mM sodium chloride, 10 mM calcium 
chloride, pH 7.4) or phosphate buffer (pH 7). Typical protein yields varied between 1-1.5 mg/L.
Primer Sequence
1. FW primer containing EcoRI restriction site 5’-ATATGAATTCGGGCGGTGGAGACAAAA
   CTCACACATGCCCACCG-3’
2. RV primers containing NheI restriction site 5’-ATATGCTAGCACTCATTTACCCGGAGAC
   AGG-3’
3. Primer used for sequencing 5’- GCCTACCTGAGATCACCGGC-3’
4. FW primer containing Ser222 Cys mutation 5’-CGCAGAAGAGCCTCTGCCTGTCTC-3’
5. RV primer containing Ser222 Cys mutation 5’-CCCGGAGACAGGCAGAGGCTC-3’
Table 1: Primers used in this study.
Transient Transfection of Fc fragment: 
155 cm2 dishes (Corning) were seeded with Human Embryonic Kidney (HEK) 293T/17 
cells at 40% confluency one day prior to transfection. Cells were maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) containing 1% penicillin/
streptomycin. Cells were incubated for 24 h at 37°C in a 7.5% CO2 incubator. Typically, 25 μg 
plasmid DNA containing Fc fragment (wildtype Fc protein or Fc mutant proteins in pFuse or 
a pcDNA3.1(+)) was used for the transfection of one 155 cm2 dish. The DNA was first added 
to 875 μL Opti-MEM, Reduced Serum Media (Life Technologies) and 105 μL poly(ethylene 
imine) (PEI, 1 mg/mL) was added to 770 μL Opti-MEM. The two solutions were combined and 
vortexed for 10 sec and incubated at room temperature for 20 min before the mixture was 
added drop-wise to the cells. The cells were incubated at 37°C o/n in the CO2 incubator. After 
24 h cells were washed with 12 mL phosphate buffered saline (PBS). 25 mL fresh Opti-MEM 
medium was added to the cells and cells were incubated for another 24 h. The medium was 
collected the next day and 25 mL fresh Opti-MEM medium was added to the cells followed 
by o/n incubation. The collected medium was centrifuged for 3 min at 5000 rpm using a table 
topper centrifuge. The supernatant was collected and stored at 4°C. The supernatant from the 
next day was processed accordingly. 
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Figure 6: Representative elution profiles for the GGG-Fc protein (left) and Cys-Fc protein (right) after 
loading media onto the Prot A column.
Mass spectrometry analysis of Fc fragment: 
To determine the mass of the Fc fragment, Fc fragment in SrtA buffer or sodium phosphate 
buffer was diluted with PBS to a final concentration of 20 µM in a final volume of 30-40 µL. To 
this solution 1 µL of PNGase F (New England Biolabs) was added and incubated overnight 
at 37 °C shaking at 400 rpm. Next day, buffer was exchanged for 25 mM TrisHCl (pH 8) 
using Amicon Ultra-0.5 spin filter unit (Millipore, 10kDa MWCO) (2-3 times with 400 µL). 
The final volume after the last centrifugation step should be 30-40 µL. Next, to this solution 
4 µL of 1M DTT solution was added and incubated at 37 °C shaking at 400 rpm for 15 min. 
After reduction, protein sample was desalted with MQ (2-3 times with 400 µL) using Amicon 
Ultra-0.5 spin filter unit (Millipore) and analysed by ESI-TOF on a JEOL AccuTOF. Samples 
were acidified with formic acid (0.1%) upon injection. Deconvoluted spectra were obtained 
using MagTran 1.03 b2. 
Sortase expression and purification: 
E.coli BL21 AI cells were transformed with the pQE30 plasmid carrying the sortase gene, 
followed by incubation in 1 mL for 1h in LB medium at 37 °C, 200 rpm. After this short 
incubation phase, the cells were transferred into 4 mL fresh LB media with ampicillin and 
were incubated at 37 °C for 4 h. This preculture was then transferred into 500 mL Terrific 
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Broth medium with ampicillin and cells were incubated for 24h at 37 °C, 200 rpm. Cells were 
pelleted and resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 5 mM imidazole 
and supplemented with 1 mM phenylmethanesulfonyl fluoride, pH 8) and lysed by sonication. 
The lysate was centrifuged at 14.000xg at 4 °C for 30 min and the supernatant was incubated 
with Ni-NTA beads (Qiagen) for 2 h at 4 °C. Ni-NTA beads were washed and the purified 
protein was eluted from the beads with buffer containing 50 mM NaH2PO4, 300 mM NaCl 
(pH 8) supplemented with 10 and 500 mm imidazole, respectively. The elution fraction was 
dialyzed against SrtA buffer at 4°C. Protein concentration was determined using a PierceTM 
BCA protein assay (Thermo Scientific). Glycerol was added to the sortase solution to a final 
concentration of 12% and the solution (500 µM) was then aliquoted, snap-frozen and stored 
at -20 °C. 
For mass spectrometry analysis, a sortase sample was diluted to a final concentration of 
20-30 µM and was desalted with MQ (3 times with 400 µL) using 10 kDA MWCO centrifugal 
filter units (Millipore) and analyzed by ESI-TOF on a JEOL AccuTOF. Samples were acidified 
with formic acid (0.1%) upon injection. Deconvoluted spectra were obtained using MagTran 
1.03 b2. Protein mass: calcd: 21947.6 Da (without N-terminal methionine), found: 21948.7 Da 
(Figure 7).
washed twice with DCM (100 mL), acidified with 1M HCl and extracted with DCM (3 × 100 
mL). The organic layer was dried with Na2SO4 and concentrated in vacuo to afford S1 (2.45 
mg, 88%) as a colorless oil. RF 0.33 (9:1, DCM:MeOH) 
2:3 mixture of rotamers, 1H NMR (CDCl3, 400 MHz): δ 11.91 (broad s, 1H, rotamer a+b), 
6.75 (d, J = 6.75 Hz, 1H, rotamer a), 5.22 (d, J = 5.22 Hz, 1H, rotamer b ), 4.41-4.28 (m, 1H, 
rotamer b), 4.19-4.07 (m, 1H, rotamer a), 3.30 (t, J = 6.8 Hz, 3H, rotamer a+b), 1.97-1.81 (m, 
1H, rotamer a+b), 1.81-1.58 (m, 3H, rotamer a+b), 1.56-1.37 (m, 11H, rotamer a+b)
HRMS (ESI+) m/z for C11H20N4O4: (M+ H
+), calcd: 295.1377, found: 295.1382
Peptide Synthesis: 
Fmoc-4-methoxy-4’-(γ-carboxypropyloxy)-benzhydrylamine linked to alanyl-aminomethyl 
resin and Wang resin (p-alkoxybenzyl alcohol resin) were purchased from Bachem. Fmoc-
L-amino acids were purchased from Novabiochem or Bachem and coupling reagents were 
purchased from Biosolve and Sigma Aldrich. Lyophilization was achieved using an ilShin 
Freeze Dryer (ilShin). Analytical HPLC was performed on a Shimadzu LC-20A Prominence 
system (Shimadzu) equipped with a C18 ReproSil column, 150 × 3 mm, particle size 3 µm 
(Screening Devices). Elution of the peptides was achieved using an CH3CN/H2O gradient 
containing 0.1% TFA (5-100%, 1-30 min, flow 0.4 mL/min). LC-MS was performed an a 
Thermo Finnigan LCQ-Fleet ESI-ion trap (Thermo Fischer) equipped with an Alltima C18 
column (50 mm, 2 mm, particle size 3 μm) (Alltech Applied Sciences BV). An CH3CN/H2O 
gradient containing 0.1% formic acid was used for elution (5-100%, over 15 min) unless stated 
otherwise.
Synthesis of azido-functionalized SrtA peptide (S2):
S2 was synthesized from 2.0 g Fmoc-4-methoxy-4’-(γ-carboxypropyloxy)-benzhydrylamine 
linked to alanyl-aminomethyl resin using Fmoc solid-phase peptide synthesis (SPPS). The 
resin was swollen in DMF for 20 min prior to use. The Fmoc-groups from the resin were 
removed with piperidine in DMF (20%, v/v) for 30 min. Functionalization of the resin with the 
first Fmoc-protected amino acid was performed for 45 min with 3 eq. of Fmoc-Gly-OH and 3.3 
eq. of N,N’-diisopropylcarbodiimide (DIPCDI) and 3.6 eq. of N-hydroxybenzotriazole (HOBt) 
in DMF. Deprotection of the Fmoc-groups was done with piperidine in DMF (20%, v/v) for 30 
min. For all subsequent coupling reactions, again 3 eq. of the required Fmoc-protected amino 
acid, 3.3 eq. of DIPCDI and 3.6 eq. HOBt in DMF were added to the resin and allowed to react 
for 45 min. After each coupling reaction and Fmoc deprotection, a Kaiser test was performed 
to ensure completion of the reaction. S1 (3 eq.) was added as the final residue and allowed 
to react for 90 min. The peptide was cleaved from the resin by treatment with a mixture of 
TFA: 1,2-ethanedithiol (EDT):H2O (95: 2.5: 2.5) for 3 h. The peptide was precipitated in Et2O 
and separated from solvent by centrifugation yielding a white solid. The crude peptide was 
purified using reversed phase HPLC on a Shimadzu LC-20A system (Shimadzu) equipped 
with a Reprosil C18 column, 250 × 10 mm (particle size: 5 µm) (Dr. Maisch GmbH, Screening 
Devices). Elution was achieved using an CH3CN/H2O gradient containing 0.1% trifluoroacetic 
acid (5-100% MeCN, 5-55 min, flow 4 mL/min). The fractions containing the peptide were 
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Figure 7: Mass spectrometry data and SDS-polyacrylamide gel electrophoresis analysis of SrtA
Synthesis of Boc-l-Lys(N3)OH (S1): 
To a solution of Boc-protected l-lysine (2.5 g, 10.150 mmol) in MeOH (50 mL) was added 
K2CO3 (2.23 g, 18.088 mmol, 1.8 eq.), copper(II) sulfate pentahydrate (253 
mg, 1.013 mmol, 0.1 eq.) and imidazole-1-sulfonyl azide, HCl salt (3.18 g, 
15.171 mmol, 1.5 eq.). After stirring for 16 h at rt half of the solvent was 
evaporated in vacuo before the solution was acidified with 2M HCl. The 
mixture was extracted with DCM (3 × 100 mL) and the organic layer was dried 
with Na2SO4 and concentrated in vacuo. The crude was then redissolved in 
DCM (100 mL) and extracted with NaHCO3 (5% aq., 3 × 100 mL). The aqueous layer was 
N
H
OH
O
N3
Boc
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combined and lyophilised yielding a white powder. LC-MS was performed an a Thermo 
Finnigan LCQ-Fleet ESI-ion trap (Thermo Fischer) equipped with an Alltima C18 column 
(50 mm, 2 mm, particle size 3 μm) (Alltech Applied Sciences BV). An CH3CN/H2O gradient 
containing 0.1% formic acid was used for elution (5-100%, 1-10 min).
LC/MS: m/z for C31H53N11O10: (M + H
+), calcd: 740.40, found: 740.36, Retention time = 5.88 
min, analytical HPLC: Retention time = 14.20 min
S2:
Synthesis of FITC-labeled SrtA peptide (1): 
To a solution of the crude S2 (20 mg, 0.027 mmol) in DMF (2 mL) was added fluorescein 
isothiocyanate isomer I (11.6 mg, 0.027 mmol, 1 eq.) and DIPEA (9.4 µL, 0.054 mmol, 2 eq.). 
After 2.5 hours stirring at rt, the mixture was concentrated in vacuo. The crude peptide was 
purified using preparative HPLC as described above. The fractions containing the peptide 
were combined and lyophilised yielding a yellow powder. LC-MS was performed an a Thermo 
Finnigan LCQ-Fleet ESI-ion trap (Thermo Fischer) equipped with an Alltima C18 column 
(50 mm, 2 mm, particle size 3 μm) (Alltech Applied Sciences BV). An CH3CN/H2O gradient 
containing 0.1% formic acid was used for elution (5-100%, 2-18 min). 
LC-MS: m/z for C52H64N12O15S: (M + H
+), calcd: 1129.43, found: 1129.80 : Retention Time: 
11.57 min, analytical HPLC: Retention Time: 20.24 min
Synthesis of peptide S3: 
S3 was synthesized from 1.0 g Fmoc-Gly-Wang resin. SPPS was performed as described 
for peptide S2 with a minor adjustment. After each coupling reaction, capping was performed 
with pyridine in DMF (20%) for 30 min. After the capping reaction, the resin was washed with 
DMF before SPPS was continued with the deprotection of the Fmoc-groups. After cleavage, 
the peptide was precipitated in Et2O and separated from solvent by centrifugation, yielding a 
white solid. 
LC-MS: m/z for C27H45N7O11: (M + H
+), calcd: 644.32, found: 644.32, Retention time = 1.44 
min, analytical HPLC: Retention time = 10.84 min
S3:
Synthesis of DBCO-functionalized SrtA peptide (3): 
To a solution of the crude S3 (20 mg, 0.031 mmol) in DMF (5 mL) was added DBCO-PEG5-
NHS ester (32.3 mg 0.047 mmol, 1.5 eq.), 10 µL of trimethylamine (0.072 mmol, 2.3 eq) and 
the mixture was stirred at rt for 2 h. The reaction mixture was concentrated in vacuo. The 
peptide was purified using preparative HPLC as described above and lyophilized yielding 
peptide 3 as a yellow powder (7.2 mg, 34%) 
LC-MS: m/z for C59H83N9O19: (M + H
+), calcd: 1222, 58, found: 1222.64, Retention time = 9.64 
min, analytical HPLC: Retention time = 20.49 min
Sortase reaction with 1: 
To determine the selectivity of the sortase reaction, 20 µM of peptide 1 and 50 µM SrtA were 
incubated with either 20 µM GGG-Fc or 20 µM WT-Fc for 2 h at 37 °C with moderate shaking 
in Srt buffer. Samples were then analyzed by SDS-polyacrylamide gel electrophoresis, in-
gel fluorescence detection and Coomassie staining. In-gel fluorescence was measured on a 
G:BOX Chemi XT4 Fluorescent & Chemiluminescent Imaging System (Syngene) using 465 
nm as excitation wavelength and emission was detected using the SW06 filter (516-600nm). 
Sortase reaction with 2: 
To form the PEG5000-LPETG conjugate, 9 µL of BCN-PEG5000 (stock concentration 10 mM in 
MilliQ) was incubated overnight with 6 µL of peptide S2 (stock concentration 10 mM in MilliQ) 
at 37°C moderate shaking. 10 eq. of the PEG5000-LPETG (2) was then added to GGG-Fc 
fragment (10 µM) and SrtA (50 µM) in a final volume of 60 µL (adjusted with Srt buffer), which 
was incubated at 37°C with moderate shaking. The reaction was followed as a function of 
time. Samples were taken at indicated time points and directly quenched by the addition of 
sample loading buffer. The samples were run on an SDS-polyacrylamide gel and subsequently 
transferred to a nitrocellulose membrane. Fc-fragment was detected by incubating with anti-
human IgG antibody modified with an IRDye® 800 (1 µL of a 1mg/mL stock solution) (tebu-bio, 
Rockland antibodies & assays) in 5 mL PBS containing 0.1% Tween and 5% milk powder for 
30-45 min for 1-2 h at rt or o/n at 4°C. Fluorescence was detected at 700 and 800 nm using 
the LI-COR Odyssey® CLx infrared imaging system.
 
Sortase reaction with 3: 
To functionalize the Fc fragment with DBCO, 3 (250 µM) and SrtA (100 µM) were added to 
Fc protein (10 µM) in a final volume of 30 µL (adjusted with Srt buffer) and incubated for 1 
h at 37°C moderate shaking. Next, the reaction mixture was incubated with 20 µL of Prot-A 
beads (3 times washed with binding buffer to remove storage buffer) in (NAbTM Protein A/G 
Spin Kit, Thermo Scientific) and incubated for 10 min at rt. Beads were centrifuged (5000 × 
g, microcentrifuge for Eppendorf tubes), supernatant removed and beads were washed with 
2 times 50 uL binding buffer; protein was eluted with 30 µL of elution buffer (pH 2.8) and 
the elution fractions were directly neutralized with 3 µL of neutralization buffer. The elution 
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fractions were incubated o/n with azido-PEG5000 (final concentration 1mM) at 37°C with 
moderate shaking. Supernatant, washing fractions and the reaction mixture were analyzed by 
SDS-polyacrylamide gel electrophoresis and Coomassie as well as silver staining.
Modification of Fc-Cys protein with mal-PEG3500:
Fc-Cys protein and WT-Fc (20 µM) were incubated with 10 eq. of mal-PEG3500 in phosphate 
buffer pH7 at rt with moderate shaking. Samples were taken at 1h and 2h and were directly 
quenched with sample loading buffer. Samples were analyzed by SDS-polyacrylamide gel 
electrophoresis and Coomassie staining. 
Modification of Fc-Cys protein with 4: 
Fc-Cys protein and WT-Fc (20 µM) were incubated with 10 eq. of mal-DBCO (4) in phosphate 
buffer pH 7 at rt with moderate shaking, followed by spin filtration (2 times with 400 µL) using 
Amicon Ultra-0.5 spin filter unit (Millipore, 10 kDa MWCO) to remove unreacted 4. Samples 
were then incubated with azido-PEG5000 (final concentration 1 mM) (Sigma Aldrich) at 37°C 
with moderate shaking for 3.5 h, before the samples were analyzed by SDS-polyacrylamide 
gel electrophoresis and Coomassie staining. 
Bacterial labeling with d-azidoalanine: 
A liquid bacterial culture was started by inoculating S.aureus (NCTC 8178, Public Health 
England) from a blood agar plate into LB medium. Typically, to 1 mL bacterial culture with an 
OD620 of 0.1-0.15 d- azidoalanine was added to a final concentration of 1 or 2 mM (100 mM 
stock in MQ, stock was filter sterilized (0.22 µm cellulose acetate membrane, VWR) prior to 
use). Bacteria were grown for 2.5 h at 37 °C at 250 rpm. 300 uL of bacterial culture were then 
pelleted (10000 × g), 2-3 times washed with phosphate buffered saline (PBS), labeled for 
60-80 min with BCN-dye at rt (50 µM final concentration, 100 uL reaction volume) and again 
washed with PBS. Cells were then fixed with 70% ice-cold EtOH (v/v) for 15 min, pelleted and 
resuspended in 100 µL PBS. Samples were protected from light.
Cells were analyzed by flow cytometry or imaged by fluorescence microscopy. For flow 
cytometry analysis, fluorescently labeled cells were analyzed on a BD LSRII flow cytometer 
(Biosciences, San Jose, CA, USA) and data were analyzed using FlowJo version 10.0.8. 
(FlowJo, LLC). Fluorescence data were expressed in arbitrary units (AU) and the geometric 
mean fluorescent intensity was calculated for all samples. 
For fluorescence microscopy, a small aliquot of cells in PBS was transferred to a diagnostic 
microscope glass slide (Thermo Scientific), dried and wetted with Vectashield® Mounting media 
containing 4’,6-diamidino-2-phenylindole (DAPI) and covered using a 24 × 60 mm cover slip 
(Menzel Gläser, Germany) (Vector Laboratories). Cells were imaged using a Leica DM2500 
microscope (Leica microsystems) at 100 × magnification and pictures were acquired with a 
Leica DFC420C camera. Fluorescence was detected using the following settings: FilterI3, 
Exc. BP 450-490, DM 510, Em. LP 515. 
Bacterial labeling with DBCO-functionalized Fc protein: 
Fc-Cys was modified with 4 as described above. WT-Fc was used as a control. Reactions 
were done in duplo, with one of the samples preincubated with PierceTM Recombinant Protein 
A (final concentration 1.5 mg mL–1) for 10 min before it was incubated with azido-labeled S. 
aureus. Briefly, to Fc-Cys or WT-Fc (20 µM) 10 eq. of 4 were added in 55 µL phosphate buffer 
(pH 7) and incubated for 2 h. Subsequently samples were spin-filtered to remove excess of 
4. Bacteria were cultured as described above. After 2.5 h 300 µL of bacterial culture were 
pelleted, 2 times washed with PBS and incubated for 2.5 h at rt with either 45 µg of DBCO-
modified Fc-Cys or 45 µg of DBCO-modified Fc-Cys + protein A in a final volume of 100 µL 
(adjusted with PBS). Cells were then three times washed with PBS (+ 2% bovine serum 
albumin (BSA)) and fixated for 15 min at rt using 2% paraformaldehyde in PBS. Next, bacteria 
were incubated with FITC-conjugated goat anti-human IgG (Fc fragment) polyclonal antibody 
(1 mg mL-1, dilution 1:200 used) (GeneTex) followed by 3 washes with PBS (+2% BSA). 
Samples were analyzed by flow cytometry. 
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Figure S2: Azido-PEG5000 was first coupled to 3 and this conjugate was then used in the SrtA reaction with 
GGG-Fc. Immunoblot analysis for the Fc fragment revealed 50 % labeling efficiency.
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Figure S3: Reaction of DBCO-modified Fc-Cys and WT-Fc with azido-PEG5000 to assess the reactivity 
of DBCO-Fc-Cys. The same proteins were also used in the experiment depicted in figure 5. SDS-PAGE 
analysis and Coomassie staining showed that DBCO-modified Fc-Cys was still shown to be reactive 
towards azides, even in the presence of protein A.
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K T I S K A K G Q P R E P Q V Y T L P P S R E E M T K N Q V S L T C L V K G F Y P S D I A V E 
W E S N G Q P E N N Y K T T P P V L D S D G S F F L Y S K L T V D K S R W Q Q G N V F S C S 
V L H E A L H N H Y T Q K S L S L S P G K  
Sequence GGG-Fc:A
green = IL2ss; blue = Fc fragment
M Y R M Q L L S C I A L S L A L V T N S I S A M V R S D K T H T C P P C P A P E L L G G P S V 
F L F P P K P K D Q L M I S R T P E V T CV V V D V S H E D P E V K F N W Y V D G V E V H N A
 K T K P R E E Q Y N S T Y R V V S V L T VL H Q D W L N G K E Y K C K V S N K A L P A P I E K 
T I S K A K G Q P R E P Q V Y T L P P S R E E M T K N Q V S L T C L V K G F Y P S D I A V E W 
E S N G Q P E N N Y K T T P P V L D S D GS F F L Y S K L T V D K S R W Q Q G N V F S C S V 
L H E A L H N H Y T Q K S L C L S P G K
green = IL2ss; blue = Fc fragment
Sequence Fc-Cys:
Figure S1: (A) Amino acid sequence of the IL2ss/GGG-Fc fragment fusion protein and amino acid 
sequence after IL2ss cleavage. Lines indicate the protein species that are likely a result of IL2ss cleavage 
variation and match the masses found by mass spectrometry analysis. (B) Amino acid sequence of the 
IL2ss/Fc-Cys fragment fusion protein and amino acid sequence after IL2ss cleavage. Cleavage of the 
C-terminal lysine has been reported as a common modification of the heavy chain and was observed for 
both mutants. (Liu et al., 2008)
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Abstract 
Quantitative mass spectrometry-based approaches have greatly contributed to the 
understanding of protein-protein and protein-DNA interactions. Currently, most approaches 
use epitope-tagging of proteins of interest in order to enrich them and their interactors from 
complex mixtures. The usually N- or C-terminus fused tags however have the potential to 
perturb protein functionality due to their size. Unnatural amino acids (UAAs) harboring small 
reactive handles can be site-specifically incorporated into proteins and could overcome the 
problems associated with conventional epitope tagging. Here, we introduce Click-MS, which 
combines the power of site-specific UAA incorporation and quantitative mass spectrometry-
based proteomics to develop a comprehensive protein-protein interaction identification 
workflow. By incorporating p-azido-l-phenylalanine (azF) in the protein of interest, the protein 
can be modified or immobilized using bioorthogonal chemistry. The system was developed 
using the mCherry-GFP model protein and extended to the methyl-CpG-binding domain 
protein 3 (MBD3), which assembles in the Nucleosome Remodeling and Deacetylase (NuRD) 
complex. With the used site of UAA incorporation and under optimized bioorthogonal chemistry 
conditions, we were able to demonstrate the validity of the Click-MS concept by specifically 
enriching MBD3 and a partial NuRD complex.
Introduction
Many proteins assemble into complexes. Typically, protein complexes comprise stoichiometric 
core subunits and substoichiometric interactors. The identification of protein-protein 
interactions (PPIs) is critical to understand protein function. During the last two decades, mass 
spectrometry-based proteomics has emerged as a powerful tool to study these protein-protein 
interactions. Traditionally, protein complexes were purified to near purity using tandem-affinity 
purification workflows (Gavin et al., 2006; Krogan et al., 2006). Recently, quantitative methods 
were developed that facilitate the identification of high-confidence PPIs using single-affinity 
purifications (Vermeulen et al., 2008). These methods rely on the incorporation of stable isotopes 
in proteins or on label-free quantification algorithms (Rinner et al., 2007; Sardiu et al., 2008; Hubner 
et al., 2010).
Affinity purifications can be based on immunoprecipitation of endogenous proteins, relying on 
high-quality antibodies that are often of limited availability (Gingras et al., 2007). Furthermore, 
these antibodies often exhibit cross reactivity, therefore requiring elaborative validation 
experiments such as knockdown of the protein of interest (POI) to obtain high-confidence 
interactors (Selbach and Mann, 2006). More often, epitope tags are fused to the target protein, 
enabling the use of well-characterized antibodies, for example TAP (Gavin et al., 2002), FLAG 
(Ho et al., 2002) and GFP tags (Cristea et al., 2005). However, proteins or peptides that are fused 
to the N- or C-terminus as a purification tag, can interfere with the structure and/or function 
of the POI, as was reported for example for Myef2 (van Riel et al., 2012). As a consequence, 
important protein-protein interactions at the termini might not be detected due to sterical 
hindrance by the fused tag.
A small reactive handle that can be placed at any position inside a protein could potentially 
overcome these technical problems. The amber suppression technology, which was developed 
by Schultz and coworkers, provides a powerful method to site-selectively incorporate an 
unnatural amino acid (UAA) into a POI (Wang et al., 2001). In this approach, an amber stop 
codon is introduced into the target protein and a 21st orthogonal tRNA and aminoacyl-tRNA 
synthetase pair is added to the endogenous translational machinery of the host organism. 
Among a variety of different UAAs, azido-functionalized UAAs have been site-selectively 
incorporated into different proteins using this methodology (Chin et al., 2002; Liu et al., 2007). The 
azide is a reactive handle that is small in size as well as bioorthogonal meaning it shows no 
interference and/or reaction with the biological surrounding (Sletten and Bertozzi, 2009; Borrmann 
and van Hest, 2014). It can be selectively functionalized with alkyne-bearing probes even in 
complex biological samples containing other nucleophiles such as amines or thiols. The first 
bioorthogonal reaction utilizing the azide was the Staudinger ligation, in which the azide reacts 
with a modified triarylphosphine (Saxon and Bertozzi, 2000). Next to triarylphosphine, azides 
can also react with alkynes (Scheme 1). Two types of reactions of alkyne-azide reactions 
are known: i) the copper-catalyzed azide–alkyne reaction (CuAAC, often referred to as 
‘click reaction) that uses Cu(I) as the catalyst for the reaction of azides with terminal alkynes 
(Rostovtsev et al., 2002; Tornoe et al., 2002) and ii) the strain-promoted azide–alkyne cycloaddition 
(SPAAC, ‘copper-free click reaction) which uses ring strain to activate the alkyne (Agard et 
al., 2004). Recently, Tirrell and coworkers have successfully developed an elegant technique 
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to monitor proteome-wide changes in expression using the azide/alkyne pair (Dieterich et al., 
2006). This method enables the specific enrichment and subsequent identification of newly 
synthesized proteins, yet it does not allow for the enrichment of a single protein of interest. 
Here, we combine the power of amber suppression technology and quantitative mass 
spectrometry-based proteomics to develop a comprehensive PPI identification workflow 
without the need of fusing a tag to the POI. By incorporating p-azido-l-phenylalanine (azF) 
in a protein of interest, the protein can be modified or immobilized using bioorthogonal 
chemistry. The immobilized protein and its interactors can subsequently be identified using 
mass spectrometry. The system was developed using the mCherry-GFP model protein and 
extended to the methyl-CpG-binding domain protein 3 (MBD3). MBD3 assembles in the 
Nucleosome Remodeling and Deacetylase (NuRD) complex (Kehle et al., 1998; Xue et al., 
1998; Zhang et al., 1998). Initially, NuRD was postulated to act as a repressor, but recently the 
complex has also been implicated in activation or modulation of transcription (Reynolds et al., 
2012; Zhang et al., 2012). The characterization of MBD3/NuRD is of high interest to dissect its 
role in transcriptional regulation. With the currently used site of UAA incorporation and under 
optimized bioorthogonal chemistry conditions, we specifically enrich MBD3 and a partial 
NuRD complex. This finding shows that direct enrichment of the protein of interest is feasible, 
but for comprehensive PPI identification multiple sites of UAA incorporation need to be tested.
Results
Amber suppression set-up
Given the limitations associated with N-or C-terminal peptide or protein fusions, we aimed to 
develop an enrichment strategy to purify a single protein and its interactors from whole cell 
lysate based on click chemistry in combination with quantitative mass-spectrometry based 
proteomics. For this purpose, we selected a tRNA and aminoacyl tRNA synthetase (aaRS) pair 
that enables the incorporation of an azido-moiety into the growing peptide chain of a protein-of-
Scheme 1: Schematic representation of the two bioorthogonal reactions employed in this chapter. 
The copper-catalyzed azide–alkyne cycloaddition (CuAAC) and the strain promoted azide–alkyne 
cycloaddition (SPAAC).
interest in response to the amber (TAG) stop codon (Figure 1A) (Ye et al., 2009; Naganathan et al., 
2013). To test the incorporation of the unnatural amino acid azF we first selected an mCherry-
GFP construct, that contains a TAG stop codon in the linker region between the two proteins 
(mCherry-GFPTAG) (Plass et al., 2012). HEK293T cells were transiently co-transfected with three 
plasmids each carrying the tRNA, aaRS or mCherry-GFPTAG genes. Cells were cultured for 
36–48 h in the presence of 250 µM azF, before being analyzed by confocal microscopy for 
orange and green fluorescence. As shown in figure 1B, green fluorescence was only detected 
when cells were grown in the presence of azF showing the successful incorporation of azF 
into mCherry-GFPTAG. Flow cytometry analysis further revealed that approximately 60% of 
all cells were successfully transfected with the mCherry-GFPTAG construct and half of these 
cells also showed green fluorescence due to amber suppression (Figure 1C). Taken together, 
these data indicate the successful incorporation of azF in response to the amber stop codon.
Figure 1: Amber suppression set up using the model protein mCherry-GFPTAG. (A) Transfection of tRNA, 
aaRS and mCherry-GFPTAG plasmids with the addition of azF results in suppression of the amber stop 
codon, incorporation of azF and expression of the full-length protein. (B) Confocal microscopy pictures of 
transfected cells with or without the addition of azF. Scale bar represents 50 µm. (C) FACS analysis of the 
transfected cells with or without the addition of azF using red and green fluorescence.
Proteomic investigation of amber suppression 
Before using amber suppression technology for quantitative mass spectrometry-based 
studies, it is important to exclude the possibility that an additional tRNA and aaRS pair inside 
the cell has an effect on the proteome of the cell. Since the TAG stop codon is a naturally 
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occurring stop codon (≈ 20% of all genes (Sun et al., 2005)), it might be that the incorporation 
of azF at those endogenous TAGs affects expression of other proteins inside the cell. To 
investigate a potential effect on the proteome, we performed a stable isotope labeling of 
amino acids in cell culture (SILAC) experiment. To this end, we incubated cells grown in 
‘heavy’ medium (supplemented with heavy lysine (13C6
15N2
1H14
16O2) and heavy arginine 
(13C6
15N4
1H14
16O2)) with 250 µM azF, while cells grown in ‘light’ medium (supplemented with 
normal lysine and arginine) were left untreated (Figure 2A). As a control, we also performed 
a ‘reverse’ experiment by incubating light-labeled cells with azF and leaving heavy-labeled 
cells untreated. After 24 h of incubation the appropriate heavy- and light-labeled cells were 
combined and lysed. Proteins were digested and prepared for mass spectrometry using filter-
aided sample preparation (FASP) (Wisniewski et al., 2009b) and analyzed by LC-MS/MS. Each 
peptide that is detected by mass-spectrometry analysis will have a heavy-to-light ratio (H/L) 
corresponding to its relative abundance in the heavy and light samples. Proteins that are 
identified in the ‘forward’ experiment and that will be affected by azF can have either a high H/L 
ratio in case of protein upregulation or a low H/L ratio in case of downregulation (Figure 2A). 
In the reverse experiment, upregulated proteins will have a low H/L ratio and downregulated 
proteins a high H/L ratio.
Using MaxQuant analysis software (Cox and Mann, 2008), we quantified ratios for all identified 
peptides and corresponding proteins to investigate the effect of azF incubation on protein 
expression. As shown in figure 2B, no substantial changes could be observed when cells were 
treated with azF. One out of 2000 quantified proteins showed a slightly changed expression 
profile. Interestingly, analysis of the SILAC samples that were transfected with the tRNA 
and aaRS carrying plasmids revealed a small upregulation of four histone proteins (Figure 
2C). Transfection of tRNA and aaRS-plasmids followed by incubation with azF resulted in 
upregulation of six proteins (Figure 2D). To increase the depth of the proteome, we applied 
strong anion-exchange (SAX) fractionation (Figure S1) (Wisniewski et al., 2009a). In total, 4600 
proteins were quantified of which only five proteins showed an over 1.5-fold upregulation. None 
of the identified regulated proteins in all experimental conditions showed an H/L ratio greater 
than three. Notably, these proteins are not directly involved in cellular pathways involving 
stress responses or cell cycle regulation. In summary, possible translational read-through at 
endogenous TAG stop codons does not seem to result in drastic changes in the proteome. 
These data suggest that the addition of the tRNA/aaRS pair and azF is well tolerated by the 
cell without affecting the expression of other proteins.
Bioorthogonal labeling and immobilization
In order to purify an azido-functionalized protein and its interactors from cell lysate, we 
next examined whether we could label the incorporated azide with an alkyne probe using 
either copper-catalyzed or copper-free click chemistry (Scheme 1). Copper(I) is used as the 
catalyst in the copper-catalyzed reaction to promote the reaction between the azide and a 
terminal alkyne, whereas in copper-free click chemistry ring strain is solely used to accelerate 
the reaction between the azide and alkyne. Since copper can complex with biomolecules, 
it is important to add a copper-binding agent to the reaction mixture when this reaction is 
performed in biological samples such as cell lysate. One commonly used ligand that has 
been successfully applied in copper-catalyzed click reactions is tris-(benzyltriazolylmethyl)
amine (TBTA) (Chan et al., 2004). To label azido-containing mCherry-GFPTAG using CuAAC, 
cells were first lysed in HEPES buffer containing 1% NP-40 followed by incubation with the 
copper catalyst, TBTA and an alkyne-modified fluorescent dye for 2 h at 25 °C. Samples 
were then analyzed by SDS-PAGE and in-gel fluorescence. As shown in figure 3B (also 
Figure S2), a fluorescent band was visible at the expected height of the mCherry-GFPTAG (≈70 
kDa), demonstrating successful labeling with the alkyne-dye. Notably, two species of lower 
molecular weight also showed fluorescent labeling. These two lower-molecular weight bands 
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are likely truncated forms of the mCherry-GFPTAG fusion protein, since immunoblot analysis 
for GFP showed the same pattern as observed for the fluorescent labeling (Figure 3A), thus 
strongly suggesting that all three protein species contain azides. An additional, but fainter 
band was observed below 50 kDa (marked with an asterisk), which likely is a result of non-
specific labeling.
For copper-free labeling, we used an azadibenzocyclooctyne (DBCO)-conjugated fluorescent 
dye that was incubated with cell lysates for 2 h at 25 °C before being analyzed for in-gel 
fluorescence. As seen in figure 3C (also Figure S2), a fluorescent signal at the expected 
height was visible, however other bands were also fluorescently labeled. These proteins were 
also labeled in the control sample that was not treated with azF, indicating azide-independent 
labeling of proteins by the DBCO-dye (Figure 3C, –UAA). It has been previously shown that 
cyclooctynes can also react with thiols and that preincubation with iodoacetamide (IAA) can 
prevent thiol-mediated labeling of proteins by cyclooctynes to a significant extent (van Geel et 
al., 2012). Therefore, we preincubated cell lysates of all samples with 50 mM IAA for 30 min 
and subsequently performed labeling with the DBCO-functionalized dye for 2 h at 25 °C. In-
gel fluorescence analysis indeed showed a decrease in background fluorescence owing from 
thiol cross-reactivity and hence an improved signal to noise ratio for the azide-specific labeling 
of mCherry-GFPTAG (Figure 3C). Again, a faint non-specifically labelled protein was observed 
(asterisk), which was also present in the empty vector control (Figure 3C, EV). These data 
confirm that both the copper-catalyzed as well as the copper-free click reaction can be utilized 
for the specific labeling of azido-containing proteins in complex protein mixtures, as was 
shown before (Rabuka et al., 2006; Ngo et al., 2009; van Geel et al., 2012; Elliott et al., 2014).
Next, we examined whether we could selectively immobilize the azido-mCherry-GFPTAG from 
cell lysate using alkyne- or DBCO-functionalized agarose beads. We performed a depletion 
experiment, in which cell lysates were incubated with alkyne- or DBCO-functionalized beads 
followed by centrifugation and immunoblot analysis of the supernatant with an anti-GFP 
antibody (Figure 3D). A decrease in mCherry-GFPTAG signal should be noticeable compared to 
the input samples, if azido-mCherry-GFPTAG was successfully captured by the beads. As seen 
in figure 3E, incubation with DBCO-modified beads indeed showed depletion of mCherry-
GFPTAG (≈80% efficiency). As a control experiment, we also incubated unmodified agarose 
beads with cell lysates and did not observe unspecific binding of proteins to the beads. 
Immunoblot analysis of the ubiquitous protein GAPDH was used as a loading control to 
assess azide-independent protein loss. Signal intensity of GAPDH was similar for all samples. 
These results indicate that azido-mCherry-GFPTAG could be selectively enriched from cell 
lysates. When the depletion experiment was performed with alkyne-modified beads and 
CuAAC, selective enrichment was not observed for the azido-mCherry-GFPTAG (Figure 3F). 
Both GAPDH and GFP signals were reduced, indicative of protein precipitation. To circumvent 
protein precipitation, we switched to the water-soluble Cu(I) ligand tris-(hydroxypropyltriazolyl)
methylamine (THPTA), which was also recently utilized for click chemistry in biological samples 
(Hong et al., 2009). The GAPDH level was only slightly affected using THPTA and 0.2 mM 
CuSO4, whereas a clear reduction was observed for the GFP level (≈50% efficiency) (Figure 
3G). In summary, azide-functionalized proteins can be selectively immobilized using either 
copper-free or copper-catalyzed click chemistry (with THPTA as the copper-chelating ligand).
Figure 3: Bioorthogonal labeling and immobilization of mCherry-GFPTAG. (A) Western blot analysis of 
mCherry-GFPTAG. (B) Copper-catalyzed and (C) copper-free click chemistry based labeling of mCherry-
GFPTAG. Arrow indicates the full-length functionalized mCherry-GFPTAG and the asterisk indicates an non-
specific labeled protein. In copper-free labeling, preincubation with iodoacetamide (IAA) blocks thiols from 
reacting with the cyclooctyne. EV stands for empty vector (negative control). (D) Schematic depiction of 
the immobilization assay using alkyne- or DBCO functionalized beads. (E, F, G) Western blot analysis 
of GFP and GAPDH for the mCherry-GFPTAG depletion in the immobilization assay. Immobilization was 
performed with copper-free (E) or copper-catalyzed chemistry using TBTA (F) or THPTA (G) as copper 
ligand.
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AzF incorporation into MBD3
To study the feasibility of click chemistry-based protein enrichment and PPI identification, we 
chose to study MBD3 that assembles in the NuRD complex. As MBD3/NuRD is involved in 
transcriptional regulation, the characterization of the complex composition is of high interest. 
We developed five different amber mutants for MBD3 spanning the entire protein (Figure 
4A). Sites were selected to be outside highly conserved regions and functional domains, but 
inside predicted hydrophilic amino acid stretches and loops. For initial screening purposes, 
we used a C-terminal GFP fusion protein. All amber mutants were validated to show MBD3-
GFP expression upon successful amber suppression by addition of azF (Figure S3). However, 
R3TAG already showed green fluorescence without the addition of azF. The integrity of the 
protein was checked by western blotting (Figure 4B). The full length protein was detected for 
all amber mutants upon azF addition, although R3TAG also gave rise to a truncated product. 
The size of this truncated product could be a result of translation initiation from an internal 
ATG codon (M74), explaining the observed azF-independent expression (Figure S3). Taken 
together, these results show the successful generation and expression of MBD3 amber 
mutants. 
The incorporation of functional azF was tested by labeling of MBD3-GFP with DBCO-dye, 
which showed azF-dependent labeling of the MBD3 ambers (Figure 4C). The full length 
protein of R3amber was weakly labeled, whereas the truncated product was not, indicating that 
only the full length product contained a functional azF. The successful labeling of these MBD3 
proteins urged us to test specific MBD3 depletion using DBCO-modified agarose beads. In 
an initial screen, the V89TAG, T211TAG and L231TAG were incubated with DBCO agarose beads 
and the remaining lysate was compared with the input levels of MBD3 (Figure 4D). The MBD3 
levels were clearly reduced in all tested MBD3 amber mutants, whereas the GAPDH levels 
were only slightly affected. Therefore, DBCO agarose beads can be used to capture azide-
functionalized MBD3 from cell lysate.
MBD3T211TAG Click-MS
The successful immobilization of MBD3 amber mutants using copper-free click chemistry 
prompted us to incorporate this enrichment strategy in our mass spectrometry-based 
protein-protein interaction screens (Hubner et al., 2010; Smits et al., 2013). We dubbed this new 
bioorthogonal chemistry-based interaction proteomics workflow Click-MS. For this purpose, 
we generated whole cell lysates from MBD3T211TAG and empty vector (EV) expressing cells, 
which both expressed tRNA and aaRS and were treated with azF (Figure 5A). The lysates 
were incubated with DBCO agarose beads, followed by extensive washing of the beads and 
on-bead digestion, before applying the peptides to LC-MS/MS. The enrichments were done in 
triplicate to allow label-free quantification and statistical testing, and the EV served as a control 
for quantitative comparison to distinguish interactors from background binding proteins.
The experiments were performed with a higher protein content than for the initial experiments 
in figure 4 in order to get good coverage of all proteins in the LC-MS/MS analysis. The 
MBD3T211TAG depletion was checked on western and showed a reduction of around 50%, 
whereas GAPDH levels remained comparable (Figure 5B). This is a slightly less efficient 
reduction, which could be due to the higher protein content of these depletions. The enriched 
proteins were digested and analyzed by mass spectrometry. The resulting quantification of all 
identified proteins was depicted in a volcano plot, which plots the false discovery rate (-log 
scale) against the observed enrichment (MBD3T211TAG/EV ratio, log2 scale) (Figure 5C). We 
observed an over 1000-fold enrichment of MBD3 compared to the EV control. This extreme 
enrichment illustrates the efficient and highly specific purification of azF-containing MBD3 
from cell lysate. We also found GATAD2A and GATAD2B enriched in these pulldowns (Figure 
5C), which are both part of the NuRD complex. Although this only resembles a partial NuRD 
complex, the identification of these protein interactors already illustrates the capability of 
Click-MS to identify protein-protein interactions.
As a second comparison, we performed a set of Click-MS experiments for MBD3T211TAG with 
and without azF as well as the empty vector control (Figure S4A). Although the noise levels 
were higher for these experiments, MBD3 was clearly enriched in the MBD3T211TAG +azF versus 
–azF (Figure S4B) as well as the MBD3T211TAG versus EV comparison (Figure S4C). However, 
the background cloud did not show a symmetric distribution when the –azF control was used 
as a control. This might lead to more false positive hits, putting forward the empty vector 
sample as the more appropriate control. Of note, these false positive hits did not contain 
endogenous amber stop codons. This experiment also allowed for the direct comparison 
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between the EV and –azF pulldowns (Figure S4D). Significantly enriched proteins in the EV 
samples compared to the –azF samples could indicate azF incorporation in endogenously 
expressed proteins that contain the amber stop codon. However, we did not identify such 
enrichment in the empty vector control (Figure S4D). This is in agreement with the notion 
that amber suppression does not perturb the cellular state as seen with the whole proteome 
analyses (Figure 2). Together, these results establish Click-MS as a method to specifically 
enrich a protein of interest and its interactors without affecting the cellular state. 
Discussion
Affinity purification combined with mass spectrometry is an important tool for the identification 
of PPIs. Conventional techniques utilize antibodies for the purification of an epitope-tagged 
protein and its interactors. The site-directed incorporation of an UAA in response to the amber 
stop codon using an orthogonal tRNA/aaRS pair in combination with bioorthogonal chemistry 
offers an elegant way to circumvent N- or C-terminal peptide or protein fusions to the POI.
The amber suppression technology has already been used for many different types of 
applications such as spatiotemporal protein activation, direct mapping of protein-protein or 
protein-ligand interactions via photo-crosslinking and fluorescent protein labeling (Chin, 2014). 
The site-directed incorporation of UAAs could even be extended from mammalian cells to the 
model organisms Caenorhabditis elegans and Drosophila melanogaster (D. melanogaster) 
(Greiss and Chin, 2011; Bianco et al., 2012). The effect of amber suppression technology in D. 
melanogaster was phenotypically examined by comparing the hatching rate of treated and 
untreated flies. In this comparison, no major differences were observed between the two 
populations. Another study by Chin and coworkers also reported no drastic effects on the 
viability of mammalian cells harboring a 21st tRNA/aaRS and UAA (Elliott et al., 2014). To the best 
of our knowledge, an analysis of the effect of amber suppression technology on a molecular 
level has not been reported yet. As a first effort, we studied the effect of amber suppression 
technology on the proteome using SILAC-based proteomics. The addition of an orthogonal 
tRNA/aaRS pair for incorporating azF inside mammalian cells resulted in the up-regulation of 
5 out of approximately 4600 quantified proteins. None of the upregulated proteins exceeded 
a 3-fold increase compared to untreated cells, indicating only a minimal effect on the cellular 
proteome. This result suggests that putative read-through at endogenous amber stop codons 
does not have an effect on other cellular pathways. 
In our experiments, cells were treated with 250 µM azF. Increasing concentrations of the 
amino acid could potentially result in more pronounced changes in the proteome. The fact 
that increased UAA concentrations can have an effect on the cellular proteome was recently 
demonstrated in a study by Tirrell and colleagues, which described the residue-specific 
incorporation of an azido-containing methionine (Met) analogue in response to Met codons 
(Bagert et al., 2014). Incubation of cells with 1 mM of the azido-containing Met analogue for 
24 h resulted in substantial expression changes for 36% of all quantified proteins. However, 
co-incubation of 1 mM of the azido-containing Met analogue with 33 µM of Met affected the 
proteome only minimally (3 out of 1257 proteins showed a slight effect). 
Once established that amber suppression does not affect the proteome, we focused on 
the selective enrichment of MBD3 using a minimal tag and bioorthogonal chemistry. We 
successfully incorporated azF into MBD3 and were able to selectively enrich MBD3 from 
cell lysate and two of its known interactors using copper-free click chemistry. Preincubation 
with iodoacetamide (IAA) was required in order to increase the specificity of the copper-free 
click chemistry with DBCO. PPIs could be influenced by the treatment with IAA, which could 
be tested in a separate experiment with conventional GFP pulldowns. The copper-catalyzed 
click reaction is much more specific than its copper-free variant and hence a pretreatment 
with IAA is not needed. However, the copper-catalyzed click reaction can induce protein 
precipitation, which interferes with the specific enrichment of azido-tagged protein. When we 
used the water-soluble copper-chelating ligand THPTA and 0.2 mM copper, we observed 
specific enrichment of azido-tagged protein without simultaneous non-specific precipitation of 
other proteins. Whether this copper-catalyzed click reaction is suitable for the identification of 
PPIs using quantitative mass spectrometry remains to be investigated. 
MBD3 is known to interact with at least all the 12 members of the NuRD complex (Smits et al., 
2013). We successfully identified two of its known interactors showing that enrichment with a 
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minimal tag is feasible. Pulldown experiments with other amber mutants, each containing the 
azide at a different site, may result in the complete identification of all interactors and may 
provide additional information on the binding site of an interactor. Furthermore, increasing the 
bead-alkyne linker length could have a beneficial effect on the labeling efficiency, especially 
for mutants that contain the azide at a less accessible site within the protein. In addition, 
structural information on the POI can guide the choice on which residues are good candidates 
for mutation. Moreover, it was recently shown that residues close to the NLS sequence 
are potentially good candidates for the introduction of pulldown tags, since these residues 
are more likely solvent-accessible (Giraud et al., 2014). The use of the amber suppression 
technology for specific protein enrichment is a viable alternative to epitope tagging, especially 
for proteins that are not N- or C-terminally taggable. 
The 1000-fold enrichment that we obtained with our pulldown strategy is comparable to 
enrichment of a GFP-tagged protein (Smits et al., 2013). In contrast to the antibody-protein 
affinity method, Click-MS protein purification relies on the formation of a covalent bond for 
enrichment. The covalent bond permits stringent purification and washing conditions, resulting 
in a strong reduction of background binding proteins. Enrichment to near homogeneity 
should be beneficial for analysis techniques that are sensitive to contamination, such as 
comprehensive PTM identification, crosslinking-MS, and chromatin immunoprecipitation 
purposes. Currently, such a homogeneous sample can only be obtained from tandem-affinity 
purification, consisting of two subsequent affinity purifications that reduce efficient recovery 
(Gingras et al., 2007). This requires very stable protein interactions and more input material. 
The Click-MS workflow holds promise for efficient, single step purification of a protein to near 
homogeneity.
Conclusion
In summary, Click-MS enables a robust, single-step purification and identification of proteins 
of interest and their interactions. Since the introduced azide is small, it only minimally, if at all, 
affects protein structure in contrast to existing epitope-tagging approaches. In principle, nearly 
any amino acid in a protein can be substituted by an UAA, which makes the method very 
flexible and allows for a comprehensive investigation of protein interactions. The site-specific 
incorporation of UAA by amber suppression technology in living organisms could in principle 
allow for the simple identification of tissue-specific protein-protein interactions and PTMs from 
whole organisms in future studies. The principle of Click-MS protein enrichment has great 
potential for both proteomics and genomics analyses, and we envision that the technique will 
be widely used to study a variety of biological systems.
Experimental Section
Cell culture: 
HEK293T cells were cultured in high-glucose Dulbecco’s modified Eagle medium (Gibco) 
supplemented with 10% (vol/vol) fetal bovine serum (Gibco) and 100 units/ml Pen/Strep 
(Gibco). For SILAC labeling, HEK293T cells were cultured in dialyzed DMEM (Gibco) 
supplemented with 10% dialyzed FBS (Dundee Cell Products), 2 mM glutamine (Gibco), 100 
units/ml (P/S), 73 µg/ml lysine (‘light’ (Sigma, L8662) or ‘heavy’ (13C6
15N2
1H14
16O2) (Silantes 
GmbH, 211603902)) and 30 µg/ml arginine (‘light’ (Sigma, A6969) or ‘heavy’ (13C6
15N4
1H14
16O2—
monohydrochloride) (Silantes GmbH, 201603902)). 
Transfections: 
Plasmids for transient transfections were purified using the Plasmid Maxiprep kits from 
Qiagen or JetStar™. For 10 cm dishes, 4.5x106 HEK293T cells were seeded the day before 
transfection. 10-15 µg total DNA was used with a 1:3 DNA to polyethylenimine (PEI) ratio 
(depending on cell density). pSVB.Yam-tRNACUA (Naganathan et al., 2013), tylRS and protein 
coding plasmids were mixed in a 1:0.3:1 ratio, respectively. DNA and PEI were mixed in 
DMEM, incubated for 20 minutes at room temperature and dropwise added to the cells. After 
incubated for 4 hours at 37 °C in serum free DMEM, 250 µM p-azido-l-phenylalanine (azF, 
Bachem) and DMEM supplemented with 20% FBS was added. The following day media was 
refreshed with 250 µM azF. 
Flow cytometry: 
0.1-1.0 x 106 cells were washed, resuspended in 500 µl PBS and applied to a BD FACSCalibur™ 
(Becton Dickson). GFP and mCherry reporter expression was determined on live cells using 
Cell Quest Pro Software and Flowing Software v2.5.
Fluorescence Microscopy:
Cells were imaged using a Leica DM IRE2 TCS SP2 AOBS Confocal microscope at 40 × 
magnification. Fluorescent images were acquired at 0.1 µm intervals using a Leica DFC 420C 
camera. Excitation was set at 488 and 561 nm, and images were taken at 489-551 nm and 
574-750 nm, for GFP and mCherry respectively. Projections of z-stacks were generated using 
Image J software. 
Whole proteome analysis: 
SILAC labeled cells were counted using an automated cell counter (TC-20 BioRad) and 
appropriate light and heavy cells were mixed in a 1:1 ratio. Cells were lysed with 5 volumes 
lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 1% NP40) and rotated for 4 hours at 4 °C. 
Lysates were subsequently cleared by centrifugation for 30 minutes at 14000xg at 4 °C.
For mass spectrometry, lysates were processed using filter aided sample preparation (FASP) 
(Wisniewski et al., 2009b). 10 µg protein was applied to 30 kDa cut off Amicon filters (Millipore). 
After washing, proteins were alkylated by 50 mM iodoacetamide (Sigma Aldrich) treatment. 
After three washes with 8 M urea and 50 mM ammonium bicarbonate, proteins were digested 
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with 0.5 µg trypsin overnight at 37 °C in a humidified chamber.
To increase proteome depth, peptides were fractionated using strong anion exchange (SAX) 
(Wisniewski et al., 2009a). Peptides were applied to SAX stage tips (2252-anion Empore) and 
the flow through as well as pH11, pH8, pH5 and pH2 elutions were collected. All samples were 
desalted and concentrated by the stage tips, before applying them to LC-MS/MS analysis with 
4 hour gradients. Spectra were recorded on a Q Exactive (Thermo Scientific) using higher-
energy collisional dissociation (HCD) fragmentation. Raw data were analyzed using MaxQuant 
(Cox and Mann, 2008) and scatterplots generated from the reported normalized ratios in R.
Site-directed mutagenesis: 
The amber mutation was introduced into the MBD3-GFP gene within pcDNA3.1(+) by PCR 
using Phusion Hot Start II High-Fidelity DNA polymerase (Thermo Scientific) and the primers 
listed below. Whole plasmid amplification was performed according to the manufacturer’s 
protocol. Next, 20 µL of the PCR reaction mixture was incubated with 1 µL of DpnI (New 
England BioLabs) for 2h at 37 °C. DH5α cells were transformed with 5 µL of the PCR reaction 
mixture by heat-shock and incubated for 45 min at 37 °C shaking at 200 rpm in 1 mL LB 
medium, before being spread on an LB agar plate containing ampicillin. Colonies were 
selected and inoculated into 5 mL LB medium containing ampicillin and grown overnight at 
37°C, shaking at 200 rpm. Plasmids were purified using the Wizard® Plus SV Minipreps 
DNA Purification System (Promega). The insertion of the amber mutation was confirmed by 
sequencing.
to the lysate. For reduction of copper, 1 mM or 1.5 mM sodium ascorbate (Sigma Aldrich) 
was added for the TBTA or THPTA samples, respectively. Finally, 50 µM alkyne cyanine dye 
718 (Sigma Aldrich) was added and the sample was incubated for 2 hours at 25 °C. For 
SPAAC, lysates were treated with 50 mM iodoacetamide for 30 minutes, before addition of 
50 µM dibenzocyclooctyne-PEG4-Fluor 545 (Sigma Aldrich) and incubation for 2 hours at 
25 °C. Labeled samples were boiled in 1× Laemmli buffer and separated on an 8% SDS-
PAGE gel. In-gel fluorescence was measured on an Odyssey CLx (Licor) using 700 nm as 
the scanning wavelength or a G:BOX Chemi XT4 Fluorescent & Chemiluminescent Imaging 
System (Syngene) using 520 nm as excitation wavelength and emission was detected using 
the UV06 filter (572-625nm) for CuAAC or SPAAC, respectively.
GFP enrichment: 
GFP enrichment were essentially done as described before (Hubner et al., 2010). Briefly, 
100 µl whole cell lysate of MBD3 amber mutants was incubated with 10µl GFP-Trap beads 
(ChromoTek) for 90 minutes at 4 ˚C. After incubation beads were washed 3 times with lysis 
buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 1% NP40). Beads containing fusion proteins 
were immediately used for bioorthogonal labeling in lysis buffer.
Protein enrichment using bioorthogonal chemistry: 
MBD3 amber mutant were enriched from lysates as obtained in ‘Bioorthogonal labeling’. 
Alkyne-agarose beads (Click Chemistry Tools) or DBCO-agarose beads (Click Chemistry 
Tools) were used for CuAAC or SPAAC based immobilization, respectively. 100 µl beads 
were washed three times in lysis buffer, before 1 ml lysate (2 mg/ml) was added. The reactions 
were performed with exactly the same conditions as for the labeling, except that the samples 
were incubated overnight at 4 °C.
For western blot analysis, 30 µl of the supernatant was boiled in 1× Laemmli buffer and 
separated on an 8% SDS-PAGE gel, blotted and probed for GFP (Roche) and GAPDH 
(Abcam). 
For mass spectrometry analysis, beads were washed twice with lysis buffer containing 
300 mM NaCl and 0.5% NP40, twice with PBS containing 0.5% NP40 and three times with 
PBS. Proteins were alkylated by 50 mM iodoacetamide and on-bead digested using 0.5 µg 
trypsin overnight at 25 °C. All samples were desalted and concentrated by the stage tips, 
before applying them to LC-MS/MS analysis with 2 hour gradients. Spectra were recorded on 
a Orbitrap Fusion (Thermo Scientific) using collision-induced dissociation (CID) fragmentation.
Data analysis: Raw data were analyzed using MaxQuant (Cox and Mann, 2008), using default 
settings and the options ‘match between runs’ and ‘label free quantification’ enabled. Resulting 
proteins were filtered for reverse hits and contaminants. Label free quantification intensities 
were log2 transformed and filtered to have at least three valid values in one triplicate 
experiment. Enrichment of proteins was determined by comparing label free intensities 
between the amber mutant and control samples. Significant enrichment was determined by 
a permutation-adapted student t-test (Perseus analysis software in the MaxQuant software 
package). 
Primer  Sequence 5’-3’  
hMBD3 R3TAG FW  TGGAGTAGAAGAGGTGGGAGTGC 
hMBD3 R3TAG RV  CTCTTCTACTCCATGGTGGTATCTCCTT 
hMBD3 V89 TAG FW  CCAGTAGAAGGGCAAGCCC   
hMBD3 V89 TAG RV  CCTTCTACTGGTTGGAGGAGTCG 
hMBD3 T211 TAG FW  ACACCTAGCAGCCCCTGTG 
hMBD3 T211 TAG RV  GGCTGCTAGGTGTTGAGCC 
hMBD3 L230 TAG FW  AAGAG TAGGTGCAGCAGGTGC 
hMBD3 L230TAG RV  CTGCACCTACTCTTCCTGCTTC 
hMBD3 H290TAG FW  GGAGTAGGTCGACCCAGCTTTCTT 
hMBD3 H290TAG RV  GACCTACTCCATCTCCGGGTCC 
Bioorthogonal labeling: 
Cells were lysed with 5 volumes lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 0.5% 
NP40) and rotated for 4 hours at 4 °C. Lysates were subsequently cleared by centrifugation 
for 30 minutes at 14000xg at 4 °C. 50 µL 1 mg/ml whole cell lysates were labeled in the case 
of mCherry-GFPTAG and GFP enriched samples were labeled in the case of MBD3 amber 
mutants. For CuAAC, 0.5-1 mM copper sulfate (CuSO4, Sigma Aldrich) with 2 mM tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, TCI Europe, N.V.) or 0.2-0.4 mM CuSO4 
with 0.5 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA, Sigma Aldrich) was added 
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contaminants. Cutoff depicted as dashed lines at 1.5 fold difference.
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The work described in this thesis aims to contribute to the development of site-specific 
bioconjugation techniques as well as to the application of bioorthogonal chemistry in biology. 
The following section summarizes the main results of each research chapter and discusses 
possibilities for future investigations. In the final part of this chapter a more general overview 
of the opportunities bioorthogonal chemistry has to offer will be presented. 
In Chapter 2 we reported the genetic incorporation of bicyclononyne-functionalized lysine 
(BCN-lysine) into proteins and its functionalization with azido- or tetrazine-containing 
compounds. We showed that BCN-lysine can be incorporated into mammalian cells and be 
used for rapid protein detection. BCN-containing proteins showed facile labeling within a few 
minutes at a low dye concentration. This might be especially useful in future studies to detect 
proteins that have only a short lifetime within the cell. As the dosage can be kept low due to 
the fast reaction kinetics the amount of background labeling will also be diminished.
A new bioconjugation strategy was added to the toolbox of chemoselective reactions, as 
reported in Chapter 3. The reaction of BCN with 1,2-quinones, termed SPOCQ, is very rapid 
and is several orders of magnitude faster than strain-promoted azide–alkyne cyclcoaddition 
(SPAAC). Furthermore, in contrast to other fast conjugation reactions, this methodology 
requires an activation step, which therefore allows spatiotemporal control over the execution 
of the SPOCQ reaction. Many catechols are commercially available and they can be easily 
incorporated into small molecules or peptides. Upon oxidation the catechol is converted into 
the corresponding quinone, which becomes a reactive handle for functionalization with BCN-
containing molecules. BCN-harboring proteins can also be site-selectively functionalized 
using the SPOCQ reaction. The formed product of BCN and the quinone slowly undergoes 
a retro-Diels–Alder reaction resulting in the formation of a phenyl ring, which is more stable. 
Future studies could focus on accelerating this retro-Diels–Alder reaction in a way that is 
compatible with biological systems. Moreover, other oxidative reagents could be tested to 
oxidize the catechol to the quinone, since the use of sodium periodate is not compatible with 
biological systems. The SPOCQ reaction is particularly useful for in vitro bioconjugation and 
could be considered as a viable alternative to maleimide or NHS-ester chemistry. Whether it 
could be used to monitor oxidative stress inside cells might be an interesting idea and remains 
to be investigated; one could consider to prepare a cell-penetrating probe containing both the 
BCN moiety as well as the catechol group. Upon oxidation of the catechol to the quinone and 
hence, the reaction of BCN with the quinone, the molecule could become fluorescent. Such a 
probe could be used as a sensor to monitor oxidative stress. 
The SPOCQ reaction can also be used in materials science. We introduced the SPOCQ 
reaction as a fast and activatable method for hydrogel formation in Chapter 4. We showed 
that catechol and BCN-functional star PEG polymers instantaneously form hydrogels upon 
the addition of sodium periodate and that different concentrations of the enzyme mushroom 
tyrosinase can be used to tune the gelation time. By using an excess of the BCN-modified 
PEG-polymer over the catechol-functionalized PEG-polymer, azido-containing molecules 
can easily be incorporated into the hydrogel, which we demonstrated with a fluorescent 
azido-dye. The large difference in reaction rates between SPOCQ and SPAAC allows for the 
simultaneous preparation and modification of hydrogels. Future studies could use biologically 
more relevant molecules such as azido-containing drugs or cell-adhering peptides to grow 
cells on these hydrogels, and make these gels suitable for biomedical applications. More 
research could also focus on finding other methods to oxidize the catechol-PEG polymers. 
In Chapter 5 we aimed to use the SPAAC reaction as method to covalently couple Fc fragments 
to the surface of bacteria to potentiate mucosal vaccination by targeting bacteria directly to Fc 
receptors, which are presented on epithelia and antigen-presenting cells. We functionalized 
bacteria with azido-groups on their cell surface and also prepared Fc fragments that were site-
selectively modified with a dibenzocyclooctyne (DBCO)-moiety. However, we were not able 
to couple the Fc fragment to the cells yet, thus more research is needed to investigate the 
effect of steric hindrance by the bacterial surface on the coupling efficiency. A longer spacer 
might be needed in order to efficiently couple the Fc fragment to the cell surface. Another 
interesting application could be to couple the Fc fragment to azido-functionalized liposomes 
or polymersomes, which are less complex than the bacterial surface. These vesicles could be 
loaded with a number of antigens and could also be used for mucosal vaccination. 
In Chapter 6 we introduced a minimal-tag approach for the enrichment of protein complexes 
for quantitative mass spectrometry-based studies, called Click-MS. We site-specifically 
incorporated an azido-functionalized amino acid into the methyl-CpG binding domain protein 
3 (MBD3) using genetic code expansion. We showed that MDB3 could then be highly enriched 
from cell lysate using DBCO-coated agarose-beads. Furthermore, two of its known interactors 
were also co-enriched using this strategy, demonstrating the feasibility of protein complex 
enrichment using a small bioorthogonal tag. However, it is known that MDB3 has more 
interactors and we were not able to identify them yet. Future studies should investigate the 
effect of the position of the azido-group within the protein on enrichment. Eventually Click-MS 
could also be used to enrich protein complexes from specific tissues. Genetic code expansion 
can be performed in whole organisms and thereby, the composition of specific complexes in 
different cell types could be investigated in future experiments.
Another application could be the comprehensive determination of posttranslational 
modifications (PTMs) on a single protein. Since the protein-of-interest is covalently bound 
to the beads, it is also possible to apply stringent washing conditions to purify the protein to 
near full purity. Due to the high purity it will be possible to determine all possible combinations 
of PTMs for an individual protein. This cannot be done with the current workflows, in which 
1000-2000 proteins are enriched and identified. Known posttranslational modifications 
of an individual protein could then be identified using search engines such as Mascot and 
MaxQuant. The enrichment of a protein to near full purity from cell lysate is not possible with 
the current methods, which rely on non-covalent protein interactions.
In summary, we have further expanded the bioconjugation toolbox and also utilized bioorthogonal 
chemistry for biologically relevant applications. This reflects the two developments ongoing in 
the field, namely designing new chemistry and utilizing the chemistry in biology.
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Future opportunities and challenges 
Bioorthogonal chemistry is undoubtedly a research field with many possibilities. It has paved 
the way for new discoveries and applications in fundamental research as well as in the 
pharmaceutical industry. The future opportunities and challenges in the field of chemical biology 
will be described in the next sections. Antibody-drug-conjugates (ADCs) will be highlighted as 
one recent example of pharmaceutical research, that benefits from (bio)orthogonal reactions. 
Finally, some intriguing examples of bioorthogonal chemistry in fundamental research will 
also be described, which truly represents the usefulness of this research field for answering 
biological questions.
An important line of research in the field of bioorthogonal chemistry is focused on improving 
or adding new reactions to the toolbox, or applying this chemistry to answer biological 
questions. Improving reactivity has always been an important subject, since fast reactions 
are highly valuable for monitoring rapid cellular processes and for in vivo applications. 
Different cyclooctyne variants, varying in reactivity and solubility, have been synthesized 
since Carolyn Bertozzi reported SPAAC in 2004 (Agard et al., 2004). Also, the search for new 
types of reactions using other reactive moieties than the azide is still being continued. The 
strain-promoted inverse electron-demand Diels–Alder cycloaddition (SPIEDAC) of TCO and 
tetrazine has been the fastest bioorthogonal reaction described so far. It has been superior in 
in vivo tumor pretargeting studies compared to other bioorthogonal reactions due to its high 
reactivity and selectivity. More research is still needed to optimize the reaction for its use in 
clinical applications (e.g. biodistribution), but promising results in mice have been obtained, 
hopefully leading to improved tumor imaging and better therapies with reduced toxicity for 
non-targeted tissues in the future.
One application in which bioorthogonal chemistry already has shown its added value is in the 
development of ADCs. Cytotoxic drugs are conjugated via a small linker to an antibody that 
specifically targets a certain antigen (e.g. a protein that is (over)expressed on a tumor cell). 
The concept of a selective delivery of the cytotoxic drug is intriguing, because it should result 
in reduced side effects, which are associated with conventional chemotherapy. However, the 
use of conjugation strategies involving lysine or cysteine residues for the covalent attachment 
of the drug to the antibody results in a heterogeneous mixture of ADCs, each having a different 
efficacy and safety profile (Junutula et al., 2008). Chemoselective reactions combined with 
recent advances in protein engineering, which allow for the incorporation of one of the 
reactive partners into the antibody, have made it possible to prepare homogenous ADCs in 
a controlled way. Moreover, these homogenous ADCs have proven to perform better than a 
heterogeneous population of ADCs (Junutula et al., 2008). The concept of ADCs was already 
described a few decades ago, but initially failed due to problems with efficacy and safety. 
Nowadays, ADCs are making their comeback as highly promising biopharmaceuticals due to 
the availability of more selective conjugation strategies, an increased knowledge about the 
antibody targets and progress in linker technology. In recent years, many biotech companies 
have been founded focusing on ADC technology, which reflects the promise ADCs hold for the 
industry as future biopharmaceuticals (Junutula et al., 2008).
Besides the development of new bioorthogonal reactions, the azide, which marked the 
beginning of the bioorthogonal chemistry era, has not become ‘outdated’. The azide as well 
as the linear alkyne excel in their small size, which makes them ideal for the installation 
into several biomolecules by simple metabolic incorporation. Substrate analogues that bear 
azides or linear alkynes have become invaluable tools as chemical reporters to study cellular 
pathways, (Prescher and Bertozzi, 2005) because these analogues are often well tolerated by 
enzymes. Once incorporated into the biomolecules, they can be visualized or enriched using 
an exogenous probe. This elegant method has proven itself already as an invaluable tool to 
answer biological questions and is nowadays increasingly applied in biology. The chemical 
reporter strategy was recently used to develop a new bacterial cell wall labeling method. This 
method utilized unnatural d-amino acid dipeptides harboring either azides or alkynes and has 
recently provided strong evidence that Chlamydia contains peptidoglycan, which was subject 
to speculation for over 50 years (Liechti et al., 2014). Another recent example of the great 
potential of the chemical reporter strategy is a study by Jäschke and coworkers (Cahova et al., 
2015). The bacterial enzyme adenosine diphosphate-ribosyl cyclase from Aplysia californica 
was shown to catalyze the trans-glycosylation of NAD with alkynyl alcohols. NAD was reported 
to be a covalent modification of bacterial mRNAs. The promiscuity of adenosine diphosphate-
ribosyl cyclase towards alkynyl alcohols allowed for the first time to identify the NAD-modified 
mRNAs and to study cellular processes to regulate this modification. More enzymes and 
cellular pathways might be found in the future that are promiscuous towards small changes in 
the structure of the substrate enabling more functional studies advancing both fundamental 
as well as applied research. Also, more fundamental insights will be gained when more 
substrate analogues for lipids and nucleic acids would become available. A challenge that 
still remains is finding a substrate analogue that is specific for one certain type of molecule 
within a class. Finding such specific analogues would enable us to study cellular processes 
in concert, when different types of bioorthogonal reactions, which do not interfere with each 
other, are used. Therefore, more bioorthogonal reactions are also needed that make use of 
small reactive groups such as the azide. To conclude, bioorthogonal chemistry is an exciting 
research field with great potential, which has started to being recognized beyond traditional 
chemical biologists.
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Summary
A large variety of biomolecules such as lipids, DNA, carbohydrates and proteins exist inside 
cells. Every biomolecule fulfills a different type of function and it is highly relevant to study these 
functions to eventually understand the development of certain diseases. In order to study the 
role of a single protein, it is necessary to selectively mark this protein inside cells. The interest 
in methods that can be used for the site-selective modification of biomolcules has increased 
tremendously over the past few years. For example, by selectively modifying a protein of 
interest with a fluorescent label inside cells or organisms, it is possible to learn more about 
its function, localization and interactions with other molecules. A frequently used method for 
the visualization of proteins is to fuse a second, fluorescent protein to the protein of interest. 
However, this fluorescent protein is large and might interfere with the function of the protein 
of interest. Therefore, scientists started searching for chemical reactions that can be used to 
couple a small dye to a protein in a very controlled manner. In addition to fundamental research, 
the site-selective modification of proteins is also important for therapeutic applications, e.g. in 
the development of biopharamceuticals. The biostability of a pharmaceutical protein can be 
improved by the attachment of certain molecules. A high level of control of the attachment is 
important in order to avoid interference with the binding of the protein to its target and hence 
influencing the therapeutic effect of the protein. Classical methods for protein modification 
involve attachment via natural functionalities such as the amine of the lysine residue or the 
thiol of the cysteine residue. These methods are slowly being replaced by chemical reactions 
that are highly selective, functional under physiological conditions, and are non-toxic. These 
reactions are called biorthogonal reactions. One of the most popular bioorthogonal reactions is 
the reaction of an azide with a cyclooctyne, called strain-promoted azide–alkyne cycloaddition 
(known as SPAAC or copper-free click chemistry). This reaction inspired many researchers to 
search for more reactions that can be used for the labeling of proteins and other biomolecules. 
Chapter one gives an overview of the application of bioorthogonal reactions in fundamental 
as well as applied research. 
Chapter two describes the genetic encoding of the new unnatural amino acid bicyclononyne-
lysine (BCN-lysine). The pyrrolysyl-tRNA and a mutant of the pyrrolysyl-tRNA synthetase 
from Methanosarcina mazei were used to site-specifically incorporate BCN-lysine into GFP 
in response to the amber stop codon. A Förster resonance energy transfer assay was used 
to study the kinetics of the reaction of BCN-modified GFP with azido- or tetrazine-containing 
fluorogenic dyes and was compared to an amino acid harboring a plain cyclooctyne moeity. 
BCN was shown to react approximately 10 times faster with azido-tetramethylrhodamine than 
plain cylcooctyne. The reaction with tetrazine was 80 times faster and is one of the fastest 
bioconjugation reactions reported so far. BCN-lysine could also be incorporated into proteins 
inside mammalian cells and could be used for fast protein labeling inside cells.
We have developed a new bioconjugation reaction based on the reaction of quinones with 
cyclootynes, which is called strain-promoted oxidation-controlled cyclooctyne–1,2-quinone 
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cycloaddition (SPOCQ). In Chapter three we characterize this reaction and show its application 
for the labeling of peptides and proteins. 1,2-quinones can be generated by oxidation from the 
corresponding catechols, which can be used as an activatable bioconjugation reaction. The 
reaction between 1,2-quinones and BCN was shown to be much faster (k = 496 ± 70 M-1s-1) 
than the reaction of BCN with azides (strain-promoted azide-alyne cycloaddition, SPAAC). In 
Chapter four we studied hydrogel formation using the SPOCQ reaction. 4-armed star-PEG-
BCN and 4-armed star-PEG containing 3,4-dihydroxyphenylacetic acid (star-PEG-DHPA) were 
mixed and upon the addition of the oxidizing agent hydrogels formed almost instantaneously. 
When the enzyme, mushroom tyrosinase, was used as the oxidizing agent gelation times could 
be tuned from seconds to several minutes by using different concentrations of the enzyme. 
By using an excess of the star-PEG-BCN polymer for hydrogel formation, we showed that 
hydrogels could be formed and simultaneously functionalized with azido-compounds because 
of the large difference in rate constants between the SPAAC and SPOCQ reactions.
 
In Chapter five, we aimed to prepare a new vaccine formulation against bacterial infections 
by decorating surfaces of bacteria with Fc fragments, which is the tail of an antibody that 
activates the immune system, using bioorthogonal chemistry. The surface of Staphylococcus 
aureus were functionalized with azido-groups by culturing the bacteria in the presence of 
d-azidoalanine. d-Azidoalanine incorporation was validated using a fluorescent cyclooctyne-
dye. Fluorescence microscopy and flow cytometry analysis showed facile incorporation of 
the azido-groups. An enzymatic as well as chemical approaches was used to modify the Fc 
protein with a cyclooctyne moiety. The latter method resulted in a higher labeling efficiency 
showing approximately 80% functionalization of Fc protein based on gel-shift assay analysis. 
Cyclooctyne-functionalized Fc fragments could not yet be coupled to the bacteria yet, because 
the reaction is most likely sterically hindered by cell-wall glycopolymers that are present in the 
cell wall of Staphylococcus aureus.
Chapter six introduces a tagless workflow for the enrichment of proteins for mass spectrometry-
based proteomics to study protein-protein interactions (PPIs). GFP, either fused to the N- or 
C-terminus of a protein of interest, is a frequent tag for the enrichment of a single protein and 
its interactors. We aimed to develop an alternative strategy for fusion tag-based enrichment 
protocols by combining amber suppression technology and bioorthogonal chemistry. Azido-
phenylalanine (azF) was first genetically encoded into the model protein mCherry-GFP. We 
then tested the efficiencies of copper-catalyzed and copper-free click chemistry for the labeling 
and enrichment of this model protein from cell lysate. Protein precipitation was observed 
with the copper-catalyzed click chemistry, whereas incubation with azadibenzocyclooctyne-
functionalized agarose beads resulted in selective enrichment of azido-tagged mCherry-
GFP from cell lysate. Testing the feasibility of our novel enrichment strategy for studying 
interactomes, we incorporated azF at position 211 into methyl-CpG-binding domain protein 3 
(MBD3), a member of the Nucleosome Remodeling and Deacetylase (NuRD) complex. Mass 
spectrometry analysis showed that MBD3 could be selectively enriched with two of its known 
interactors. This finding shows that direct enrichment of a protein of interest and its interactors 
is feasible. Based on this result, we hypothesize that MS-data from experiments with different 
mutants, each containing one azF at another position, might be combined for the complete 
identification of all PPIs. 
Samenvatting
Cellen zijn opgebouwd uit heel veel verschillende biomoleculen zoals lipiden, DNA, suikers 
en eiwitten. Deze biomoleculen hebben allemaal een andere functie en het is erg belangrijk 
om hun rol te bestuderen, om hierdoor vervolgens ook ziektes te kunnen begrijpen. Om de 
functie van een bepaald biomolecuul te kunnen bestuderen, is het nodig om dit biomolecuul 
in de cel selectief te kunnen markeren. De interesse om chemische reacties te ontwikkelen 
waarmee je biomoleculen selectief kunt modificeren, is de laatste jaren erg toegenomen. 
Door bijvoorbeeld een eiwit selectief met een lichtgevend molecuul te modificeren is het 
mogelijk om de functie, lokalisatie en de interacties hiervan met andere moleculen in de cel 
te bestuderen. Een vaak gebruikte methode om een eiwit in de cel zichtbaar te maken is om 
er een fluorescent eiwit aan te bevestigen. Alleen is dit fluorescente eiwit groot en zou dit de 
functie van het andere eiwit kunnen beïnvloeden. Daarom zijn wetenschappers begonnen 
om naar chemische reacties te zoeken waarmee je heel selectief kleinere kleurstoffen aan 
een eiwit kunt koppelen. Naast dit soort fundamenteel onderzoek is het selectief veranderen 
van een eiwit ook heel belangrijk voor therapeutische toepassingen waarbij eiwitten als 
medicijnen worden gebruikt. De biologische stabiliteit van een eiwit kan worden verhoogd 
door bepaalde moleculen eraan te verbinden. Als je controle hebt over het bevestigen, dan 
kan dat voorkomen dat de binding van het eiwit met zijn doel beïnvloedt wordt en hierdoor dus 
het therapeutische effect van het eiwit bewaard blijft. Klassieke methodes om therapeutische 
eiwitten te modificeren gebruiken de natuurlijk voorkomende functionele groepen in eiwitten, 
zoals amines van lysine zijketens, of thiolgroepen van cysteïne zijketens. Deze niet heel 
selectieve methoden worden nu langzaam vervangen door chemische reacties die juist heel 
selectief zijn, werken onder fysiologische omstandigheden en die niet toxisch zijn. Dit type 
reacties wordt bioorthogonaal genoemd. Een van de populairste reacties is die van een 
azide met een cyclooctyne, welke strain-promoted azide-alkyne cycloaddition (SPAAC of 
kopervrije click chemie) genoemd wordt. Deze reactie heeft vele onderzoekers geïnspireerd 
om naar meer reacties te zoeken die gebruikt kunnen worden voor het selectief markeren van 
eiwitten en andere biomoleculen. Hoofdstuk één geeft een overzicht over de toepassing van 
bioorthogonale reacties in fundamenteel en toegepast onderzoek.
Hoofdstuk twee beschrijft het inbouwen van een niet-natuurlijk aminozuur genaamd 
bicyclononyne-lysine (BCN-lysine) in eiwitten via de amber suppression technology, waarbij 
een speciale tRNA het amber stop codon herkend om een aminozuur in de groeiende 
peptideketen in te bouwen. Hiervoor zijn de pyrrolysyl-tRNA en een mutant van de pyrrolysyl-
tRNA synthetase van het organisme Methanosarcina mazei gebruikt om BCN-lysine plaats-
specifiek in te kunnen bouwen in GFP (green fluorescent protein). Een Förster resonance 
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energy transfer (FRET) assay werd gebruikt om de kinetiek van de reactie van BCN-
gemodificeerd GFP met azide- en tetrazine-bevattende fluorogene kleurstoffen. Dit werd 
vergeleken met een ander ingebouwd aminozuur dat een simpel cyclooctyne bevat. Het werd 
aangetoond dat BCN 10 keer sneller met azido-tetramethylrhodamine reageert dan met de 
simpelere cyclooctyne. De reactie met tetrazine was zelfs 80 keer sneller en is een van de 
snelste bioconjugatie reacties die tot nu toe zijn beschreven. BCN-lysine kon ook worden 
ingebouwd in eiwitten in zoogdiercellen en kon daar worden gebruikt voor snelle markering 
van eiwitten in deze cellen.
We hebben op basis van de reactie van quinones met cyclooctynes een nieuwe bioconjugatie 
reactie ontwikkeld, die strain-promoted oxidation-controlled cyclooctyne–1,2-quinone 
cycloadditie (SPOCQ) genoemd wordt. In hoofdstuk drie karakteriseren wij deze reactie en 
laten we de toepassing hiervan zien bij het markeren van peptiden en eiwitten. 1,2-quinones 
kunnen gemaakt worden via de oxidatie van de overeenkomstige catecholen. Hierdoor kan de 
SPOCQ reactie worden gebruikt als activeerbare bioconjugatie reactie, door de oxidatie van het 
catechol als activatie stap te gebruiken. Het werd aangetoond dat de reactie van 1,2-quinones 
met BCN vele malen sneller (k = 496 ± 70 M-1s-1) verloopt dan de reactie van BCN met azides 
(SPAAC). In hoofdstuk vier bestudeerden wij het vormen van hydrogels met behulp van 
de SPOCQ reactie. 4-armige ster PEG-BCN en 4-armige ster-PEG gefunctionaliseerd met 
3,4-dihydroxyphenylacetic acid (ster-PEG-DHPA) werden met elkaar gemengd, waarbij na 
het toevoegen van het oxiderende middel bijna meteen hydrogels werden gevormd. Als ster-
PEG-DHPA geoxideerd werd door het enzym mushroom tyrosinase, dan kon de stollingstijd 
van de gel gestuurd worden van een paar seconden tot enkele minuten, afhankelijk van de 
gebruikte enzym concentratie. We lieten ook zien dat door een overmaat van star-PEG-BCN 
polymeer te gebruiken, hydrogels gevormd konden worden die gedurende de gel-vorming 
direct gefunctionaliseerd kunnen worden met azide-bevattende moleculen. Vanwege het 
grote verschil in reactiviteit van de SPAAC en SPOCQ reacties werd de gel vorming niet 
beïnvloed door de functionalisatie reactie.
In hoofdstuk vijf hadden wij als doel om een nieuw vaccin tegen bacteriële infecties te maken 
door de buitenkant van bacteriën te decoreren met Fc fragmenten via bioorthogonale chemie. 
Het Fc fragment is de staart van een antilichaam en het deel dat het immuun systeem activeert. 
De oppervlakte van Staphylococcus aureus werd gefunctionaliseerd met azide-groepen door 
de bacteriën in aanwezigheid van d-azidoalanine te laten groeien. d-azidoalanine inbouw 
werd gevalideerd met een fluorescente cyclooctyne kleurstof. Fluorescentie microscopie 
en flow cytometrie hebben de inbouw van azide-groepen aangetoond. Een enzymatische 
en een chemische methode werden getest voor het modificeren van het Fc eiwit met een 
cyclooctyne-groep. De laatste methode resulteerde in een hogere labeling efficiëntie van het 
eiwit. Ongeveer 80% van de Fc eiwitten werd gefunctionaliseerd, wat aangetoond werd door 
een gel-shift assay. Fc fragmenten konden niet gekoppeld worden aan de buitenkant van de 
bacteriën, wat waarschijnlijk werd veroorzaakt door sterische hindering van glycopolymeren 
die op de celwand van Staphylococcus aureus aanwezig zijn.
In hoofdstuk zes wordt een nieuwe manier voor het verrijken van eiwitten voor 
massaspectrometrie (MS)-gebaseerde proteomics geïntroduceerd om eiwit-eiwit interacties te 
bestuderen. Een vaak gebruikt label voor het verrijken van een enkel eiwit is GFP, dat aan de 
N- of C-terminus van het eiwit gefuseerd wordt. Wij wilden een alternatieve verrijkingsmethode 
ontwikkelen die geen gebruik maakt van GFP of peptide labels, door amber suppression 
technologie met bioorthogonale chemie te combineren. Allereerst hebben wij het niet-
natuurlijk aminozuur azido-phenylalanine (azF) ingebouwd in het modeleiwit mCherry-GFP 
om de efficiëntie van kopervije en koper-gekatalyseerde click reacties voor het selectieve 
verrijken van een eiwit uit cellysaat met gefunctionaliseerde agarose beads te testen. Eiwit 
precipitatie werd geobserveerd bij de koper-gekatalyseerde click reactie. Daarentegen leidde 
de kopervrije click chemie met azadibenzocyclooctyne-gefunctionaliseerde agarose beads 
tot een selectieve verrijking van azide-mCherry-GFP uit cellysaat. Om te testen of deze 
nieuwe methode ook geschikt was om een eiwit met zijn interactoren te verrijken, hebben 
wij azF ingebouwd op positie 211 in methyl-CpG-binding domain protein 3 (MBD3), een eiwit 
van het Nucleosome Remodeling and Deacetylase (NuRD) complex. Massa spectrometrie 
analyse liet zien dat MBD3 selectief verrijkt kon worden samen met twee van zijn bekende 
interactoren. Dit resultaat is een bewijs dat onze nieuwe methode, die geen gebruik maakt 
van een GFP of peptide label voor het verrijken van een eiwit, geschikt is voor het bestuderen 
van interactomes. Gebaseerd op deze vinding denken wij dat MS-data van meerdere 
experimenten met verschillende mutanten, die elk azF op een andere positie bevatten, 
gecombineerd zouden moeten worden om alle eiwit-eiwit interacties te kunnen identificeren.  
Zusammenfassung
Zellen sind aufgebaut aus vielen verschieden Biomolekülen wie zum Beispiel Lipiden, DNA, 
Kohlenhydraten und Eiweißen. Zum besseren Verständnis verschiedener Krankheiten ist die 
Erforschung der unterschiedlichen Funktionen von Biomolekülen von großer Bedeutung. Um 
ein bestimmtes Biomolekül erforschen zu können, muss man dieses mit einer spezifischen 
Markierung versehen. Das Interesse an Methoden, die die positionsspezifische Veränderung 
von Biomolekülen ermöglichen, hat in den letzten Jahren enorm zugenommen. Durch die 
spezifische Markierung mit einem fluoreszierenden Label ist es zum Beispiel möglich die 
Funktion eines Proteins, seine Lokalisierung innerhalb der Zelle und seine Interaktion mit 
anderen Molekülen  zu erforschen. Eine häufig verwendete Methode zur Visualisierung von 
Eiweißen ist die Fusion mit einem zweiten, fluoreszierenden Protein, das mit dem N- oder 
C-terminus des entsprechenden Proteins verbunden wird. Fluoreszierende Proteine sind 
allerdings sehr groß und können die Funktion des anderen Proteins negativ beeinflussen. 
Darum suchen Wissenschaftler nach chemischen Reaktionen, die es ermöglichen, auf sehr 
kontrollierte Art einen kleinen fluoreszierenden Farbstoff an ein Eiweiß zu koppeln. Nicht 
nur in der Grundlagenforschung spielt die positionsspezifische Veränderung von Proteinen 
eine wichtige Rolle, sondern auch bei der Entwicklung von therapeutischen Proteinen. Die 
Biostabilität eines Proteins kann durch das Anhängen von bestimmten Molekülen erhöht 
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werden. Auch hier ist es wichtig, dass diese Moleküle kontrolliert an das Eiweiß gekoppelt 
werden, da sonst die therapeutische Funktion des Eiweißes blockiert werden könnte. 
Traditionelle Methoden, die zur Modifizierung von Eiweißen eingesetzt werden, sind zum 
Beispiel Reaktionen mit Aminogruppen von Lysinresten oder Thiolgruppen von Cysteinresten. 
Diese Methoden werden jedoch zunehmend ersetzt durch sehr selektive Reaktionen, die 
unter physiologischen Bedingungen durchführbar und nicht toxisch sind. Letztere werden 
auch als bioorthogonale Reaktionen bezeichnet. Eine der bekanntesten bioorthogonalen 
Reaktionen ist die spannungsgetriebene Azid-Alkin-Cycloaddition (auch bekannt als SPAAC 
oder kupferfreie Klick-Chemie). Diese Reaktion hat viele Wissenschaftler inspiriert nach 
weiteren Reaktionen zu suchen, die sich zur selektiven Markierung von Eiweißen und 
anderen Biomolekülen eignen. Kapitel eins gibt eine Übersicht über die unterschiedlichen 
Anwendungen bioorthogonaler Reaktionen in der Grundlagen- und in der angewandten 
Forschung. 
Kapitel zwei beschreibt die genetische Kodierung der neuen nichtnatürlichen Aminosäure 
Bicyclononin-Lysin (BCN-Lysin). Die pyrrolysyl-tRNA und eine Mutante der pyrrolysyl-
tRNA Synthetase von Methanosarcina mazei wurden benutzt um BCN-Lysin durch die 
Unterdrückung des Amber-Stop-Kodons positionsspezifisch in GFP (grün fluoreszierendes 
Protein) einzubauen. Mit Hilfe eines auf resonantem Fluoreszenzenergietransfer basierenden 
Assays wurden Kinetiken der Reaktion von BCN-markiertem GFP mit Azid- und Tetrazin-
modifizierten fluorogenen Farbstoffen untersucht und verglichen mit einer Aminosäure, die 
eine einfache Cyclooctingruppe besitzt. BCN reagierte ungefähr 10 mal schneller mit Azid-
Tetramethylrhodamin als das einfache Cyclooctin. Die Reaktion mit Tetrazin war 80 mal 
schneller und ist bislang eine der schnellsten Biokonjugationsreaktionen, die beschrieben 
wurden. BCN-Lysin konnte außerdem auch in Proteine in Säugetierzellen eingebaut und dort 
für schnelle Proteinmarkierung verwendet werden. 
Wir haben eine neue Reaktion zur Biokonjugation entwickelt, die auf der Reaktion von 
Chinonen mit Cyclooktinen basiert und die wir strain-promoted oxidation-controlled 
cyclooctyne–1,2-quinone Cycloaddition (SPOCQ) genannt haben. In Kapitel drei 
charakterisieren wir diese Reaktion und zeigen wie sie zur Modifizierung von Peptiden 
und Eiweißen genutzt werden kann. 1,2-Chinone sind relativ leicht zu generieren durch die 
Oxidation des entsprechenden 1,2-Dihydroxybenzols, womit die SPOCQ-Reaktion als eine 
aktivierbare Biokonjugationsreaktion benutzt werden kann. Die Reaktion von 1,2-Chinonen 
mit BCN verläuft viel schneller (k = 496 ± 70 M-1s-1) als die Reaktion von Aziden mit BCN 
(SPAAC). In Kapitel vier wird erläutert, wie wir die SPOCQ-Reaktion zur Herstellung 
von Hydrogelen genutzt haben. Eine nahezu instantane Bildung des Hydrogels konnte 
beobachtet werden, wenn das Oxidationsmittel zu einer wässrigen Lösung von 4-armed 
star-PEG-BCN und 3,4-dihydroxyphenylacetic acid-funktionalisiertem 4-armed star-PEG 
gegeben wurde. Bei Verwendung unterschiedlicher Konzentrationen des Enzyms Mushroom 
Tyrosinase als Oxidationsmittel konnte die Verfestigungszeit des Gels von ein paar Sekunden 
bis hin zu einigen Minuten reguliert werden. Wenn ein Übermaß von star-PEG-BCN zur 
Herstellung der Gele verwendet wurde, konnten wegen des großen Unterschieds in den 
Reaktionsgeschwindigkeiten der SPAAC und SPOCQ Reaktionen Hyrdogele geformt und 
gleichzeitig mit Azid-Gruppen funktionalisiert werden.
In Kapitel fünf war das Ziel, eine neue Art von Impfstoff gegen bakterielle Infektionen 
herzustellen. Mit Hilfe bioorthogonaler Chemie sollte die Außenseite von Bakterien mit Fc 
Proteinen, die den Immunsystem aktivierenden Teil des Antikörpers bilden, dekoriert werden. 
Die Außenseite von Staphylococcus aureus konnte mit Azid-Gruppen funktionalisiert werden, 
wenn die Bakterien in d-azidoalaninehaltigem Medium kultiviert wurden. Der Einbau der Azid-
Gruppen wurde durch Fluoreszenz Mikroskopie und Flow Cytometry mit einem fluoreszierenden 
Cyclooktin-Farbstoff bestätigt Eine enzymatische und eine chemische Methode wurden für 
die positionsspezifische Modifizierung des Fc Proteins mit einer Cyclooktin-Gruppe getestet. 
Die letztere Methode führte zu einer höheren Modifizierungseffizienz. Ein Gel-shift Assay 
zeigte, dass ungefähr 80% der Fc Proteine mit einer Cyclooktin-Gruppe funktionalisiert 
werden konnten. Die Cyclooktin-funktionalisierten Fc Proteine konnten bisher noch nicht 
an die Außenseite der Bakterien gekoppelt werden. Eine mögliche Erklärung hierfür könnte 
eine sterische Blockierung der in der Zellwand von Staphylococcus aureus vorhandenen 
Glycopolymere sein. 
In Kapitel sechs stellen wir einen neuen Workflow zur Anreicherung von Eiweißen für 
Massenspektrometrie-basierte Proteomikstudien vor, der zur Untersuchung von  Protein-
Protein-Interaktionen (PPIs) genutzt werden kann. Häufig wird GFP als Affinitäts-Tag 
zur Anreicherung eines Protein verwendet. GFP wird bei dieser Methode mit dem N- 
oder C-Terminus des jeweiligen Proteins fusioniert. In diesem Kapitel beschreiben wir 
eine alternative Methode, die keine GFP oder Pepitd-Tags benutzt, sondern die Amber-
Unterdrückungstechnologie mit bioorthogonaler Chemie kombiniert um Eiweiße anzureichern. 
Zuerst haben wir die nichtnatürliche Aminosäure azido-Phenylalanin (azF) in das Modelleiweiß 
mCherry-GFP eingebaut. Dann haben wir die Anreicherung diese Modeleiweißes mit kupfer-
katalysierter und kupferfreier Klick-Chemie getestet. Bei der kupfer-katalysierten Klick-
Chemie wurde Präzipitatsbildung beobachtet, wohingegen kupferfreie Klick-Chemie mit 
azadibenzocyclooctin-funktionalisierten Agarose-beads zu einer selektiven Anreicherung von 
Azid-mCherryGFP führte. Als nächstes wurde getestet, ob diese Art der Anreicherung auch zur 
Anreicherung von Interaktoren genutzt werden konnte. Zu diesem Zweck haben wir azF auf 
Position 211 in methyl-CpG-binding domain protein 3 (MBD3), das ein Teil des Nucleosome 
Remodeling and Deacetylase (NuRD) Komplexes ist, eingebaut. Die massenspektrometrische 
Analyse hat gezeigt, dass MBD3 mit zwei bekannten Interaktoren selektiv angereichert 
werden konnte. Dieses Ergebnis zeigt, dass unser neuer Workflow zur Identifikation von PPIs 
genutzt werden kann. Es ist jedoch möglich, dass die Daten von mehreren Mutanten, bei 
denen azF jeweils an einer anderen Position eingebaut wurde, kombiniert werden müssen 
um alle PPIs zu identifizieren. 
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time and good luck for your future! Yvette, jou bedankt voor je inzet bij het vaccine-project, 
wat zeker een complex project was, maar waarin jij je weg hebt gevonden. Succes bij je 
volgende baan! Mark, jij wist nog niet zo veel van de chemie, maar je durfde desondanks ons 
uitdagend Click-MS project aan, waaraan je een belangrijke bijdrage hebt geleverd. Succes 
met je PhD in Wageningen!
I would also like to thank the entire Rutjes group, that has also been a part of the great 
time at the Organic Chemistry department in wing 1 and for the lunches at the hospital. 
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Stefan en Bram, jullie waren de gezellige mede-PhD studenten, met wie ik de ‘stress’ van 
het afronden goed kon delen ;). Bedankt hiervoor! Our lunches, Emilia, were always a nice 
break from a work day full of experiments and running back and forth between NCMLS and 
Huygens. Dani and Abbas, I always enjoyed our chats at work or in the bus/train, you both 
are such cheerful persons. Thanks a lot! Gaston, jou heb ik in mijn eerste jaar Nijmegen 
leren kennen. Nu zit je in de hoofdstad van Nederland en we hebben nog steeds contact, wat 
ik erg leuk vind. Bedankt voor de gezelligheid! Marcel, met jouw ‘Biertje?’-vraag wist ik dat 
het einde van de werkweek weer naderde en het tijd was voor de vrijdagmiddagborrel bij de 
Aesuclaaf ! Many thanks to you, Dani, Maria, Alejandra (muchas gracias), Alberto, Ivan, 
Rens, Torben, Ruud, Lianne, Bastiaan, Bram, Selma, Joep, Peter S., Julia and Caroline 
that made this end-of-the-week-borrel so enjoyable during the last months of my PhD. A big 
‘Thank you’ also goes to the entire BMC department! You were always so helpful and you 
welcomed us (the OC-group) warmly. Thanks for the Tuesday-cakes and the paaslunch! En 
natuurlijk een bedankje aan mijn ‘mede-bioorthogonale-chemie-strijders’: Kim, Selma, Fleur 
en Lianne. Ilmar, jou ook bedankt voor de plezierige gesprekken over vakanties en dergelijke 
en de hulp bij eiwitexpressieproblemen. En Siebe (die nu op de derde zit bij Moleculaire 
Ontwikkelingsbiologie) wil ik ook hartelijk danken voor de hulp met (en het redden van ;) ) de 
FPLC en andere lab-issues. 
Ik wil natuurlijk ook de vaste staff van de afdelingen bedanken voor hun hulp en dat ze 
ervoor zorgen dat alle apparaten werkend blijven. Hans bedankt voor de peptides en de 
peptidecursus, die ik bij jou mocht volgen ;). Jan, hartelijk dank voor je hulp op het lab en 
het beantwoorden van alle chemische vragen. Het SPOCQ-chapter was zeker minder mooi 
geworden zonder de compounds, die jij hebt gemaakt. Helene en Peter, bedankt voor jullie 
hulp bij mass spec-gerelateerde vragen en problemen. Peter, bedankt voor het regelen van 
de bestellingen (van Maxi-Preps tot een step :D)! Ad, Theo, René en Paul jullie ook bedankt 
voor de hulp; met vragen kon ik ook altijd bij jullie terecht. En de vier dames in kamer 03.028: 
Desiree, Paula, Jacky en Marieke. Bedankt voor de kletsmomenten en jullie hulp bij van 
alles en nog wat. Marieke, bedankt voor het regelen van zo veel dingen (en ik was graag je 
tolk voor rare Duitse woorden of gezegdes ;) ). 
En andere plek waar ik vaak te vinden was, was het celkweeklab op de 2de verdieping. Walter 
hielp bij het opzetten van mijn experimenten in het begin van mijn celkweektijd, waar ik hem 
erg dankbaar voor ben. Met vragen over cellen (en het verzoek om mijn cellen door te zetten 
;) ) kon ik altijd bij jou, José, terecht. Jij en Dorine, bedankt dat jullie het celkweeklab altijd 
draaiend houden! En Stephanié bedankt voor de gezelligheid op het kweeklab. Als ik mooie 
plaatjes van cellen moest maken kon ik altijd bij jou, Liesbeth, binnenlopen. Bedankt hiervoor!
During the last four years, I have also worked in other labs because of collaborations, that I 
always enjoyed and that were great experiences! The time at the EMBL was very inspiring 
and motivating. Thank you, Edward, for giving me the opportunity to work in your lab and 
thanks to you and Sigrid for the nice collaboration, the fruitful discussions, and the many 
things I learned from you. Also thanks to Tilman and Carsten and the other members of the 
Lemke lab (Christine, Swati, Nicollo, Gustavo, Jed, and Ivana) for the great time. I really 
appreciate all your help during my stay. I always felt welcome (especially around Easter )!
Marien, jou wil ik ook graag bedanken voor de leuke en prettige samenwerking met LKI. 
Jouw enthousiasme kon ik altijd erg waarderen en meetings met jou waren ook steeds 
extra-motiverend. Als er problemen waren of ik een bepaalde expertise nodig had, kon ik 
altijd bij jou om hulp vragen. Dimitri, jou ook erg bedankt voor de hulp, interesse en de 
inspirerende gesprekken, waar ik veel van heb geleerd. Christa, jij hebt me op het ML-II lab 
geïntroduceerd en jouw Tips & Tricks voor de bacteriële kweek met mij gedeeld (en bijgestaan 
bij het openen van de S.aureus ampullen). Bedankt hiervoor! Het WidM-brainstorming met 
Elles en Erika was ook altijd erg grappig, ook al hadden we het misschien niet altijd goed… 
Elles en Mark bedankt voor het beantwoorden van alle vragen, de hulp bij het FACSen, 
maar ook voor de gezelligheid! Ook bedankt aan Jeroen, Erika en Laurens voor de hulp! 
En natuurlijk dankjewel aan iedereen van LKI en LKO. Jullie waren altijd erg behulpzaam en 
heel vriendelijk, wat de verre weg vanuit het Huygens (op de step) veel minder erg maakte.
Michiel, de samenwerking met jou was heel leuk en leerzaam. Het was super cool dat Arne 
en ik de kans van jou en Jan hebben gekregen om ons Click-MS idee om te zetten. Je 
was altijd erg motiverend en je voelde mee met onze tegenslagen en successen en je hebt 
nooit het vertrouwen in ons idee verloren. Ik bewonder je enthousiaste en goedlachse manier 
waarmee jij je nog jonge maar al succesvolle onderzoeksgroep leidt. Also thanks to Pascal, 
Marijke, Ino, Nelleke, Irem, Susan, Christina, Matthew, Rik, Lisa, Xiaofei and Raghu for 
your help, cookie-times and to temporally adopt me in the Vermeulen-group during the Click-
MS project 
Martijn V., Sander en William, ik heb onze discussies en gesprekken over het onderzoek 
altijd gewaardeerd en wil jullie ook bedanken voor alle suggesties en ideeën!
I also would like to thank Thomas Sakmar, Manija, Sarmistha, Saranga, and Eric. Thomas, 
I was very happy that I got the chance to do my 7-month Master’s internship in your group. 
With Sarmistha as my daily (and patient ;) ) supervisor I learned a lot about research, which 
was so valuable for my own PhD studies. And to top it off: I had the chance to live in NYC  in 
a very nice apartment in Queens with the best landlady ever: Manija! From the first day on you 
and your lovely family were so friendly and helpful. Thank you, without you guys it wouldn’t 
have been the same. Sarmistha and Saranga, thanks for your help and fun times in the lab. 
Eric, thanks for the great (Mexican) parties and proofreading my first review. Good luck in 
Toronto, I am sure you’ll do great! 
Wouter, Anne, Rike, Jan, and Daan: Thanks for the nice dinners, parties and fun times! 
Daan, Wouter en Anne, ik vind het heel leuk dat we elkaar nog regelmatig zien en ik hoop 
dat jullie ook op bezoek komen in Duitsland. Rike, während des Studiums hatten wir schon 
immer viel Spaβ zusammen als de twee Duitse meisjes van MLW und auch während des 
PhDs haben wir uns noch regelmäßig getroffen zum Bijkletsen.
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Natürlich möchte ich mich auch gerne meine Mädels (Sarah, Katharina, Jessica, Katharina 
und Maren) erwähnen, die (trotz der immer größer werdenden Entfernungen) für die nötige 
Ablenkung gesorgt haben bei unseren vielen Klöntreffen oder über Skype. Katharina, Sarah 
und Katharina, bei euch konnte ich den Arbeitsstress, den manchmal eine Promotion mit 
sich bringt, loswerden. Danke! Jessica und Hendrik, danke für euer Interesse, unsere 
Spieleabende, die immer sehr lustig waren, und die gemeinsamen Treffen. 
Plonie en Martin, heel erg bedankt voor jullie interesse en de steun in de afgelopen vier 
jaren! Niet alleen de gezamelijke skivakanties met Familie Vroege zorgden voor de nodige 
ontspanning, maar ook alle andere familiemomenten. Met jullie konden Arne en ik de stress, 
maar ook de vele mooie momenten van het promoveren delen. Maira, Henri, Annelies, Ivo 
en natuurlijk Oma Smits: bedankt voor de support en alle interesse, met die jullie mijn tijd in 
Nijmegen hebben gevolgd. 
Auch ein großes Dankeschön an: Susanne, Axel, Oma, Opa, Brigitte, Charlie, Monika und 
Berti, die immer Interesse gezeigt haben, die sich immer danach erkundigt haben wie es läuft 
und die auch für das Wohlbefinden außerhalb der Arbeit gesorgt haben.
Mama und Papa: vielen, vielen Dank für Alles!! Ihr habt mir so vieles ermöglicht, ihr habt 
mich immer bei all meinen Plänen und Ideen unterstützt und seid immer für mich da! Was mit 
einem Open Dag ;) anfing, wurde zu einem neunjährigen Abenteuer in Nijmegen. Danke für 
euer Interesse und dass ihr immer zugehört habt, egal ob es um missglückte Experimente 
ging oder ich von den coolen Erlebnissen während meiner Promotion erzählt habe. Und 
natürlich auch ein großes Danke an meinen Bruder (den besten großen Bruder, den man 
sich vorstellen kann), der auch in Nijmegen studiert hat und mir schon vor meiner eigenen 
Studienzeit einen kleinen Einblick ins Studentenleben gegeben hat bei den Pubquiz im Irish 
Pub. Danke für deine Unterstützung und Hilfe!
Und das Beste zum Schluss  mein lieber Schatz, den ich während des Studiums 
kennengelernt habe, wofür ich so dankbar bin! Nach unserem gemeinsamen, super tollen NY-
Abenteuer kam auch schon das nächste: die Promotion. Arne, mit dir konnte ich immer die 
Höhen und Tiefen der Promotion teilen. Danke für deine Geduld, dein Verständnis und deine 
Unterstützung! Du stehst immer hinter mir (sogar beim letzten Teil der Promotion, worüber ich 
mich sehr freue). Danke, dass du für mich da bist! Ich liebe dich! Und ich freue mich schon auf 
die gemeinsamen Abenteuer, die noch vor uns liegen. 
